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Abstract
Clinical effectiveness and cost-effectiveness of open and
arthroscopic rotator cuff repair [the UK Rotator Cuff Surgery
(UKUFF) randomised trial]
Andrew J Carr,1* Cushla D Cooper,1 Marion K Campbell,2
Jonathan L Rees,1 Jane Moser,1 David J Beard,1 Ray Fitzpatrick,3
Alastair Gray,3 Jill Dawson,3 Jacqueline Murphy,3 Hanne Bruhn,2
David Cooper2 and Craig R Ramsay2
1Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences,
University of Oxford, Oxford, UK
2Centre for Healthcare Randomised Trials, Health Services Research Unit, University of Aberdeen,
Aberdeen, UK
3Nuffield Department of Population Health, University of Oxford, Oxford, UK
*Corresponding author andrew.carr@ndorms.ox.ac.uk
Background: Uncertainty exists regarding the best management of patients with degenerative tears of the
rotator cuff.
Objective: To evaluate the clinical effectiveness and cost-effectiveness of arthroscopic and open rotator
cuff repair in patients aged ≥ 50 years with degenerative rotator cuff tendon tears.
Design: Two parallel-group randomised controlled trial.
Setting: Nineteen teaching and district general hospitals in the UK.
Participants: Patients (n= 273) aged ≥ 50 years with degenerative rotator cuff tendon tears.
Interventions: Arthroscopic surgery and open rotator cuff repair, with surgeons using their usual and
preferred method of arthroscopic or open repair. Follow-up was by telephone questionnaire at 2
and 8 weeks after surgery and by postal questionnaire at 8, 12 and 24 months after randomisation.
Main outcome measures: The Oxford Shoulder Score (OSS) at 24 months was the primary outcome
measure. Magnetic resonance imaging evaluation of the shoulder was made at 12 months after surgery to
assess the integrity of the repair.
Results: The mean OSS improved from 26.3 [standard deviation (SD) 8.2] at baseline to 41.7 (SD 7.9) at
24 months for arthroscopic surgery and from 25.0 (SD 8.0) at baseline to 41.5 (SD 7.9) at 24 months for
open surgery. When effect sizes are shown for the intervention, a negative sign indicates that an open
procedure is favoured. For the intention-to-treat analysis, there was no statistical difference between the
groups, the difference in OSS score at 24 months was –0.76 [95% confidence interval (CI) –2.75 to 1.22;
p= 0.452] and the CI excluded the predetermined clinically important difference in the OSS of 3 points.
There was also no statistical difference when the groups were compared per protocol (difference in OSS
score –0.46, 95% CI –5.30 to 4.39; p= 0.854). The questionnaire response rate was > 86%. At 8 months,
77% of participants reported that shoulder problems were much or slightly better, and at 24 months this
increased to 85%. There were no significant differences in mean cost between the arthroscopic group and
the open repair group for any of the component resource-use categories, nor for the total follow-up costs
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at 24 months. The overall treatment cost at 2 years was £2567 (SD £176) for arthroscopic surgery and
£2699 (SD £149) for open surgery, according to intention-to-treat analysis. For the per-protocol analysis
there was a significant difference in total initial procedure-related costs between the arthroscopic group
and the open repair group, with arthroscopic repair being more costly by £371 (95% CI £135 to £607).
Total quality-adjusted life-years accrued at 24 months averaged 1.34 (SD 0.05) in the arthroscopic repair
group and 1.35 (SD 0.05) in the open repair group, a non-significant difference of 0.01 (95% CI –0.11 to
0.10). The rate of re-tear was not significantly different across the randomised groups (46.4% and 38.6%
for arthroscopic and open surgery, respectively). The participants with tears that were impossible to repair
had the lowest OSSs, the participants with re-tears had slightly higher OSSs and the participants with
healed repairs had the most improved OSSs. These findings were the same when analysed per protocol.
Conclusion: In patients aged > 50 years with a degenerative rotator cuff tear there is no difference in
clinical effectiveness or cost-effectiveness between open repair and arthroscopic repair at 2 years for the
primary outcome (OSS) and all other prespecified secondary outcomes. Future work should explore new
methods to improve tendon healing and reduce the high rate of re-tears observed in this trial.
Trial registration: Current Controlled Trials ISRCTN97804283.
Funding: This project was funded by the National Institute for Health Research Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 19, No. 80.
See the NIHR Journals Library website for further project information.
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Plain English summary
The rotator cuff is a group of muscles and tendons that control shoulder movement. Degenerative tearsof the tendons are a common cause of shoulder pain and dysfunction and some patients may be
offered surgery to repair the tear if non-surgical treatment has been unsuccessful.
The UK Rotator Cuff Surgery (UKUFF) trial was designed with patient involvement to assess the best
surgical technique for repairing rotator cuff tears. Two different surgical approaches are currently used:
open surgery, in which the tendons are reattached to bone under direct vision through a normal surgical
incision, and arthroscopic surgery, in which small incisions allow thin metal tubes containing surgical
cameras and instruments to be used to carry out the repair. It is unclear which technique produces the
best and most cost-effective outcome for patients.
Patients were asked to participate in the study in 47 different hospitals around the UK and were assigned
to have either open surgery or arthroscopic surgery.
Patients involved in the study were followed up with telephone and postal questionnaires asking if their
symptoms had changed after surgery for 2 years and with a magnetic resonance imaging scan at 1 year to
see if the repair had been successful.
Generally, patients in the study benefited from a significant improvement in their symptoms and the rate
of complications was very low, even though 40% of the repairs had not healed.
The results of the study show that both open and arthroscopic types of surgery are equally effective and
cost-effective in treating shoulder pain and function in patients with rotator cuff tear.
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Scientific summary
Background
Painful shoulders are a significant socioeconomic burden; disability of the shoulder can result in time off
work and impair the ability to work or perform household tasks. Shoulder problems account for 2.4% of
all general practitioner (GP) consultations in the UK and 4.5 million visits to physicians annually in the USA.
More than 300,000 surgical repairs for rotator cuff pathologies are performed annually in the USA, where
the annual financial burden of shoulder pain management has been estimated to be US$3B. The most
frequent indications for surgery are persistent and severe pain combined with functional restrictions that
are resistant to conservative treatment. Open surgery involves the rotator cuff being repaired under direct
vision through an incision in the skin. Arthroscopic surgery involves the repair being performed through
smaller arthroscopic portals with a camera used to visualise the operative site on a monitor. There is
conflicting evidence regarding the effectiveness of open and arthroscopic repair. It has been suggested
that arthroscopic rotator cuff surgery may have advantages over standard open techniques by causing less
trauma to the deltoid muscle and overlying soft tissue. Arguably, this causes less postoperative patient
discomfort and allows an earlier return of movement. However, the success of the repair depends partly
on the ability of the surgeon to achieve a secure attachment of tendon to bone. This may be more easily
and reliably achieved by open surgery. Other potential disadvantages of the arthroscopic approach include
longer time in the operating room and greater use of costly equipment.
Objective
To determine the effectiveness and cost-effectiveness of open compared with arthroscopic rotator cuff repair.
Methods
Eligible patients were those for whom care had been provided by a participating surgeon, who were
deemed suitable for rotator cuff repair surgery and for whom the surgeon was uncertain which surgical
procedure was better. In addition, patients had to be aged ≥ 50 years, have symptoms from a degenerative
full-thickness rotator cuff tear and be able to give informed consent. Surgery was either arthroscopic
(fixation of tendon to bone using only arthroscopic techniques) or open (fixation to bone under direct vision
through a surgically created opening in the deltoid muscle). The precise technique and method of fixation
were not prescribed and surgeons used their preferred and usual technique. The primary outcome measure
was the Oxford Shoulder Score (OSS), completed at 24 months after randomisation. The primary measure
of cost-effectiveness was the incremental cost per quality-adjusted life-year (QALY). The secondary outcome
measures were used to assess functional outcome and patient health-related quality of life. These assessed
a range of symptoms often experienced with rotator cuff tears, for example pain, weakness and a loss of
function. The measures used included the Shoulder Pain and Disability Index (SPADI), the Mental Health
Inventory 5 (MHI-5), the European Quality of Life-5 Dimensions (EQ-5D), participants’ ratings of how
pleased they were with shoulder symptoms at 12 and 24 months after randomisation, patients’ views of
the overall state of their shoulder at 8, 12 and 24 months after randomisation and intraoperative and
postoperative surgical complications at 2 and 8 weeks post surgery and 12 and 24 months after
randomisation. All patients who underwent a rotator cuff repair were assessed with magnetic resonance
imaging (MRI) or high-definition ultrasound imaging at 12 months after surgery by an experienced clinician
blinded to the treatment group. The sample size was designed to detect a difference in OSS score of 0.38
of a standard deviation (SD) for the comparison of arthroscopic surgery with open surgery. Initially, a
conservative comparator (rest then exercise) was included, but because of high rates of crossover to surgery
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(77%) this arm was closed down and the trial was reconfigured to a randomised comparison of open and
arthroscopic repair. An additional 173 patients from 28 further centres formed surgeon preference groups
(91 arthroscopic repair and 82 open repair) and were followed up in the same way.
Results
Nineteen centres throughout the UK recruited to the randomised open surgery and randomised arthroscopic
surgery comparison and a further 28 centres recruited to the preference groups where surgeons performed
either only open repair or only arthroscopic repair. Recruitment to the trial began on 9 November 2007
and finished on 28 February 2012, although not all centres enrolled over the total period because of the
staggered introduction of centres (range 6–39 months from the first to the last participant randomised).
Tears were small or medium in size (< 3 cm) in about 75% of participants. The average age of the
participants was 63 years, 40% were female and 90% were right-handed. The mean time that the
participants had had the shoulder problem before surgery was approximately 2.5 years. There were no
substantive differences within or between the groups for any of the sociodemographic factors. The mean
OSS was 25.7 across the groups. The EQ-5D, MHI-5 and SPADI measures were not significantly different
across and within the groups.
Only around 9% of the participants had received no previous treatment to their shoulder. Previous
treatments primarily included physiotherapy and/or cortisone injections. The high frequency of previous
conservative treatment probably explains the difficulty in achieving a comparison of a further programme
of conservative care, the rest-then-exercise programme, in the context of a pragmatic trial in 47 centres
during routine NHS care.
Of the 137 participants randomised to receive open surgical management, 85 (62.0%) underwent an open
repair of a tear and five (3.6%) an arthroscopic repair. Of the 136 patients randomised to receive
arthroscopic surgical management, 100 (73.5%) received arthroscopic surgery but only 63 (46.3%)
received an arthroscopic repair; nine (6.6%) began as an arthroscopic procedure and converted to open
surgery. The size of tear and surgical completeness were similar between the randomised groups. The ease
of repair, although broadly similar, was reported to be easier in the open procedure (18% of arthroscopic
repairs were determined by the surgeon to be easy to perform vs. 36% of the open repairs). Only 162 of
273 (59%) patients randomised to surgery underwent cuff repair. In total, 59 of 273 (22%) withdrew
while on the waiting list, with the most common reasons for this being improvement in symptoms and the
development of other medical conditions, and 52 of 273 (19%) underwent subacromial decompression
and no cuff repair, with the most common reasons for this being that no tear was found or that the tear
was impossible to repair.
The mean operation time in minutes was statistically significantly lower in the open procedure group
[–12.2, 95% confidence interval (CI) –21.4 to –3.0; p= 0.010], as was mean total time in theatre in
munites (–12.7, 95% CI –23.5 to –1.9; p= 0.021). The number of intraoperative adverse events was
generally low. There were 11 (8.1%) participants with any intraoperative complication in the randomised
arthroscopic group compared with nine (6.6%) in the open group. The difference was not statistically
significant (difference 3.1%, 95% CI –4.8% to 11.0%; p= 0.190). Post operation, three participants in the
arthroscopic group and three in the open group required inpatient hospitalisation as a result of taking part
in the trial. The inpatient admissions were as a result of two participants in each group requiring revision
surgery and a single participant in each group having a postoperative complication. One complication was
a deep infection requiring formal debridement and vacuum pump application. The patient had this surgery
after 3 weeks of treatment by his GP with antibiotics. The other complication involved a participant
requiring a longer stay in hospital for a continuous interscalene block in the shoulder for postoperative
pain relief and some bleeding during surgery. All complications and revision surgeries were managed
within 17 months of randomisation. There were no deaths related to the surgery.
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At 2 weeks post surgery very few participants reported being pain free and approximately two-thirds were
taking painkillers. Of those participants who were employed, about 80% were still off sick. At 8 weeks the
results were similar, with the exception that those who reported no or mild pain increased from 35% to
50%, with an apparent concomitant effect of reducing painkiller use from 66% to 55% and increasing
the number of participants returning to usual work (none or a little interference) from 28% to 55%. There
were no clinically important differences between or within the groups at either 2 or 8 weeks.
Outcomes at 8, 12 and 24 months were primarily obtained from questionnaire returns. The return rates
were similar across groups and ranged from 90% at 8 and 12 months to 86% at 24 months. The OSS
increased markedly from baseline (mean 25.7) to 8 months (mean 36.5) and continued to increase
thereafter (at a much slower rate) to 24 months (mean 41.5). The groups followed a similar pattern with
regard to the EQ-5D, SPADI and MHI-5. At 8 months, 77% of participants reported that shoulder
problems were much or slightly better, and this increased to 85% at 24 months. When asked how pleased
the participants were with their shoulder symptoms, 77% on average were very or fairly pleased at
8 months, and this increased to 83% by 24 months. Again, the groups responded in a similar manner.
The mean OSS improved from 26.3 (SD 8.2) at baseline to 41.7 (SD 7.9) at 24 months for arthroscopic surgery
and from 25.0 (SD 8.0) at baseline to 41.5 (SD 7.9) at 24 months for open surgery for the intention-to-treat
(ITT) analysis. There was no statistically significant difference between the groups. When effect sizes are shown
for the intervention, a negative sign indicates that an open procedure is favoured. For the ITT analysis there
was no statistical difference between the groups, the difference in OSS score at 24 months was –0.76 (95% CI
–2.75 to 1.22; p= 0.452) and the CI excluded the predetermined clinically important difference in the OSS of
3 points. There was also no statistically significant difference when the groups were compared per protocol
(difference in OSS score –0.46, 95% CI –5.30 to 4.39; p= 0.854). The rate of re-tear was 46.4% in the
arthroscopy group and 38.6% in the open group (p= 0.256). In the non-randomised groups the rates were
36.6% for arthroscopic repair and 35.0% for open repair. These differences were not significant. A healed
repair (a participant having no tear on the MRI assessment at 12 months) resulted in the greatest improvement
in the OSS. In the randomised group the OSS improved from 26.3 (SD 8.2) at baseline to 44.5 (SD 4.1) for the
arthroscopic group and from 25.0 (SD 8.0) to 43.6 (SD 5.8) for the open group. The next best results for OSS
were for the repaired tears that re-tore, which improved to 41.8 (SD 8.8) in the arthroscopic group and 40.8
(SD 7.6) in the open group. The worst OSS results were seen for the tears that were impossible to repair,
which improved to 37.3 (SD 6.1) in the arthroscopic group and 33.8 (SD 9.5) in the open group. The results
were similar for the non-randomised groups.
Recognising that caution must be used when interpreting the per-protocol group, we nevertheless note
that the lack of important differences between the arthroscopic and the open ITT groups was also
observed in the per-protocol data.
Economic evaluation
For the base-case ITT analysis (without adjustment for covariates) there were no significant differences in
mean costs between the arthroscopic repair group and the open repair group for any of the component
resource-use categories, nor for the total follow-up costs at 12 months or 24 months. The total cost of
surgery alone (excluding nights in hospital) was significantly different between the two groups, at £463
(95% CI £260 to £660) more costly for arthroscopic repair. Total QALYs accrued at 2 years averaged 1.34
(SD 0.04) in the arthroscopic repair group and 1.35 (SD 0.04) in the open repair group. The overall
treatment cost at 2 years was £2567 (SD £176) for arthroscopic surgery and £2699 (SD £149) for open
surgery by ITT analysis. Neither the difference in costs nor the difference in quality-of-life outcomes were
statistically significant between the arthroscopic repair group and the open repair group.
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Overall, arthroscopic repair was less costly but less effective than open repair in the base-case analysis,
resulting in a point estimate for the incremental cost-effectiveness ratio of £30,001 per QALY gained.
The probability of arthroscopic repair being less costly than open repair was 75%, and the probability of it
being more effective than open repair was 45%.
Comparison with similar randomised trials
The trial was considered in relation to the only other randomised clinical trial of open compared with
arthroscopic rotator cuff repair published in 2013. This was a single-centre study of 100 patients with small
and medium tears with unblinded follow-up to 1 year using the Disabilities of the Arm, Shoulder and Hand
score. This trial also reported no difference in outcome between the groups. It did not include a health
economic analysis.
Conclusions
In patients aged ≥ 50 years with a degenerative rotator cuff tear there was no difference in effectiveness or
cost-effectiveness between open and arthroscopic repair at 2 years for the primary outcome (OSS) and all
other prespecified secondary outcomes. Rotator cuff surgery resulted in marked improvement in symptoms
(OSS 25.7/48 at baseline to 41.5/48 at 2 years). A healed repair gave the best outcome, followed by a repair
that subsequently re-tore. The worst outcome was in patients whose tear was unrepairable at surgery.
Re-tears were found in 93 of 233 (40%) patients who underwent repair surgery, with no difference
between the open group and the arthroscopic group. Re-tears occurred after repairs to all tear sizes and
the risk of re-tear was not influenced by age.
Implications for health care
Rotator cuff surgery results in a significant improvement in symptoms in patients who have completed a
programme of conservative care with symptom duration of > 12 months and there is no difference in
clinical effectiveness or cost-effectiveness between open and arthroscopic rotator cuff repair. There is no
evidence of an effect of age or tear size on clinical outcome. The overall re-tear rate was 40%, with no
difference between the groups. The statistically significant treatment effect seen in all patients, including
those in whom a repair was not possible or in whom there was a postoperative re-tear, suggests that there
are other treatment effects. Per protocol the costs of arthroscopic surgery were significantly greater than
those of open surgery. This is largely because of the longer operating time.
Recommendations for research
This unique study cohort provides the opportunity to determine the longer-term consequences of rotator
cuff tear and repair. There is a case for continuing the follow-up of the patients who underwent surgery
and who had a repair that healed, re-tore or was impossible to repair. There is early evidence at 2 years’
follow-up that these groups have different outcomes. It is important to know whether these differences
remain in the longer term and whether or not particular groups are prone to further deterioration.
There is a need to evaluate cost-effectiveness over a longer period than 24 months, using further follow-up
data from this study and elsewhere on the longer-term consequences of rotator cuff tear and repair.
It would be of value to explore the basis of the treatment effect seen with a randomised controlled trial of
rotator cuff repair compared with placebo surgery.
SCIENTIFIC SUMMARY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xxiv
Trial registration
This trial is registered as ISRCTN97804283.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Introduction
This report describes the results of the UK Rotator Cuff Surgery (UKUFF) trial assessing the clinicaleffectiveness and cost-effectiveness of arthroscopic compared with open rotator cuff repair for people
with full-thickness rotator cuff tears. This comparison was commissioned and funded by the National
Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme. The trial began in
2007 and initially also included a non-operative comparator of a rest-then-exercise programme. However,
because of high crossover from the rest-then-exercise group to surgery, the trial was reconfigured in 2010
to a comparison of arthroscopic and open repair only.
Rotator cuff tear
The prevalence of shoulder complaints in the UK is estimated to be 14%, with 1–2% of adults consulting
their general practitioner (GP) annually regarding new-onset shoulder pain.1 Rotator cuff pathology,
including tendonitis, calcific tendonitis and rotator cuff tears, reportedly accounts for up to 70% of shoulder
pain problems.2 Painful shoulders pose a substantial socioeconomic burden. Disability of the shoulder can
impair the ability to work or perform household tasks and can result in time off work.3,4 Shoulder problems
account for 2.4% of all GP consultations in the UK and 4.5 million visits to physicians annually in the USA.5,6
More than 300,000 surgical repairs for rotator cuff pathologies are performed annually in the USA, where
the annual financial burden of shoulder pain management has been estimated to be US$3B.7
Rotator cuff pathology is associated with progressive change in the shape of the acromion, with ‘spurs’
forming at its anteroinferior margin. Some reports suggest that these spurs narrow the subacromial space,
thereby making physical contact more likely in certain positions of the arm. This is most notable in abduction
and elevation of the arm and is sometimes referred to as ‘painful arc’ or impingement because pain is
maximal in the mid-range of movement. This process is argued to result in inflammation of the rotator cuff
tendons (particularly the supraspinatus tendon) and the overlying subacromial bursa. A conflicting theory
suggests that such mechanisms are not causative and that intrinsic age-related degeneration of the tendon
is the main determinant of inflammation and symptoms.8,9
Rotator cuff tear refers to structural failure in one or more of the four muscles and tendons that form the
rotator cuff. Any tear that does not extend all the way through the tendon is termed a partial-thickness
tear. Asymptomatic full-thickness tears of the rotator cuff are very common in the general population.
It is estimated that the overall prevalence of tears is 34% and that risk increases significantly with age.10
Partial tears are more prevalent than full-thickness tears.11
Conservative management
Conservative treatment may include rest, exercise, topical non-steroidal anti-inflammatory drugs (NSAIDs),
oral corticosteroids, oral paracetamol, opioid analgesics, physiotherapy, activity modification, acupuncture,
platelet-rich plasma injections, extracorporeal shockwave therapy, suprascapular nerve block, laser treatment,
autologous blood injections, intra-articular NSAID injections, subacromial corticosteroid injections, electrical
stimulation, ice and ultrasound.
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A search of MEDLINE, EMBASE and The Cochrane Library up to August 2009 for treatment of shoulder
pain was undertaken.12 Harm alerts from relevant organisations, such as the US Food and Drug
Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA), were
included. The review found 71 systematic reviews, randomised controlled trials (RCTs) or observational
studies that met the inclusion criteria. Grading of Recommendations Assessment, Development and
Evaluation (GRADE) of the quality of evidence for interventions was performed.2 It is not known whether
topical NSAIDs, oral corticosteroids, oral paracetamol or opioid analgesics improve shoulder pain, although
oral NSAIDs may be effective in the short term in people with acute tendonitis/subacromial bursitis. If pain
control fails, the diagnosis should be reviewed and other interventions considered. Physiotherapy may
improve pain and function in people with mixed shoulder disorders compared with placebo. Platelet-rich
plasma injections may improve the speed of recovery in terms of pain and function in people having open
subacromial decompression for rotator cuff impingement, but further evidence is needed. Acupuncture
may not improve pain or function in people with rotator cuff impingement compared with placebo or
ultrasound. Extracorporeal shockwave therapy may improve pain in calcific tendonitis. There is some
evidence that suprascapular nerve block, laser treatment, arthroscopic subacromial decompression and
rotator cuff repair may be effective in some people with shoulder pain. There is no evidence to support the
use of autologous blood injections, intra-articular NSAID injections, subacromial corticosteroid injections,
electrical stimulation, ice or ultrasound. Concern exists regarding the potential longer-term damaging
consequences of corticosteroid injection.13
Role of imaging
Imaging is most useful in directing treatment in secondary care if conservative care has failed. A large
proportion of the general population will demonstrate abnormalities on imaging of the rotator cuff.14
Imaging findings need to be interpreted in the context of symptoms, disability and response to treatment.
A high proportion of patients with rotator cuff pain will respond to conservative treatment.15 The only
reliable non-interventional method of determining if a rotator cuff tear has healed is use of postoperative
imaging, either magnetic resonance imaging (MRI) or ultrasonography.
Surgical management
The most frequent indications for surgery are persistent and severe pain combined with functional
restrictions that are resistant to conservative measures. Symptoms of pain and weakness typically disrupt
daily activities and night pain affects sleep. Symptoms of a minimum of 3 months’ duration that are
sufficiently severe to disrupt daily activities and rest or sleep and failure of standard conservative care
(analgesics, rest and physiotherapy and cortisone injection) are usually required before surgery is considered.
Surgical repair may be advised in cases of full-thickness rotator cuff tear with persistent pain and weakness
after conservative treatment. A rotator cuff repair operation aims to reattach the torn tendons to the
humeral bone. In general, two approaches are available for surgical repair. Open surgery involves
the rotator cuff being repaired under direct vision through an incision in the skin. Arthroscopic surgery is
keyhole surgery and involves the repair being performed through arthroscopic portals into the shoulder.
A subacromial decompression (SAD) or acromioplasty to create space around the repaired tendon is usually
performed in association with the tendon repair. Reports of the outcome of such surgery are conflicting
and evidence for effectiveness is unclear.16–18 An assessment of the treatment cost of impingement suggests
that the addition of surgery, in comparison with exercise treatment alone, is not cost-effective.19
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Comparative studies of subacromial decompression and non-operative treatment options such as
physiotherapy have not shown any significant difference in outcome between the two treatment
modalities.20–23 A growing number of studies have tried to assess the effectiveness of subacromial
decompression against a control. Three studies of patients undergoing rotator cuff repair, including or
excluding subacromial decompression in their operative treatment, did not demonstrate any difference in
outcome between the groups.24–26 A RCT of subacromial decompression plus subacromial bursectomy
compared with bursectomy alone reported no significant difference in clinical outcome between the two
groups. This finding suggests that removing acromial spurs might not be necessary.27
The management of partial tears is particularly controversial and patients with such tears have commonly
been treated conservatively. Favourable results have been reported following debridement of partial tears in
association with subacromial decompression.28 Higher rates of re-rupture are associated with repairs of
larger tears, increased patient age and increased fatty degeneration of the cuff muscles.29–32 Partial tears are
most commonly managed without repair, but some authors advocate repair to prevent progression to
full-thickness tears. The evidence supporting this approach is weak.11 There is also uncertainty regarding the
relative value of conservative care, repair surgery and debridement surgery for large and massive tears.33–36
High failure rates of 13–68% have been reported for surgical repair of rotator cuff tears, irrespective of the
surgical technique employed.37–39 Some studies have suggested that re-rupture rates are associated with
poorer outcomes.40 Surgical decision-making in the management of rotator cuff tears was reviewed by
Dunn et al.41 They surveyed surgeons in the USA and found considerable variation in decision-making. This
included the type of surgery, the surgical techniques employed and the type and duration of conservative
treatment, including cortisone injections, physiotherapy, rest, analgesia and home exercises. Rates of
medical visits for rotator cuff pathology in the USA were reviewed between 1996 and 2006. The volume of
rotator cuff repairs had increased by 141% and the unadjusted number of arthroscopic repairs increased by
600% compared with a 34% increase in open repairs.42 The volume of arthroscopic subacromial
decompressions has also increased significantly over time. Recent figures from the USA report a 240%
increase (from 30.0 to 101.9 per 100,000 people per year) in use of the procedure in New York state
between 1996 and 2006.43 This compares to a 78.3% increase in ambulatory orthopaedic surgery overall.
Similar increases have recently been reported in the UK.44 The introduction of less invasive arthroscopic
techniques accounts for some of the overall increased rate of surgery, but does not explain regional
variation. Patient and disease characteristics have not changed over time and there is a growing concern
that this procedure is being overused. Observational studies of subacromial decompression surgery show
positive results in terms of pain reduction and functional outcome, with high patient satisfaction rates.
However, equally good outcomes have been noted in two studies following patients who had arthroscopic
rotator cuff debridement or open rotator cuff repair in the absence of a subacromial decompression.
Rationale for the study design
The objective of the original commissioned call was to conduct a pragmatic multicentre randomised clinical
trial to obtain good-quality evidence of the effectiveness and cost-effectiveness of conservative care
compared with arthroscopic surgical repair compared with open surgical repair for the treatment of
degenerative rotator cuff tears. Because of high crossover from the conservative arm to surgery the study
was reconfigured to a comparison of the two surgical techniques only. There is conflicting evidence
regarding the effectiveness of open and arthroscopic repair.12,45–47 Proponents of arthroscopic rotator cuff
surgery suggest that the procedure may have advantages over standard open techniques by causing less
trauma to the deltoid muscle and overlying soft tissue. Arguably, this causes less postoperative patient
discomfort together with earlier return of movement. However, the success of the repair depends partly on
the ability of the surgeon to achieve a secure attachment of tendon to bone. This may be more easily and
reliably achieved by open/mini-open surgery. Other potential disadvantages of the arthroscopic approach
include increased technical difficulty and longer time in theatre. There is a need to compare the outcomes
of the two surgical techniques.
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Literature update since the call
A review updating the literature published since the original commissioned call was undertaken to inform
this report and set the results in context. Only reports of RCTs were included. Quasi-RCTs, which use
methods of allocating participants to a treatment that are not strictly random, for example date of birth,
hospital record number or alternation, were excluded.
Types of participants
Randomised controlled trials of adults aged ≥ 18 years with a degenerative rotator cuff tear as reported in
the primary studies (e.g. confirmed by physical examination, MRI, ultrasound or MRI arthrogram) were
included. RCTs of adults undergoing surgery for other types of rotator cuff disease, shoulder instability,
joint replacement or fractures were excluded.
Types of interventions
All randomised comparisons between a surgical procedure (e.g. open or arthroscopic) and another surgical
procedure for treating rotator cuff tear were included. Randomised comparisons between a surgical procedure
and a non-surgical procedure (e.g. physiotherapy, drug therapy) were also included. RCTs in which the primary
aim was to compare different types of surgical technique (e.g. different suturing techniques) as part of the
surgical repair of the rotator cuff were excluded.
Types of outcome measures
The primary outcome for each RCT and time point when measured, as reported by the authors, was
recorded. When reported by the authors, the primary outcome was that used for the calculation of the
sample size. Primary outcomes included pain, disability or function measured using shoulder-specific
instruments such as the Constant score,48 American Shoulder and Elbow Surgeons (ASES) Shoulder
Score49 or the Disabilities of the Arm, Shoulder and Hand (DASH) score.50
Search methods for identification of studies
We searched Ovid MEDLINE from 2006 to March 2014 for possible reports of RCTs. The search strategy used
was based on one developed by Coghlan et al.16 for a Cochrane review of surgery for rotator cuff disease.
This search strategy was modified to account for changes to the medical subject heading (MeSH) terms since
the original search was conducted in 2006, the addition of free-text terms and the replacement of the original
RCT filter used with the Cochrane sensitivity- and precision-maximising version RCT filter [2008 version;
see http://handbook.cochrane.org/chapter_6/box_6_4_b_cochrane_hsss_2008_sensprec_pubmed.htm
(accessed 23 August 2015)] (see Appendix 4 for search strategy). We also searched the World Health
Organization (WHO) International Clinical Trials Registry Platform51 to identify reports of any ongoing RCTs.
One author screened the titles and abstracts of all retrieved records. Full articles were then obtained for any
potentially eligible studies and assessed using the predefined eligibly criteria described earlier.
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Results
Description of studies
The search strategy identified 477 potentially eligible studies. Of these, eligible studies were identified as
those comparing a surgical intervention with another surgical intervention and those comparing a surgical
intervention with a non-surgical intervention.
Surgery compared with surgery
Six RCTs26,52–56 comparing a surgical intervention with another surgical intervention were identified
(Table 1). Of these six trials, one RCT56 is ongoing, with completed recruitment but final results awaiting
publication. Two other trials57,58 were identified comparing two different types of surgical intervention;
however, these were excluded as the patients were not randomised.
Of the five completed RCTs,26,52–55 three were single-centre studies and all were relatively small, ranging
from 73 to 114 participants per trial, with a mean participant age between 57 and 60 years. Four RCTs
included participants with full-thickness rotator cuff tears26,52,54,55 and one included participants with small
and medium rotator cuff tears.53 The type of surgical interventions differed between trials, with one RCT
comparing arthroscopic repair with mini-open repair,53 one comparing mini-open repair arthroscopic
acromioplasty with open surgical repair55 and three comparing arthroscopic with acromioplasty repair with
arthroscopic without acromioplasty repair.26,52,54 The choice of primary outcome also varied across studies
and included pain, disability or function measured using shoulder-specific instruments. Four26,52,54,55 of the
five completed RCTs reported blinded assessment of these outcomes. Overall, no RCT showed a statistically
significant difference between the two types of surgical intervention being compared.
Surgery compared with non-surgery
Three RCTs59–61 comparing a surgical intervention with a non-surgical intervention were identified, of which
one61 is ongoing, having completed recruitment but with final results awaiting publication (Table 2).
Of the two completed RCTs, one59 was a multicentre study and both were relatively small, ranging from
103 to 173 participants per trial, with a participant age of between 60 and 65 years. One RCT59 was a
three-arm trial comparing open surgical repair, acromioplasty and physiotherapy with acromioplasty and
physiotherapy and physiotherapy alone. This trial found no statistically significant difference between
the interventions being compared at 1 year based on the Constant shoulder score.48 The other RCT60
compared open surgical repair (or mini-open repair) with physiotherapy and found a statistically significant
difference in favour of surgery at 1 year based on the Constant shoulder score.48
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Chapter 2 Methods
A t the outset (July 2007) the UKUFF study had two complementary components [UKUFF originalResearch Ethics Committee (REC) reference number 07/Q1606/49]:
1. a multicentre, pragmatic RCT comparing open and arthroscopic surgical treatments with a
non-operative programme of rest then exercise to assess their relative clinical effectiveness
2. an economic evaluation of the treatments to compare the cost-effectiveness of the management
streams, identify the most efficient provision of future care and describe the resource impact that
various policies for surgical rotator cuff repair would have on the NHS.
Eligible patients who consented to participate in the study were randomly allocated to arthroscopic
surgery, open surgery or a programme of rest then exercise. Participants completed patient-reported
outcome measures (PROMs) at baseline and then at 8, 12 and 24 months post randomisation.
Questionnaires were also completed by telephone at 2 and 8 weeks post treatment. For those patients
randomised to surgery, who had a complete repair of the rotator cuff, MRI or an ultrasound scan was also
performed 12 months after their surgery.
Randomisation in the original study design was organised within three strata depending on surgeons’
stated preparedness to randomise. A detailed survey of the members of the British Elbow & Shoulder
Society (BESS) was conducted in preparation for this study. This survey showed that, at the time, only
around 15% of surgeons regularly undertook arthroscopic surgery. Of the surgeons who regularly
performed arthroscopic surgery, only 8% indicated that they would be prepared to randomise between
surgical treatments. The remainder were happy to randomise between arthroscopic surgery and the
rest-then-exercise programme. The majority of surgeons indicated that they performed only open surgery.
Surgeons who performed only open surgery did not appear to have equipoise for open surgery compared
with arthroscopic surgery.
Reflecting this lack of individual uncertainty around certain comparisons, the trial was designed such that
surgeons could randomise between:
l stratum A – arthroscopic surgery compared with open surgery compared with rest then exercise
l stratum B – arthroscopic surgery compared with rest then exercise
l stratum C – open surgery compared with rest then exercise.
Reconfigured study design
A high rate of crossover (77%) of the 214 patients in the rest-then-exercise programme to surgery was
observed and so the trial was adapted and reconfigured on the instruction of the funder in 2009 after
consultation with the Trial Steering Committee (TSC) and the Data Monitoring Committee (DMC).
Crossover did not occur at a consistent or predictable time point. The reconfigured design was a two-way
parallel-group RCT of open compared with arthroscopic rotator cuff repair (UKUFF reconfigured REC
reference number 10/H0402/24, April 2010). At the time of reconfiguration there were 131 participants in
stratum A (n= 43, arthroscopic surgery; n= 44, open surgery; and n= 44, rest then exercise), 181 in
stratum B (n= 91, arthroscopic surgery; and n= 90, rest then exercise) and 162 in stratum C (n= 82,
open surgery; and n= 80, rest then exercise). The 87 patients already randomised between arthroscopic
and open surgery (stratum A) were carried through to the subsequent reconfigured trial. After the
reconfiguration it was calculated that a further 180 patients should be recruited and followed up for 2 years
as per the original protocol, leading to a total of 267 patients treated with surgery.
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During the period between 2007 and 2010, surgical opinion had changed and an increased number of
surgeons were in equipoise between open and arthroscopic surgery. The UKUFF trial was reconfigured as a
pragmatic multicentre study involving 20 surgeons from 16 UK centres; 15 of these surgeons had originally
recruited to stratum A.
Patient and public involvement and engagement
From the outset patients were involved and engaged in the design of the trial. A patient representative
(D Farrar-Hockley) was a member of the group designing the trial. He subsequently became a member of
the TSC.
Interventions
Conservative care
For the original study a conservative regime of rest then exercise was developed. In view of the lack of
evidence for type or dose of exercise therapy, a consensus approach was adopted with input from five
physiotherapists, all with expertise and publications in shoulder physiotherapy. It was anticipated that most
patients would have already undergone physiotherapy before referral to a surgeon and therefore further
similar treatment would not be appropriate. In addition, there was a need for standardisation across a
large geographical area and number of locations over a considerable period of time. It was decided to
deliver, by post, a high-quality booklet to patients in their own home with an accompanying compact disc (CD)
showing moving images. Information was given regarding rotator cuff tears and general and specific exercise
options. The package included a sling, with advice to start with relative shoulder rest, using the sling if
necessary, and to then start exercising. A free telephone helpline was available with physiotherapy expertise.
However, because of the high crossover rate to surgery (77%), this treatment arm was discontinued in the
reconfigured trial.
Surgery and surgeons
Surgery was either arthroscopic (fixation of tendon to bone using only arthroscopic techniques) or open
(fixation to bone under direct vision through a surgically created opening in the deltoid muscle). The
precise technique and method of fixation were not prescribed and surgeons used their preferred and usual
technique. Details of the surgical technique used, including the method of repair and theatre equipment
used (e.g. types of anchor), were recorded on a standard form (see Appendix 5), as well as the size of the
tear, the ease of repair and the completeness of the repair. If circumstances dictated that the allocated
surgical technique could not be carried out then any alternative procedure was recorded.
Participating surgeons required a ‘minimum level of expertise’ for the types of surgery undertaken. Only
consultant orthopaedic shoulder surgeons with a minimum of 2 years’ experience in consultant practice
could participate. Surgeons had to perform a minimum of five cases per year. The participating surgeons
represented a cross-section of high-, medium- and low-volume practitioners from both general hospitals and
teaching hospitals. Because of the nature of the study’s NHS setting, some patients recruited to the UKUFF
study had their surgery performed by non-UKUFF surgeons. The trial accepted data from patients who
were recruited by a UKUFF surgeon but who went on to have their surgery performed by a colleague of the
same or similar experience and position or by a supervised senior trainee. An assessment of the surgeons’
position and experience was made by the chief investigator. NIHR local research networks provided help
with patient identification, recruitment and obtaining any required data from patient notes. Patient eligibility
was confirmed by the local consultant orthopaedic surgeons.
METHODS
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Study population
Eligible patients were those for whom care had been provided by a participating surgeon and who were
deemed suitable for rotator cuff repair surgery, with the surgeon uncertain which surgical procedure was
better. In addition, patients had to be aged ≥ 50 years, have symptoms from a degenerative full-thickness
rotator cuff tear and be able to give informed consent.
Study registration/consent to randomise
Recruitment of patients occurred through a two-step process. A patient’s eligibility was assessed by the
local consultant orthopaedic surgeon, who introduced the trial to the patient using a prompt sheet
and a patient assessment form. If the patient was interested in participating, the surgeon then provided
the patient with a copy of the patient information sheet (see Appendix 6), which summarised what the
study involved and answered any questions the patient might have.
If the patient was willing to enter the trial then an initial consent form was signed, which allowed
the patient’s details to be forwarded to the central study office in Oxford. The office then issued to the
participant, by post, an invitation letter, the comprehensive patient information sheet (see Appendix 6), a
consent form and a baseline questionnaire (see Appendix 7) with a prepaid return envelope. Patients were
encouraged to contact the office or their surgeon if they had any further questions or concerns. Patients
who had not returned their questionnaire and consent form within a week were telephoned by a member
of the study team in Oxford. This contact allowed the patient to ask questions about the study and
permitted the team to assess whether the patient was still willing to participate. When the full consent
form and baseline questionnaire had been returned to the Oxford office the patient then officially entered
the trial and was randomised to one of the surgical options. A copy of the signed consent form was
returned to the patient.
Randomisation was by computer allocation using the service provided by the Centre for Healthcare
Randomised Trials (CHaRT) at the Health Services Research Unit, University of Aberdeen. Allocation was
minimised using surgeon, age and size of tear. After randomisation the participant was considered
irrevocably part of the trial for the purpose of the research, irrespective of what occurred subsequently.
Outcomes
The primary outcome measure was the Oxford Shoulder Score (OSS)62 completed at 24 months after
randomisation. The OSS is a 12-item shoulder-specific PROM that was developed, with patients, for the
assessment of shoulder pain and function in the context of shoulder surgery, particularly in trials. Items
refer to the past 4 weeks and each offers five ordinal response options. Originally, these were scored
from 1 to 5 (5=most severe) and then summed to produce a summary score ranging from 12 to 60.
Subsequently, the recommended method of scoring was changed.63 Under the new system, each item on
the OSS is scored from 0 to 4, with 4 representing the best outcome (i.e. the opposite direction from the
original method of scoring). When the 12 items are summed, this produces an overall score ranging from
0 to 48, with 48 being the best outcome. The OSS has been demonstrated to be reliable, valid, responsive
and very acceptable to patients.
The primary measure of cost-effectiveness was the incremental cost per quality-adjusted life-year (QALY).
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The secondary outcome measures were used to further assess functional outcome and patient health-related
quality of life. These assessed a range of symptoms often experienced with rotator cuff tears, for example
pain, weakness and loss of function. These included:
l Shoulder Pain and Disability Index (SPADI)64 at 8, 12 and 24 months after randomisation. The SPADI is
a self-administered questionnaire, developed by a panel of rheumatologists and a physiotherapist, to
measure shoulder pain and disability in an outpatient setting.64 It contains 13 items that assess two
domains: shoulder pain (five items) and disability (eight items), all with reference to the last week. The
original version scored each item on a visual analogue scale (VAS). A second version, used in this trial,
replaced the VAS with a 0–10 numerical rating scale.65 Item responses within each subscale are
summed and transformed to a score out of 100. A mean is taken of the two subscales to give a total
score out of 100, with a higher score indicating greater impairment or disability. The SPADI is reliable,
valid and responsive.64
l Mental Health Inventory 5 (MHI-5)66 at 8, 12 and 24 months after randomisation. The MHI-5 is the mental
health subscale of the Short Form questionnaire-36 items (SF-36) generic health status measure.67 It
contains five items that address anxiety, depression, loss of behavioural or emotional control and
psychological well-being, all with reference to the past 4 weeks. Each item offers responses on a 6-point
scale (ranging from ‘all of the time’ to ‘none of the time’). The total score is calculated by reversing the
answers to two items (the third and fifth), summing the scores, and transforming the raw scores to a scale
ranging from 0 to 100. A higher score indicates better mental health. The MHI-5 has been demonstrated to
be good at detecting major depression, affective disorders generally and anxiety disorders.66
l European Quality of Life-5 Dimensions three levels (EQ-5D-3L)65,68 at 8, 12 and 24 months after
randomisation. The EQ-5D-3L is a standardised generic instrument for use as a self-completed measure
of health outcome. It provides a simple descriptive profile and a single index value for health status that
can be used in the clinical and economic evaluation of health care, as well as population health
surveys, and consists of five items on mobility, self-care, pain, usual activities and psychological status,
with three possible answers for each item (1= no problem, 2=moderate problem, 3= severe problem).
The response for each item/domain is converted to a quality-of-life estimate using an algorithm
(see Chapter 6 for further details) to produce an index score for each patient. Negative scores represent
health states worse than death, 0 represents the state of worst health and 1.00 represents full health.
l The OSS62 completed at 8 and 12 months after randomisation.
l Participants’ view of the overall state of their shoulder compared with an earlier time point (‘transition
item’) at 8, 12 and 24 months after randomisation. There were five possible responses to this item:
‘much better’, ‘slightly better’, ‘no change’, ‘slightly worse’ or ‘much worse’.
l Participants’ rating of how pleased they were with their shoulder symptoms at 12 and 24 months after
randomisation. There were four possible responses to this item: ‘very pleased’, ‘fairly pleased’, ‘not very
pleased’ or ‘very disappointed’.
l Surgical complications (intra- and postoperative) at 2 and 8 weeks post surgery and at 12 and
24 months after randomisation.
l 12-month postoperative imaging.
Data collection
Outcome assessment was conducted using questionnaires that participants self-completed and, as such,
interviewer bias and clinical rater bias were avoided. This form of outcome measurement has consistently
performed well compared to clinician-based assessments and general health status measures. All
participants, including those who had withdrawn from their allocated intervention but who still wished to
be involved in the study, were followed up, with analysis based on the intention-to-treat (ITT) principle.
Participants received questionnaires at the following time points:
l baseline (see Appendix 7) – questionnaire completed before randomisation
l 2 and 8 weeks post treatment (see Appendix 8) – questionnaire completed by telephone
l 8, 12 and 24 months post randomisation (see Appendix 9) – questionnaire completed by post.
METHODS
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The baseline and 12 and 24 months’ post-randomisation questionnaires also incorporated a section that
measured cost-effectiveness. This included questions relating to primary care consultations, other
consultations, out-of-pocket costs and the work impact of the intervention received.
The study team based at the Health Services Research Unit, University of Aberdeen, contacted participants
whose questionnaires had not been returned. In the first instance this was through a reminder letter by
post or e-mail, depending on participant preference. If a questionnaire had still not been returned within
the specified time frame, the study team telephoned the participant and addressed any administrative
issues that may have arisen, such as change of address or loss of questionnaire. If any clinical issues were
identified, the study team in Oxford contacted participants, if appropriate, and addressed these issues.
The time period allocated to the follow-up checks depended on which outcome assessment was involved.
Magnetic resonance imaging and ultrasound scans
Postoperative imaging was performed on patients who had undergone a repair. It was not performed if a
repair was either impossible to perform or when no tear was found. Both the MRI and the ultrasound
scans were undertaken locally to the participant and were arranged by the study office in Oxford, at a time
agreed by the trust and the participant. The scans were collected centrally. The MRI scans were reported
by an independent consultant radiologist who was blinded to the type of surgery that was performed.
Because of the operator-dependent nature of the ultrasound scans, an independent report on these was
not valid. The report obtained from the site was used to determine the tear status. Any re-tears were not
reported to the participating surgeons, so that no deviation occurred from their normal practice.
Statistical analysis of outcomes
Statistical analyses were based on all people randomised, irrespective of subsequent compliance with the
randomised intervention. The principal comparison was all those allocated arthroscopic surgery compared
with all those allocated open surgery. When an effect size is shown for the intervention, a negative sign on
the effect size indicates that an open procedure is favoured over an arthroscopic procedure.
Reflecting the possible clustering in the data, the outcomes were compared using repeated-measures
mixed models with centre as a random effect and with adjustment for minimisation variables (size of tear
and age) and participant baseline values (when available) as fixed effects. Statistical significance was at the
5% level, with corresponding confidence intervals (CIs) derived. All participants remained in their allocated
group for analysis (ITT).
Preplanned subgroup analyses on the primary outcome included exploration of tear size (small/medium vs.
large/massive) and age (≤ 65 years vs. > 65 years); these analyses were conducted by including a subgroup
by treatment interaction term in the primary outcome model described above. Conservative levels of
statistical significance (p< 0.01) were sought, reflecting the exploratory nature of these subgroup analyses.
Non-response analysis
Descriptive data comparing the baseline characteristics of participants who did and did not respond at
24 months were displayed. The t-test (continuous outcomes) and chi-squared test (dichotomous outcomes)
were used to estimate the statistical significance of the differences between responders and non-responders.
Sensitivity analysis: treatment received (per protocol)
Reflecting the level of non-compliance, the effect on the primary outcome of those participants who actually
received an arthroscopic or open repair was estimated. In an open trial design a per-protocol analysis can
have substantial selection bias. To minimise the effects of selection bias we used the instrumental variable
approach as described by Nagelkerke et al.69 The method used a two-stage least-squares approach whereby
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treatment randomised was regressed onto treatment received and the residuals from that model were
used as an independent variable in a second model, together with the treatment received, to estimate the
effects on the primary outcome measure. As with the ITT analysis, the model also adjusted for centre,
minimisation variables (age, size of tear) and baseline OSS score.
Learning curve
The main analyses adjusted for centre effects and therefore adjusted for the majority of differences
between centres. Learning effects may, however, be present in the trial (i.e. the surgeon’s performance
improves throughout the trial). To test for these effects a covariate for each surgeon was developed that
indicates the increasing surgeon experience in the trial (e.g. first patient randomised= 1; second= 2, etc.).
This covariate was used in subsequent adjusted analyses to measure the size of the trend in effects
over time.
Health economics methods
A cost-effectiveness analysis was performed. A simple patient cost-related questionnaire was sent out at
baseline and at 12 and 24 months post randomisation to obtain information on primary care consultations,
other consultations, out-of pocket costs, the work impact of the intervention received and return to work
(when relevant). Although longer intervals between questionnaires may result in recall errors (in particular
under-reporting of health-care use70) more frequent data collection can result in a higher proportion of
missing responses, which introduces uncertainty. It has been argued that there is no optimal interval for
self-reported data collection70 and as such the timing of questionnaire distribution was chosen to coincide
with those for the clinical study outcomes. Unit costs came from national sources and participating
hospitals. The patient questionnaire was also used to administer the European Quality of Life-5 Dimensions
(EQ-5D), which was obtained at baseline. The main health economic outcome was within-trial and
extrapolated QALYs, estimated using the EQ-5D.71
Incremental cost-effectiveness was calculated as the net cost per QALY gained for arthroscopic surgery
compared with open surgery. Power calculations (see following section) were based on clinical effectiveness
rather than cost-effectiveness outcomes, which were estimated rather than used in hypothesis testing.
Cost-effectiveness ratios and acceptability curves were calculated.
An important component of this trial was the assessment of cost. Therefore, obtaining an accurate record
of procedures at each of the proposed centres was essential. To evaluate the costs of each type of surgery,
information was collected from the operating theatres. Resources used, equipment costs and standard
procedures for rotator cuff repairs were examined. Per-case information was also analysed. A checklist of
equipment, consumables, implants, time and staff utilised during each case was completed by theatre
staff. Information from theatres was collected by the Oxford office and used in a cost comparison of the
arthroscopic and open surgery approaches.
Sample size
In the original UKUFF trial, with three randomised strata, the sample size was constructed to detect a
difference in the OSS 24-month postoperative score of 0.38 of a standard deviation (SD) for the
comparison between arthroscopic surgery and open surgery at 80% power. We did not propose any
amendment to that clinically important difference in the reconfigured study. This defined difference was
based on our experience of developing the OSS score and using it in a variety of settings; a 3-point score
difference (0.33 of a SD) was deemed a clinically important difference. In the original UKUFF trial, the
detectable difference of 0.38 was constructed by combining evidence from a direct randomised
comparison with indirect (non-randomised) comparison data from the other strata. Incorporating indirect
effects is a suboptimal approach to measuring effectiveness because unmeasured confounders can bias the
outcomes. The proposed change in this proposal was to achieve the detectable difference of 0.38 of a SD
METHODS
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by direct randomised comparison data only at 85% power. As described earlier, such an approach was
feasible by 2010 because of the increased number of surgeons in equipoise between the arthroscopic
approach and the open approach.
Attrition was expected to be low (10%), as were the effects of clustering of outcomes by surgeon
[intracluster correlation (ICC) < 0.03].72,73 Although we did not have a direct estimate from a shoulder trial,
other orthopaedic data sets available to our team support this low ICC estimate. Both of these factors
required the sample size to be inflated; however, the primary analysis adjusted for baseline OSS score,
which conversely allowed the sample size to be decreased by a factor of (1 – correlation squared).74 Our
previous studies showed that the correlation in the OSS score pre surgery to 6 months post surgery in
patients similar to the potential trial participants was 0.57. Assuming a conservative correlation of 0.5
implied that the sample size could be reduced by 25% and still maintain the same power. Therefore, a
study with a total of 267 participants would still have 85% power to detect a clinically important
difference in each comparison, assuming that attrition and clustering accounted for approximately 25%
of variation in the data.
Data monitoring
An independent DMC met on four occasions and did not recommend any fundamental changes to
the protocol. The decision in 2009 to reconfigure the trial was made by the NIHR HTA programme. The
committee did not meet after recruitment was completed.
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Chapter 3 Description of the study population
This chapter describes the derivation of the populations that took part in the UKUFF study, the characteristicsof the participants at presurgical assessment and the baseline characteristics of included participants.
Recruitment to the study
Participants were recruited in 47 clinical centres, all within the UK (Table 3). Nineteen centres recruited to the
randomised arthroscopic surgery and randomised open surgery comparison (referred to as the stratum A
comparison). Thirteen of these centres also randomised participants to stratum A prior to reconfiguration of
the study in December 2010 (see Chapter 2). Twenty centres recruited to stratum B (arthroscopic surgery vs.
rest then exercise) and 18 to stratum C (open surgery vs. rest then exercise). A total of 660 participants
were recruited to the study, with 317 in stratum A (n= 136, allocated to arthroscopic surgery; n= 137,
allocated to open surgery; and n= 44, allocated to rest then exercise prior to reconfiguration), 181 in
stratum B (n= 91, allocated to arthroscopic surgery; and n= 90, allocated to rest then exercise prior to
reconfiguration) and 162 in stratum C (n= 82, allocated to open surgery; and n= 80, allocated to rest then
exercise prior to reconfiguration). Table 3 shows recruitment by centre. No centre contributed more than
12% of participants to stratum A. Recruitment to the trial began on 9 November 2007 and continued until
28 February 2012, although not all centres enrolled over the total period because of the staggered
introduction of centres and early closure for reconfiguration of the study (range 6 months to 39 months
from first to last participant randomised in stratum A). Data were closed to follow-up on 31 December 2013.
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Study conduct
The derivation of the main study groups and their progress through the stages of follow-up in the trial is shown
in Figure 1 This is in the form of a Consolidated Standards of Reporting Trials (CONSORT) flow diagram. In
total, 811 patients were considered for trial entry and 38 (5%) of these were found not to meet one or more
of the eligibility criteria. Of the 111 patients eligible for the study but not recruited, 84 declined to participate
and the remaining 27 could not be randomised while the study underwent reconfiguration (because of the
requirement for new research ethics and research and development approvals). Two participants were
excluded post randomisation because each had received previous surgery prior to randomisation. Details of
the clinical management actually received are provided in Chapter 4. The median [interquartile range (IQR)]
time intervals in days between randomisation by the trial office and each subsequent follow-up are shown in
Table 4; all were similar between groups, as would be expected. The 2-week and 8-week follow-ups were
timed to occur at 2 weeks and 8 weeks after surgery. Table 5 illustrates the success of this strategy in the
subgroup of participants who did receive a surgical procedure.
The overall rates of return of follow-up questionnaires at 8, 12 and 24 months were equivalent to > 85%
of the study participants allocated to surgery (see Figure 1). There were no substantive differences in
response rates between the surgery groups. Seven participants are known to have died by the end of the
2-year follow-up. There was no evidence that these deaths were linked to trial participation.
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NIHR Journals Library www.journalslibrary.nihr.ac.uk
22
Assessed for eligibility
(n = 811)
Patients randomised
(n = 662)
Randomisation
Post-randomisation exclusions
(n = 2)
Ineligible (n = 38)
Declined to participate (n = 84)
Assessed but not recruited (n = 27)
Follow-up at 
24 months after
randomisation
Response, n = 117
Non-response, 
n = 13
Withdrawal, n = 4
Deceased, n = 2
OSS, n = 114
Follow-up at 
24 months after
randomisation
Response, n = 118
Non-response, 
n = 14
Withdrawal, n = 4
Deceased, n = 1
OSS, n = 115
Follow-up at 
24 months after
randomisation
Response, n = 34
Non-response, 
n = 6
Withdrawal, n = 4
OSS, n = 34
Follow-up at 
24 months after
randomisation
Response, n = 79
Non-response, 
 n = 6
Withdrawal, n = 3
Deceased, n = 3
OSS, n = 78
Follow-up at 
24 months after
randomisation
Response, n = 64
Non-response, 
n = 17
Withdrawal, n = 9
OSS, n = 64
Follow-up at 
24 months after
randomisation
Response, n = 75
Non-response, 
n = 6
Deceased, n = 1
OSS, n = 75
Follow-up at 
24 months after
randomisation
Response, n = 57
Non-response, 
n = 13
Withdrawal, n = 10
OSS, n = 56
Follow-up at 
12 months after
randomisation
Response, n = 123
Non-response, 
n = 10
Withdrawal, n = 2
Deceased, n = 1
Follow-up at 
12 months after
randomisation
Response, n = 123
Non-response, 
n = 11
Withdrawal, n = 3
Follow-up at 
12 months after
randomisation
Response, n = 37
Non-response, 
n = 3
Withdrawal, n = 4
Follow-up at 
12 months after
randomisation
Response, n = 84
Non-response, 
n = 7
Follow-up at 
12 months after
randomisation
Response, n = 67
Non-response, 
n = 16
Withdrawal, n = 7
Follow-up at 
12 months after
randomisation
Response, n = 76
Non-response, 
n = 5
Deceased, n = 1
Follow-up at 
 12 months after
randomisation
Response, n = 62
Non-response, 
n = 10
Withdrawal, n = 8
Follow-up at 
8 months after
randomisation
Response, n = 121
Non-response, 
n = 12
Withdrawal, n = 2
Deceased, n = 1
Follow-up at 
8 months after
randomisation
Response, n = 127
Non-response, 
n = 8
Withdrawal, n = 2
Follow-up at 
8 months after
randomisation
Response, n = 39
Non-response, 
n = 2
Withdrawal, n = 3
Follow-up at 
8 months after
randomisation
Response, n = 85
Non-response, 
n = 6
Follow-up at 
8 months after
randomisation
Response, n = 69
Non-response, 
n = 16
Withdrawal, n = 5
Follow-up at 
8 months after
randomisation
Response, n = 75
Non-response, 
n = 6
Deceased, n = 1
Follow-up at 
8 months after
randomisation
Response, n = 62
Non-response, 
n = 10
Withdrawal, n = 8
Follow-up at 
8 weeks after 
surgery
Response, n = 97
Non-response, 
n = 37
Withdrawal, n = 1
Deceased, n = 1
Follow-up at 
8 weeks after 
surgery
Response, n = 113
Non-response, 
n = 24
Follow-up at 
8 weeks after 
surgery
Response, n = 40
Non-response, 
n = 4
Follow-up at 
8 weeks after 
surgery
Response, n = 70
Non-response, 
n = 21
Follow-up at 
8 weeks after 
surgery
Response, n = 65
Non-response, 
n = 23
Withdrawal, n = 2
Follow-up at 
8 weeks after 
surgery
Response, n = 58
Non-response, 
n = 24
Follow-up at 
8 weeks after 
surgery
Response, n = 56
Non-response, 
n = 20
Withdrawal, n = 4
Follow-up at 
2 weeks after 
surgery
Response, n = 94
Non-response, 
n = 42
Follow-up at 
2 weeks after 
surgery
Response, n = 112
Non-response, 
n = 25
Follow-up at 
2 weeks after 
surgery
Response, n = 26
Non-response, 
n = 18
Follow-up at 
2 weeks after 
surgery
Response, n = 70
Non-response, 
n = 21
Follow-up at 
2 weeks after 
surgery
Response, n = 61
Non-response, 
n = 29
Follow-up at 
2 weeks after 
surgery
Response, n = 71
Non-response, 
n = 11
Follow-up at 
2 weeks after 
surgery
Response, n = 55
Non-response, 
n = 25
Stratum A
Allocated to
arthroscopic
surgery
(n = 136)
Received 
allocated 
procedure
(n = 100)
Received 
allocated repair
(n = 63)
Stratum A
Allocated to open
surgery
(n = 137)
Received 
allocated 
procedure
(n = 85)
Received 
allocated repair
(n = 85)
Stratum A
Allocated to rest
then exercise
(n = 44)
Received only RtE
(n = 5)
Completed RtE 
and surgery
(n = 24)
Received surgery
before 
completing
RtE (n = 14)
Withdrawn
intervention
(n = 1)
Stratum B
Allocated to
arthroscopic
surgery
(n = 91)
Received 
allocated
procedure
(n = 74)
Received 
allocated repair
(n = 50)
Stratum B
Allocated to rest
then exercise
(n = 90)
Received only RtE
(n = 16)
Completed RtE 
and surgery
(n = 31)
Received surgery
before 
completing
RtE (n = 36)
Withdrawn
intervention
(n = 7)
Stratum C
Allocated to open
surgery
(n = 82)
Received 
allocated
procedure
(n = 40)
Received 
allocated repair
(n = 40)
Stratum C
Allocated to rest
then exercise
(n = 80)
Received only RtE
(n = 15)
Completed RtE 
and surgery
(n = 33)
Received surgery
before 
completing
RtE (n = 27)
Withdrawn
intervention
(n = 5)
FIGURE 1 Consolidated Standards of Reporting Trials (CONSORT) diagram. RtE, rest then exercise.
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TABLE 4 Median (IQR) number of days between randomisation and follow-up
Follow-up
Stratum A Stratum B Stratum C
Arthroscopic
(n= 136)
Open
(n= 137)
Rest then
exercise
(n= 44)
Arthroscopic
(n= 91)
Rest then
exercise
(n= 90)
Open
(n= 82)
Rest then
exercise
(n= 80)
2 weeks 99
(65–137)
97
(65–134)
93
(63–126)
82
(62–108)
99
(65–126)
87
(60–129)
101
(75–126)
8 weeks 135
(105–169)
139
(102–178)
149
(114–181)
126
(106–152)
134
(110–162)
142
(107–177)
141
(113–167)
8 months 231
(227–248)
230
(227–236)
232
(228–244)
231
(227–248)
232
(227–245)
229
(227–239)
234
(228–246)
12 months 374
(369–387)
373
(369–383)
371
(369–389)
374
(370–383)
375
(369–389)
371
(368–378)
372
(369–386)
24 months 737
(733–745)
736
(733–745)
740
(734–754)
738
(734–754)
739
(733–754)
736
(734–752)
736
(733–746)
TABLE 5 Median (IQR) number of days between surgery and follow-up
Follow-up
Stratum A Stratum B Stratum C
Arthroscopic (n= 100) Open (n= 114) Arthroscopic (n= 74) Open (n= 68)
2 weeks 14 (14–16) 14 (14–15) 14 (14–16) 14 (14–15)
8 weeks 56 (56–59) 56 (56–58) 57 (56–61) 57 (56–60)
8 months 161 (117–194) 155 (122–188) 169 (147–201) 164 (122–197)
12 months 307 (258–336) 296 (262–335) 316 (292–342) 306 (259–333)
24 months 656 (620–693) 654 (622–699) 682 (647–708) 672 (623–712)
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Description of the groups at trial entry
Clinical assessment at baseline
Table 6 displays the results of the presurgical assessment at recruitment. Approximately two-thirds of the
tears were diagnosed using ultrasound. Tears were small or medium in about 75% of the participants in
strata A and C and in 58% of participants in stratum B. Within the randomised groups there were no
apparent imbalances. Around 10% of participants had received no previous treatment to their shoulder.
Previous treatments primarily included physiotherapy and/or cortisone injections.
TABLE 6 Clinical assessment at baseline
Assessment
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Rest then
exercise
(n= 44)
Arthroscopic
(n= 91)
Rest then
exercise
(n= 90)
Open
(n= 82)
Rest then
exercise
(n= 80)
Size of tear
Small/medium 103 (75.7) 103 (75.2) 34 (77.3) 53 (58.2) 52 (57.8) 62 (75.6) 62 (77.5)
Large/massive 33 (24.3) 34 (24.8) 10 (22.7) 38 (41.8) 38 (42.2) 20 (24.4) 18 (22.5)
Method of diagnosing tear
MRI 41 (30.1) 36 (26.3) 9 (20.5) 20 (22.0) 20 (22.2) 19 (23.2) 12 (15.0)
Ultrasound 87 (64.0) 93 (67.9) 32 (72.7) 64 (70.3) 60 (66.7) 60 (73.2) 56 (70.0)
Missing 8 (5.9) 8 (5.8) 3 (6.8) 7 (7.7) 10 (11.1) 3 (3.7) 12 ( 15.0)
Received no treatment
on shoulder in the last
5 years
15 (11.0) 10 (7.3) 2 (4.5) 9 (9.9) 9 (10.0) 3 (3.7) 8 (10.0)
Received physiotherapy on affected shoulder in the last 5 years
Yes 77 (56.6) 83 (60.6) 28 (63.6) 54 (59.3) 64 (71.1) 59 (72.0) 49 (61.3)
No 41 (30.1) 38 (27.7) 10 (22.7) 22 (24.2) 21 (23.3) 12 (14.6) 23 (28.8)
Missing 18 (13.2) 16 (11.7) 6 (13.6) 15 (16.5) 5 (5.6) 11 (13.4) 8 (10.0)
Duration of physiotherapy (weeks)
≤ 4 17 (22.1) 20 (24.1) 7 (25.0) 10 (11.0) 13 (20.3) 16 (27.1) 10 (20.4)
5–12 24 (31.2) 22 (26.5) 11 (39.3) 15 (16.5) 18 (28.1) 17 (28.8) 13 (26.5)
> 12 19 (24.7) 21 (25.3) 8 (28.6) 21 (23.1) 19 (29.7) 16 (27.1) 13 (26.5)
Missing 17 (22.1) 20 (24.1) 2 (7.1) 45 (49.5) 14 (21.9) 10 (16.9) 13 (26.5)
Received an injection in affected shoulder in the last 5 years
Yes 79 (58.1) 83 (60.6) 30 (68.2) 52 (57.1) 46 (51.1) 59 (72.0) 53 (66.3)
No 40 (29.4) 35 (25.5) 9 (20.5) 25 (27.5) 34 (37.8) 14 (17.1) 21 (26.3)
Missing 17 (12.5) 19 (13.9) 5 (11.4) 14 (15.4) 10 (11.1) 9 (11.0) 6 (7.5)
continued
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TABLE 6 Clinical assessment at baseline (continued )
Assessment
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Rest then
exercise
(n= 44)
Arthroscopic
(n= 91)
Rest then
exercise
(n= 90)
Open
(n= 82)
Rest then
exercise
(n= 80)
Number of injections
1 34 (43.0) 35 (42.2) 14 (46.7) 26 (50.0) 24 (52.2) 25 (42.4) 21 (39.6)
2 21 (26.6) 29 (34.9) 8 (26.7) 13 (25.0) 10 (21.7) 17 (28.8) 16 (30.2)
3 10 (12.7) 10 (12.0) 4 (13.3) 9 (17.3) 5 (10.9) 8 (13.6) 6 (11.3)
4 3 (3.8) 2 (2.4) 1 (1.9) 2 (4.3) 2 (3.4) 3 (5.7)
5 2 (2.5) 1 (1.2) 1 (3.3) 2 (3.4) 1 (1.9)
6 1 (1.3) 3 (3.6) 1 (1.9) 1 (2.2) 1 (1.9)
7 1 (1.3) 1 (1.7) 1 (1.9)
9 1 (1.7)
10 1 (1.9)
Missing 7 (8.9) 3 (3.6) 3 (10.0) 1 (1.9) 4 (8.7) 3 (5.1) 4 (7.5)
Received other treatment on the affected shoulder in the last 5 years
Yes 18 (13.2) 28 (20.4) 5 (11.4) 5 (5.5) 2 (2.2) 16 (19.5) 13 (16.3)
No 72 (52.9) 61 (44.5) 20 (45.5) 43 (47.3) 48 (53.3) 36 (43.9) 32 (40.0)
Missing 46 (33.8) 48 (35.0) 19 (43.2) 43 (47.3) 40 (44.4) 30 (36.6) 35 (43.8)
Other treatment
Acupuncture 2 (11.1) 5 (17.9) 3 (60.0) 3 (60.0) 5 (31.3) 5 (38.5)
Analgesics 6 (33.3) 13 (46.4) 1 (20.0) 1 (6.3)
Chiropractor 3 (16.7) 2 (7.1) 1 (20.0) 5 (31.3) 2 (15.4)
Exercises 2 (7.1) 1 (50.0)
Hydrotherapy 2 (11.1)
Massage 1 (6.3)
Nerve block 1 (5.6)
Osteopathy 1 (3.6) 1 (50.0) 1 (6.3) 2 (15.4)
TENS 1 (5.6) 2 (7.1) 1 (20.0) 1 (6.3)
Ultrasound 1 (3.6) 3 (23.1)
Missing 3 (16.7) 2 (7.1) 1 (20.0) 2 (12.5) 1 (7.7)
Are there any problems with other shoulder?
No problems 84 (61.8) 86 (62.8) 27 (61.4) 49 (53.8) 64 (71.1) 47 (57.3) 49 (61.3)
Mild problems 32 (23.5) 29 (21.2) 9 (20.5) 24 (26.4) 11 (12.2) 23 (28.0) 22 (27.5)
Moderate problems 11 (8.1) 12 (8.8) 3 (6.8) 14 (15.4) 11 (12.2) 9 (11.0) 7 (8.8)
Severe problems 4 (2.9) 5 (3.6) 2 (4.5) 2 (2.2) 3 (3.3) 1 (1.2)
Missing 5 (3.7) 5 (3.6) 3 (6.8) 2 (2.2) 1 (1.1) 2 (2.4) 2 (2.5)
TENS, transcutaneous electrical nerve stimulation.
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Participant and sociodemographic factors
Participant and sociodemographic characteristics are shown in Table 7. The average age of the participants
was 63 years, 40% were female and 90% were right-handed. The mean period of time that the
participants reported having the shoulder problem prior to surgery was approximately 2.5 years; however,
the mean was driven by a few extreme values in each group relating to participants who had had shoulder
problems for decades. The median (IQR) time that the participants had had the shoulder problem prior
to recruitment was 1.2 (0.7–2.5) years. There were no substantive differences within or between strata on
any of the sociodemographic factors.
TABLE 7 Participant and sociodemographic characteristics at baseline
Characteristic
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Rest then
exercise
(n= 44)
Arthroscopic
(n= 91)
Rest then
exercise
(n= 90)
Open
(n= 82)
Rest then
exercise
(n= 80)
Age (years), n, mean (SD) 136, 62.9
(7.1)
137, 62.9
(7.5)
44, 62.9
(7.5)
91, 65.7
(7.9)
90, 64.7
(8.0)
82, 61.9
(6.5)
80, 61.3
(6.8)
Years with shoulder
problem, n, mean (SD)
136, 2.6
(5.3)
137, 2.5
(4.1)
43, 2.0
(2.7)
90, 2.5
(3.4)
87, 2.2
(3.3)
82, 2.7
(4.7)
79, 2.3
(2.6)
Sex
Male 81 (59.6) 88 (64.2) 28 (63.6) 53 (58.2) 63 (70.0) 49 (59.8) 51 (63.8)
Female 55 (40.4) 49 (35.8) 16 (36.4) 36 (39.6) 27 (30.0) 33 (40.2) 29 (36.3)
Missing 2 (2.2)
Handedness
Right-handed 125 (91.9) 115 (83.9) 40 (90.9) 83 (91.2) 78 (86.7) 66 (80.5) 66 (82.5)
Left-handed 7 (5.1) 17 (12.4) 1 (2.3) 8 (8.8) 9 (10.0) 11 (13.4) 8 (10.0)
Both 4 (2.9) 5 (3.6) 2 (4.5) 3 (3.3) 4 (4.9) 5 (6.3)
Missing 1 (2.3) 1 (1.2) 1 (1.3)
Highest qualification
None 63 (46.3) 59 (43.1) 23 (52.3) 39 (42.9) 37 (41.1) 34 (41.5) 25 (31.3)
Secondary 41 (30.1) 49 (35.8) 16 (36.4) 37 (40.7) 38 (42.2) 33 (40.2) 41 (51.3)
Higher 32 (23.5) 27 (19.7) 5 (11.4) 12 (13.2) 12 (13.3) 15 (18.3) 12 (15.0)
Missing 2 (1.5) 3 (3.3) 3 (3.3) 2 (2.5)
Housing tenure
Home owner 107 (78.7) 119 (86.9) 34 (77.3) 78 (85.7) 78 (86.7) 69 (84.1) 68 (85.0)
Private rent 7 (5.1) 1 (0.7) 3 (6.8) 3 (3.3) 2 (2.2) 5 (6.1) 4 (5.0)
Council rent 17 (12.5) 9 (6.6) 5 (11.4) 7 (7.7) 7 (7.8) 5 (6.1) 2 (2.5)
Other 4 (2.9) 8 (5.8) 2 (4.5) 2 (2.2) 2 (2.2) 3 (3.7) 5 (6.3)
Missing 1 (0.7) 1 (1.1) 1 (1.1) 1 (1.3)
continued
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TABLE 7 Participant and sociodemographic characteristics at baseline (continued )
Characteristic
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Rest then
exercise
(n= 44)
Arthroscopic
(n= 91)
Rest then
exercise
(n= 90)
Open
(n= 82)
Rest then
exercise
(n= 80)
Lives alone
Yes 23 (16.9) 12 (8.8) 6 (13.6) 15 (16.5) 19 ( 21.1) 14 (17.1) 12 (15.0)
No 101 (74.3) 118 (86.1) 34 (77.3) 74 (81.3) 67 (74.4) 66 (80.5) 64 (80.0)
Missing 12 (8.8) 7 (5.1) 4 (9.1) 2 (2.2) 4 (4.4) 2 (2.4) 4 (5.0)
Employment status
Full-time 47 (34.6) 58 (42.3) 12 (27.3) 22 (24.2) 30 (33.3) 28 (34.1) 35 (43.8)
Part-time 18 (13.2) 15 (10.9) 7 (15.9) 13 (14.3) 10 (11.1) 13 (15.9) 8 (10.0)
Homemaker 4 (2.9) 5 (3.6) 3 (3.3) 2 (2.4)
Retired 59 (43.4) 54 (39.4) 22 (50.0) 52 (57.1) 45 (50.0) 36 (43.9) 32 (40.0)
Unemployed 7 (5.1) 4 (2.9) 3 (6.8) 1 (1.1) 5 (5.6) 3 (3.7) 4 (5.0)
Missing 1 (0.7) 1 (0.7) 1 (1.3)
Type of work
Manual 36 (55.4) 41 (56.2) 12 (63.2) 22 (62.9) 27 (67.5) 24 (58.5) 24 (55.8)
Non-manual 26 (40.0) 28 (38.4) 6 (31.6) 12 (34.3) 11 (27.5) 16 (39.0) 15 (34.9)
Not sure 3 (4.6) 3 (4.1) 1 (5.3) 1 (2.9) 1 (2.5) 1 (2.4) 3 (7.0)
Missing 1 (1.4) 1 (2.5) 1 (2.3)
Off sick or working reduced duties
Yes, off sick 7 (10.8) 6 (8.2) 3 (15.8) 2 (5.7) 5 (12.5) 3 (7.3) 4 (9.3)
Yes, working reduced
duties
10 (15.4) 7 (9.6) 5 (26.3) 5 (14.3) 8 (20.0) 9 (22.0) 8 (18.6)
No 45 (69.2) 58 (79.5) 11 (57.9) 28 ( 80.0) 27 (67.5) 29 (70.7) 31 (72.1)
Missing 3 (4.6) 2 (2.8)
Would you be able to do your job or everyday activities with your arm in a sling?
No 70 (51.5) 76 (55.5) 18 (40.9) 51 (56.0) 48 (53.3) 41 (50.0) 43 (53.8)
Yes, with difficulty 62 (45.6) 59 (43.1) 19 (43.2) 39 (42.9) 35 (38.9) 39 (47.6) 31 (38.8)
Yes, no difficulty 3 (2.2) 1 (0.7) 4 (9.1) 1 (1.1) 2 (2.2) 5 (6.3)
Missing 1 (0.7) 1 (0.7) 3 (6.8) 5 (5.6) 2 (2.4) 1 (1.3)
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Health status
The health-related quality-of-life measures are shown in Table 8. The mean OSS was approximately
26 across the groups. The EQ-5D, MHI-5 and SPADI measures were broadly similar across and within
the strata.
TABLE 8 Health status at baseline
Measure
Stratum A, n, mean (SD) Stratum B, n, mean (SD) Stratum C, n, mean (SD)
Arthroscopic
(n= 136)
Open
(n= 137)
Rest then
exercise
(n= 44)
Arthroscopic
(n= 91)
Rest then
exercise
(n= 90)
Open
(n= 82)
Rest then
exercise
(n= 80)
OSS 136, 26.2 (8.1) 137, 25.2
(7.9)
44, 23.7
(8.3)
91, 25.3
(8.9)
90, 23.5
(8.0)
82, 25.9
(8.4)
80, 26.2
(7.9)
SPADI 136, 60.9 (22.0) 136, 61.6
(22.0)
44, 66.9
(22.1)
91, 60.6
(23.1)
90, 67.8
(20.4)
82, 60.7
(20.1)
79, 62.3
(20.1)
SPADI pain 136, 70.0 (19.5) 137, 70.1
(20.5)
44, 73.0
(22.0)
91, 70.0
(21.8)
89, 73.1
(19.4)
82, 69.6
(19.5)
80, 69.4
(18.2)
SPADI
disability
136, 55.1 (25.0) 135, 56.4
(24.7)
44, 63.0
(23.7)
91, 54.7
(25.9)
90, 64.4
(22.1)
82, 55.2
(21.9)
77, 57.7
(23.3)
MHI-5 136, 22.5 (4.9) 137, 22.9
(4.5)
44, 21.5
(5.5)
90, 22.4
(5.1)
90, 22.7
(4.9)
82, 22.1
(4.7)
80, 22.9
(4.6)
EQ-5D 135, 0.548 (0.299) 136, 0.519
(0.291)
43, 0.448
(0.332)
91, 0.514
(0.326)
89, 0.503
(0.287)
81, 0.536
(0.287)
79, 0.538
(0.298)
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Attitudes to surgery
As expected, there was variation in participants’ attitudes to undergoing surgery in general, but the
variation was not different between groups (Table 9).
TABLE 9 Attitudes to surgery
Question
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Rest then
exercise
(n= 44)
Arthroscopic
(n= 91)
Rest then
exercise
(n= 90)
Open
(n= 82)
Rest then
exercise
(n= 80)
To what extent do you agree that doctors rely on surgery too much?
Strongly agree 2 (2.2)
Agree 3 (2.2) 3 (2.2) 3 (6.8) 6 (6.6) 5 (5.6) 1 (1.2) 5 (6.3)
Uncertain 52 (38.2) 51 (37.2) 26 (59.1) 40 (44.0) 35 (38.9) 26 (31.7) 29 (36.3)
Disagree 72 (52.9) 76 (55.5) 13 (29.5) 35 (38.5) 42 (46.7) 52 (63.4) 39 (48.8)
Strongly disagree 7 (5.1) 4 (2.9) 2 (4.5) 7 (7.7) 7 (7.8) 2 (2.4) 5 (6.3)
Missing 2 (1.5) 3 (2.2) 1 (1.1) 1 (1.1) 1 (1.2) 2 (2.5)
To what extent do you agree that doctors place too much trust in surgery?
Strongly agree 1 (0.7) 1 (2.3) 2 (2.2)
Agree 6 (4.4) 4 (2.9) 9 (20.5) 9 (9.9) 7 (7.8) 1 (1.2) 8 (10.0)
Uncertain 66 (48.5) 61 (44.5) 22 (50.0) 47 (51.6) 35 (38.9) 39 (47.6) 33 (41.3)
Disagree 54 (39.7) 62 (45.3) 11 (25.0) 27 (29.7) 43 (47.8) 36 (43.9) 33 (41.3)
Strongly disagree 9 (6.6) 5 (3.6) 1 (2.3) 5 (5.5) 4 (4.4) 3 (3.7) 3 (3.8)
Missing 1 (0.7) 4 (2.9) 1 (1.1) 1 (1.1) 3 (3.7) 3 (3.8)
To what extent do you agree that you worry about surgery risks?
Strongly agree 5 (3.7) 5 (3.6) 3 (6.8) 13 (14.3) 12 (13.3) 2 (2.4) 4 (5.0)
Agree 58 (42.6) 51 (37.2) 20 (45.5) 37 (40.7) 35 (38.9) 30 (36.6) 33 (41.3)
Uncertain 21 (15.4) 18 (13.1) 8 (18.2) 13 (14.3) 14 (15.6) 22 (26.8) 16 (20.0)
Disagree 43 (31.6) 49 (35.8) 12 (27.3) 23 (25.3) 23 (25.6) 22 (26.8) 20 (25.0)
Strongly disagree 8 (5.9) 12 (8.8) 1 (2.3) (5.5) 4 (4.4) 3 (3.7) 4 (5.0)
Missing 1 (0.7) 2 (1.5) 2 (2.2) 3 (3.7) 3 (3.8)
To what extent do you agree that surgery should be only a last resort?
Strongly agree 17 (12.5) 19 (13.9) 6 (13.6) 20 (22.0) 12 (13.3) 11 (13.4) 11 (13.8)
Agree 75 (55.1) 67 (48.9) 17 (38.6) 41 (45.1) 48 (53.3) 38 (46.3) 36 (45.0)
Uncertain 19 (14.0) 24 (17.5) 9 (20.5) 14 (15.4) 12 (13.3) 16 (19.5) 13 (16.3)
Disagree 23 (16.9) 22 (16.1) 11 (25.0) 9 (9.9) 15 (16.7) 13 (15.9) 15 (18.8)
Strongly disagree 1 (0.7) 4 (2.9) 1 (2.3) 7 (7.7) 3 (3.3) 2 (2.4) 2 (2.5)
Missing 1 (0.7) 1 (0.7) 2 (2.4) 3 (3.8)
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Summary
There was no evidence of any important imbalances between the groups. With a mean OSS of around 26,
the population was representative of those in other shoulder studies (see Chapter 1). Most participants had
undergone some form of non-surgical intervention (such as physiotherapy) before the trial and had had
symptoms for over a year. In Chapter 4, the results of the randomised trial of arthroscopic compared with
open surgery will be reported. A description of the findings from the rest-then-exercise programme will be
provided in Chapter 5.
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Chapter 4 Results: arthroscopic surgery compared
with open surgery
This chapter describes the comparison between arthroscopic surgery and open surgery and includesoperative characteristics and outcomes at 2 and 8 weeks post surgery as well as 8, 12 and 24 months
after randomisation.
Analysis populations
Throughout the analyses presented in this chapter, the participants in the formal randomised comparison
between arthroscopic surgery and open surgery (stratum A) are kept separate from those in the arthroscopic
and open groups in strata B and C respectively. All 273 participants who joined the randomised
arthroscopic compared with open surgery component in stratum A are referred to as the randomised ITT
population; the 148 (n= 63 arthroscopic; n= 85 open) within this group who actually received a repair over
the 2-year follow-up period are referred to as the per-protocol population. The non-randomised population
refers to the 91 participants allocated to arthroscopic surgery from stratum B and the 82 participants allocated
to open surgery in stratum C (included in this chapter for completeness and visual inspection of data).
No statistical analysis is performed on the non-randomised population.
Surgical management
Randomised intention-to-treat population
Table 10 shows the types of procedure undertaken in each group. For the 136 participants randomised to
receive arthroscopic surgical management, 63 (46.3%) underwent an arthroscopic repair of a tear,
nine (6.6%) began as an arthroscopic procedure and converted to an open repair, 28 (20.6%) underwent an
arthroscopic procedure (that did not involve a repair of a tear) and 36 (26.5%) withdrew and did not undergo
any surgery. Of the arthroscopic procedures not involving a repair, a shoulder subacromial decompression
was the most common procedure undertaken. Some 100 (73.5%) participants received the intended
randomised arthroscopic surgical management, although only 63 (46.3%) received an arthroscopic repair.
Of the 137 participants randomised to receive open surgical management, 85 (62.0%) underwent an open
repair of a tear and five (3.6%) an arthroscopic repair (see Table 10). Some 24 participants underwent an
arthroscopic procedure and, as with the participants randomised to arthroscopic management, the most
common procedure was a shoulder subacromial decompression. Twenty-three participants withdrew from
any surgery. The principal reasons for participants withdrawing from surgery were related to medical
conditions (primarily cardiac events) or participants being asymptomatic and not judged to be associated
with either of the allocated procedures.
Non-randomised population
Similar proportions of non-randomised participants as randomised participants received the various
management strategies, suggesting that the participants were broadly similar and their management was
not biased by the surgeons’ preferred techniques.
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TABLE 10 Surgical management
Surgical management
Randomised, n (%) Non-randomised, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Arthroscopic
(n= 91)
Open
(n= 82)
Received an arthroscopic repair 63 (46.3) 5 (3.6) 50 (54.9) 2 (2.4)
Received a converted arthroscopic procedure 9 (6.6) 1 (1.1)
Received an open repair 85 (62.0) 40 (48.8)
Received an arthroscopic procedure 28 (20.6) 24 (17.5) 23 (25.3) 26 (31.7)
Details of procedure
SAD 20 (14.7) 16 (11.7) 14 (15.4) 18 (22.0)
SAD and ACJ resection 1 (0.7) 3 (2.2) 4 (4.4) 6 (7.3)
Biceps tenotomy 2 (1.5) 1 (1.1)
Capsular release 1 (0.7) 2 (1.5) 1 (1.2)
PTT repair 1 (0.7)
Partial repair 1 (0.7)
Type of procedure not documented 4 (3.0) 1 (0.7) 4 (4.4) 1 (1.2)
Withdrawn from intervention 36 (26.5) 23 (16.8) 15 (16.5) 12 (14.6)
Awaiting surgery when study ended 2 (1.5) 2 (1.5) 2 (2.2)
Cancelled because of other surgery 2 (1.5) 1 (1.1)
Complete withdrawal from study 2 (1.5)
Family commitments 2 (1.5) 1 (0.7)
No surgery on medical grounds 11 (8.1) 1 (0.7) 3 (3.3) 2 (2.4)
Patient asymptomatic 7 (5.1) 7 (5.1) 2 (2.2) 5 (6.1)
Patient deceased 1 (0.7)
Patient did not want surgery 3 (2.2) 2 (1.5) 3 (3.3) 2 (2.4)
Patient not happy with hospital 1 (1.1)
Patient withdrew from NHS waiting list 4 (2.9) 5 (3.6) 1 (1.2)
Personal reasons 2 (2.4)
Shoulder problem improved without surgery 1 (1.1)
Unknown 1 (0.7) 1 (0.7) 2 (2.2)
Work commitments 3 (2.2) 2 (1.5)
Surgery type missing 2 (2.2) 2 (2.4)
ACJ, acromioclavicular joint; PTT, partial-thickness tear.
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Operative details
Procedural details are shown in Table 11 for those participants who received any surgery. The size of tear
and surgical completeness were similar between the randomised groups. In the randomised group the
ease of repair, although broadly similar, was reported to be easier for the open procedure (18% of
arthroscopic operations were easy vs. 36% of open repairs). Such a difference was not observed in the
non-randomised groups and therefore any difference must be interpreted with caution. However, the
difference may be a proxy measure that the surgeons in the randomised comparison were more
comfortable with the open than the arthroscopic approach.
TABLE 11 Operative details
Operative detail
Randomised, n (%) Non-randomised, n (%)
Arthroscopic
(n= 136) Open (n= 137)
Arthroscopic
(n= 91) Open (n= 82)
Did not receive intervention 36 (26.5) 23 (16.8) 17 (18.7) 14 (17.1)
Received allocated repair 63 (46.3) 85 (62.0) 50 (54.9) 40 (48.8)
Received allocated procedure 100 (73.5) 85 (62.0) 74 (81.3) 40 (48.8)
Received any surgery 100 (73.5) 114 (83.2) 74 (81.3) 68 (82.9)
Procedure side
Left 40 (40.0) 33 (28.9) 22 (29.7) 27 (39.7)
Right 59 (59.0) 80 (70.2) 51 (68.9) 41 (60.3)
Missing 1 (1.0) 1 (0.9) 1 (1.4)
Ease of repair
Easy 18 (18.0) 41 (36.0) 13 (17.6) 11 (16.2)
Moderate 28 (28.0) 27 (23.7) 19 (25.7) 14 (20.6)
Difficult 17 (17.0) 12 (10.5) 11 (14.9) 11 (16.2)
Impossible 7 (7.0) 9 (7.9) 8 (10.8) 8 (11.8)
Missing 30 (30.0) 25 (21.9) 23 (31.1) 24 (35.3)
Size of tear
Small 23 (23.0) 26 (22.8) 11 (14.9) 7 (10.3)
Medium 27 (27.0) 36 (31.6) 10 (13.5) 12 (17.6)
Large 13 (13.0) 19 (16.7) 18 (24.3) 13 (19.1)
Massive 15 (15.0) 13 (11.4) 18 (24.3) 16 (23.5)
Not a tear 21 (21.0) 16 (14.0) 15 (20.3) 20 (29.4)
Missing 1 (1.0) 4 (3.5) 2 (2.7)
Surgical opinion of completeness of repair
Poor 8 (8.0) 7 (6.1) 4 (5.4) 6 (8.8)
Good 41 (41.0) 46 (40.4) 29 (39.2) 22 (32.4)
Excellent 16 (16.0) 35 (30.7) 9 (12.2) 11 (16.2)
Missing 35 (35.0) 26 (22.8) 32 (43.2) 29 (42.6)
Total time in theatre (minutes), n, mean (SD) 73, 100.3 (42.0) 96, 87.6 (28.9) 46, 86.8 (32.5) 49, 85.9 (46.7)
Operation time (minutes), n, mean (SD) 72, 69.4 (36.7) 89, 57.2 (21.9) 36, 57.3 (27.2) 39, 63.3 (36.0)
DOI: 10.3310/hta19800 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 80
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Carr et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
35
The operation time is also shown in Table 11. For the randomised trial, the mean operation time in
minutes was statistically significantly lower in the open procedure group (–12.2, 95% CI –21.4 to –3.0;
p= 0.010) as was the mean total time in minutes in theatre (–12.7, 95% CI –23.5 to –1.9; p= 0.021).
In the non-randomised groups, the times were similar.
Intraoperative complications
Table 12 shows the intraoperative complications. The number of events was generally low. There were
11 (8.1%) participants with any intraoperative complication in the randomised arthroscopic group
compared with nine (6.6%) in the randomised open group. The difference was not statistically significant
(difference 3.1%, 95% CI –4.8% to 11.0%; p= 0.190). The event rates in the non-randomised population
were similar to those in the randomised population. There were no perioperative deaths.
Adverse events and deaths
Three participants in the randomised arthroscopic group and three in the randomised open group required
inpatient hospitalisation as a result of taking part in the UKUFF trial. The inpatient admissions were as a
result of two participants in each group requiring revision surgery and a single participant in each group
having a postoperative complication. The first complication involved a participant with a deep infection,
which required formal debridement and vacuum pump application. He had this surgery after 3 weeks of
treatment by his GP with antibiotics. The second complication involved a participant requiring a longer stay
in hospital following a continuous interscalene block in the shoulder for postoperative pain relief and
some bleeding during surgery. There was a single case of revision surgery in each of the non-randomised
groups. All complications and revision surgeries were managed within 17 months of randomisation.
Seven participants died while in follow-up (n= 3 randomised arthroscopic; n= 1 randomised open; n= 3
non-randomised arthroscopic; n= 1 non-randomised open). Two participants died of cancer, two were
involved in road traffic accidents, one died of an unrelated and undisclosed illness and two had an
unknown cause of death.
TABLE 12 Intraoperative complications
Complication
Randomised, n (%) Non-randomised, n (%)
Arthroscopic (n= 136) Open (n= 137) Arthroscopic (n= 91) Open (n= 82)
Intraoperative problem
Anaesthetic 1 (1.0) 1 (0.9) 1 (1.4) 1 (1.5)
Equipment 3 (3.0) 1 (0.9) 2 (2.7) 2 (2.9)
Implant 1 (0.9) 1 (1.4) 1 (1.5)
Surgical 9 (9.0) 2 (1.8) 4 (5.4) 2 (2.9)
Other 5 (5.0) 6 (5.3) 7 (9.5) 10 (14.7)
Staff problems 2 (2.9)
Any intraoperative problem 11 (8.1) 9 (6.6) 14 (15.4) 11 (13.4)
Did the procedure change as a result of an intraoperative problem?
Yes 4 (36.4) 3 (33.3) 9 (64.3) 6 (54.5)
No 7 (63.6) 4 (44.4) 4 (28.6) 3 (27.3)
Unsure 1 (7.1)
Missing 2 (22.2) 2 (18.2)
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Two-week follow-up
Follow-up measures timed to occur at 2 weeks post surgery are shown in Table 13. Very few participants
reported being pain free and approximately two-thirds were taking painkillers. Of those participants
who were employed, about 80% were still off sick. There were no clinically important differences between
or within any of the randomised or non-randomised groups.
TABLE 13 Two-week follow-up
Question
Randomised, n (%) Non-randomised, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Arthroscopic
(n= 91)
Open
(n= 82)
Completed follow-up forms 94 (69.1) 112 (81.8) 70 (76.9) 71 (86.6)
Within the last 24 hours, have you been wearing a sling at all?
Yes 60 (63.8) 78 (69.6) 44 (62.9) 47 (66.2)
No 32 (34.0) 31 (27.7) 26 (37.1) 21 (29.6)
Missing 2 (2.1) 3 (2.7) 3 (4.2)
If yes, how long have you worn the sling for?
> 12 hours 52 (86.7) 71 (91.0) 39 (88.6) 30 (63.8)
Between 6 and 12 hours 4 (6.7) 5 (6.4) 1 (2.3) 9 (19.1)
> 3 hours but < 6 hours 4 (6.7) 1 (1.3) 2 (4.5) 5 (10.6)
< 3 hours 1 (1.3) 1 (2.1)
Missing 2 (4.5) 2 (4.3)
Within the last 24 hours, how would you describe the worst pain from your shoulder?
None 6 (6.4) 6 (5.4) 5 (7.1) 7 (9.9)
Mild 30 (31.9) 34 (30.4) 25 (35.7) 18 (25.4)
Moderate 36 (38.3) 50 (44.6) 23 (32.9) 33 (46.5)
Severe 17 (18.1) 19 (17.0) 12 (17.1) 9 (12.7)
Unbearable 3 (3.2) 1 (0.9) 5 (7.1) 1 (1.4)
Missing 2 (2.1) 2 (1.8) 3 (4.2)
Within the last 24 hours, how much has pain from your shoulder interfered with your usual work?
Not at all 17 (18.1) 18 (16.1) 22 (31.4) 16 (22.5)
A little bit 16 (17.0) 10 (8.9) 14 (20.0) 10 (14.1)
Moderately 24 (25.5) 43 (38.4) 11 (15.7) 18 (25.4)
Greatly 24 (25.5) 25 (22.3) 9 (12.9) 17 (23.9)
Totally 11 (11.7) 13 (11.6) 14 (20.0) 7 (9.9)
Missing 2 (2.1) 3 (2.7) 3 (4.2)
continued
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TABLE 13 Two-week follow-up (continued )
Question
Randomised, n (%) Non-randomised, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Arthroscopic
(n= 91)
Open
(n= 82)
Were you troubled by pain from your shoulder in bed last night?
No, not at all 25 (26.6) 25 (22.3) 17 (24.3) 19 (26.8)
Yes, just at first 8 (8.5) 6 (5.4) 4 (5.7) 5 (7.0)
Yes, during some of the night 38 (40.4) 44 (39.3) 32 (45.7) 27 (38.0)
Yes, throughout the night 21 (22.3) 35 (31.3) 17 (24.3) 17 (23.9)
Missing 2 (2.1) 2 (1.8) 3 (4.2)
Within the last 24 hours, have you taken any painkillers because of your shoulder?
Yes 62 (66.0) 76 (67.9) 45 (64.3) 49 (69.0)
No 29 (30.9) 34 (30.4) 25 (35.7) 19 (26.8)
Missing 3 (3.2) 2 (1.8) 3 (4.2)
If yes, how many painkillers have you taken in the last 24 hours?
1 29 (46.8) 38 (50.0) 23 (51.1) 25 (51.0)
2 23 (37.1) 30 (39.5) 16 (35.6) 15 (30.6)
3 7 (11.3) 5 (6.6) 6 (13.3) 6 (12.2)
4 1 (1.6) 1 (1.3) 2 (4.1)
5 1 (1.6) 1 (1.3) 1 (2.0)
Missing 1 (1.6) 1 (1.3)
During the (last 2 weeks) time since the completion of surgery or rest then exercise, have you received any additional
treatment on your shoulder?
Yes 3 (3.2) 17 (15.2) 8 (11.4) 3 (4.2)
No 84 (89.4) 87 (77.7) 59 (84.3) 56 (78.9)
Missing 7 (7.4) 8 (7.1) 3 (4.3) 12 (16.9)
If yes, what was the additional treatment?
Injection 1 (12.5)
Antibiotics 1 (5.9)
Physiotherapy 1 (33.3) 4 (23.5) 4 (50.0) 1 (33.3)
Wound or dressing 5 (29.4) 2 (25.0) 1 (33.3)
Not shoulder 1 (33.3) 2 (11.8) 1 (33.3)
Pain relief 1 (33.3) 5 (29.4) 1 (12.5)
Are you currently employed?
Yes 46 (48.9) 57 (50.9) 31 (44.3) 38 (53.5)
No 46 (48.9) 53 (47.3) 39 (55.7) 30 (42.3)
Missing 2 (2.1) 2 (1.8) 3 (4.2)
Are you currently off sick or working reduced duties?
Yes, off sick 38 (82.6) 44 (77.2) 23 (74.2) 26 (68.4)
Yes, working reduced duties 3 (6.5) 5 (8.8) 3 (9.7) 4 (10.5)
No, working usual hours or duties 5 (10.9) 8 (14.0) 4 (12.9) 6 (15.8)
Missing 1 (3.2) 2 (5.3)
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Eight-week follow-up
Follow-up measures timed to occur at 8 weeks post surgery are shown in Table 14. The results were
similar to those at the 2-week follow-up with the exception that the percentage reporting no or mild pain
improved from 35% to 50% with an apparent concomitant effect of reducing painkiller use from 66% to
55% and increasing the number of participants returning to usual work (no or a little interference) from
28% to 55%. There were no clinically important differences between or within any of the randomised or
non-randomised groups.
TABLE 14 Eight-week follow-up
Question
Randomised, n (%) Non-randomised, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Arthroscopic
(n= 91)
Open
(n= 82)
Completed follow-up forms 97 (71.3) 113 (82.5) 70 (76.9) 58 (70.7)
Within the last 24 hours, have you been wearing a sling at all?
Yes 6 (6.2) 14 (12.4) 6 (8.6) 7 (12.1)
No 91 (93.8) 99 (87.6) 64 (91.4) 51 (87.9)
If yes, how long have you worn the sling for?
> 12 hours 1 (16.7) 3 (21.4) 3 (50.0) 1 (14.3)
Between 6 and 12 hours 1 (16.7) 4 (28.6) 1 (14.3)
> 3 hours but < 6 hours 1 (16.7) 7 (50.0) 1 (16.7) 1 (14.3)
< 3 hours 3 (50.0) 2 (33.3) 2 (28.6)
Missing 2 (28.6)
Within the last 24 hours, how would you describe the worst pain you have had from your shoulder?
None 11 (11.3) 12 (10.6) 8 (11.4) 7 (12.1)
Mild 38 (39.2) 50 (44.2) 22 (31.4) 24 (41.4)
Moderate 33 (34.0) 29 (25.7) 21 (30.0) 20 (34.5)
Severe 14 (14.4) 20 (17.7) 15 (21.4) 7 (12.1)
Unbearable 1 (1.0) 1 (0.9) 4 (5.7)
Missing 1 (0.9)
Within the last 24 hours, how much has pain from your shoulder interfered with your usual work?
Not at all 31 (32.0) 26 (23.0) 20 (28.6) 18 (31.0)
A little bit 23 (23.7) 35 (31.0) 20 (28.6) 15 (25.9)
Moderately 32 (33.0) 37 (32.7) 14 (20.0) 18 (31.0)
Greatly 9 (9.3) 12 (10.6) 11 (15.7) 6 (10.3)
Totally 2 (2.1) 3 (2.7) 5 (7.1) 1 (1.7)
Were you troubled by pain from your shoulder in bed last night?
No, not at all 37 (38.1) 40 (35.4) 25 (35.7) 23 (39.7)
Yes, just at first 8 (8.2) 9 (8.0) 4 (5.7) 2 (3.4)
Yes, during some of the night 35 (36.1) 38 (33.6) 23 (32.9) 21 (36.2)
Yes, throughout the night 17 (17.5) 26 (23.0) 18 (25.7) 12 (20.7)
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TABLE 14 Eight-week follow-up (continued )
Question
Randomised, n (%) Non-randomised, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Arthroscopic
(n= 91)
Open
(n= 82)
Within the last 24 hours, have you taken any painkillers for your shoulder?
Yes 44 (45.4) 59 (52.2) 36 (51.4) 32 (55.2)
No 53 (54.6) 54 (47.8) 34 (48.6) 26 (44.8)
If yes, how many painkillers have you taken?
1 25 (56.8) 34 (57.6) 17 (47.2) 15 (46.9)
2 13 (29.5) 19 (32.2) 9 (25.0) 8 (25.0)
3 4 (9.1) 3 (5.1) 4 (11.1) 1 (3.1)
4 1 (2.3) 1 (3.1)
Missing 1 (2.3) 3 (5.1) 6 (16.7) 7 (21.9)
During the time (last 6 weeks) since we spoke to you last, have you had any additional treatment for
your shoulder?
Yes 7 (7.2) 10 (8.8) 5 (7.1) 7 (12.1)
No 85 (87.6) 100 (88.5) 63 (90.0) 49 (84.5)
Missing 5 (5.2) 3 (2.7) 2 (2.9) 2 (3.4)
If yes, what additional treatment did you receive?
Injection 1 (10.0)
Surgery 1 (20.0)
Antibiotics 2 (20.0) 1 (14.3)
Physiotherapy 7 (100.0) 4 (40.0) 2 (40.0) 6 (85.7)
Wound or dressing 1 (10.0)
Pain relief
Hospital admission 1 (20.0)
Surgery and antibiotics 2 (20.0)
Injection and antibiotics 1 (20.0)
Are you currently employed?
Yes 47 (48.5) 60 (53.1) 26 (37.1) 26 (44.8)
No 50 (51.5) 52 (46.0) 41 (58.6) 28 (48.3)
Missing 1 (0.9) 3 (4.3) 4 (6.9)
Are you currently off sick or working reduced hours?
Yes, off sick 23 (48.9) 29 (48.3) 13 (50.0) 14 (53.8)
Yes, working reduced duties 9 (19.1) 12 (20.0) 4 (15.4) 4 (15.4)
No, working usual hours/duties 15 (31.9) 18 (30.0) 9 (34.6) 8 (30.8)
Missing 1 (1.7)
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Outcomes at 8, 12 and 24 months
Outcomes at 8, 12 and 24 months were primarily obtained from questionnaire returns. As described in
Chapter 3 and reiterated here in Table 15, the return rates were similar across groups and ranged from
90% at 8 and 12 months to 86% at 24 months. There were no notable differences in baseline
characteristics between those who had completed a questionnaire at 24 months and those who had not
(Table 16). The only exception to this was a statistically significant difference in housing status, with 84.7%
of homeowners in the responder group compared with 71.1% in the non-responder group. Given the
possibility of multiple statistical testing, the difference should be interpreted with caution. As described in
Chapter 2, these results confirmed that a repeated measures analysis assuming no differential loss to
follow-up could be considered.
Health status
Health status measures at 8, 12 and 24 months are shown in Table 17. Full details of the statistical testing
of the health status measures can be found in the following sections.
TABLE 15 Questionnaire response rates at 8, 12 and 24 months
Time point (months)
Randomised, n (%) Non-randomised, n (%)
Arthroscopic (n= 136) Open (n= 137) Arthroscopic (n= 91) Open (n= 82)
8 121 (89.0) 127 (92.7) 85 (93.4) 75 (91.5)
12 123 (90.4) 123 (89.8) 84 (92.3) 76 (92.7)
24 117 (86.0) 118 (86.1) 79 (86.8) 75 (91.5)
TABLE 16 Baseline characteristics of responders and non-responders at 24 months
Characteristic Responder, n (%) Non-responder, n (%) p-value (two-sided)
Age (years), n, mean (SD) 235, 62.8 (7.0) 38, 63.1 (9.1) 0.824
Years with shoulder problem, n, mean (SD) 235, 2.4 (4.0) 38, 3.1 (8.0) 0.404
OSS, n, mean (SD) 235, 25.9 (7.9) 38, 24.0 (8.5) 0.165
SPADI, n, mean (SD) 234, 60.3 (21.8) 38, 67.3 (22.3) 0.068
SPADI pain, n, mean (SD) 235, 69.3 (19.8) 38, 74.9 (20.6) 0.109
SPADI disability, n, mean (SD) 233, 54.7 (24.7) 38, 62.5 (24.9) 0.072
MHI-5, n, mean (SD) 235, 22.7 (4.7) 38, 22.9 (4.6) 0.771
EQ-5D, n, mean (SD) 233, 0.543 (0.290) 38, 0.472 (0.319) 0.170
Sex
Male 144 (61.3) 25 (65.8) 0.595
Female 91 (38.7) 13 (34.2)
Handedness
Right-handed 210 (89.4) 30 (78.9) 0.184
Left-handed 18 (7.7) 6 (15.8)
Both 7 (3.0) 2 (5.3)
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TABLE 16 Baseline characteristics of responders and non-responders at 24 months (continued )
Characteristic Responder, n (%) Non-responder, n (%) p-value (two-sided)
Highest qualification
None 101 (43.0) 21 (55.3) 0.207
Secondary 80 (34.0) 10 (26.3)
Higher 53 (22.6) 6 (15.8)
Missing 1 (0.4) 1 (2.6)
Housing tenure
Home owner 199 (84.7) 27 (71.1) 0.020
Private rent 6 (2.6) 2 (5.3)
Council rent 19 (8.1) 7 (18.4)
Other 11 (4.7) 1 (2.6)
Missing 1 (2.6)
Lives alone
Yes 27 (11.5) 8 (21.1) 0.253
No 191 (81.3) 28 (73.7)
Missing 17 (7.2) 2 (5.3)
Employment status
Full-time 89 (37.9) 16 (42.1) 0.567
Part-time 31 (13.2) 2 (5.3)
Homemaker 8 (3.4) 1 (2.6)
Retired 97 (41.3) 16 (42.1)
Unemployed 8 (3.4) 3 (7.9)
Missing 2 (0.9)
Type of work
Manual 67 (55.8) 10 (55.6) 0.474
Non-manual 48 (40.0) 6 (33.3)
Not sure 4 (3.3) 2 (11.1)
Missing 1 (0.8)
Off sick or working reduced duties
Yes, off sick 13 (10.8) 0.096
Yes, reduced duties 12 (10.0) 5 (27.8)
No, working usual hours 91 (75.8) 12 (66.7)
Missing 4 (3.3) 1 (5.6)
Able to do job
No 127 (54.0) 19 (50.0) 0.443
Yes, but with difficulty 104 (44.3) 17 (44.7)
Yes, with no difficulty 3 (1.3) 1 (2.6)
Missing 1 (0.4) 1 (2.6)
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Oxford Shoulder Score
Figure 2 graphically displays the OSS over the course of the follow-up period for the randomised and
non-randomised groups. All groups followed a similar pattern. The OSS increased markedly from baseline
(mean 25.7) to 8 months (mean 36.5) and continued to increase thereafter (at a much slower rate) to
24 months (mean 41.5).
European Quality of Life-5 Dimensions
Figure 3 displays the EQ-5D score over the follow-up period. The pattern is similar to that seen for the OSS.
Shoulder Pain and Disability Index
The SPADI overall score, together with the pain and disability subscales (Figures 4–6), followed a similar
pattern to that for the OSS (note that a lower SPADI score is a better outcome), with a large improvement
from baseline at 8 months followed by a smaller rate of improvement thereafter. All randomised and
non-randomised groups followed a similar pattern.
Mental Health Inventory
The MHI-5 scores showed very little change across time from baseline (Figure 7).
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Symptoms
A comparison of current shoulder problems with baseline levels is given in Table 18. In response to a
transition item concerning change in their shoulder problems at 8 months, 77% of participants reported
that shoulder problems were much or slightly better, increasing to 85% at 24 months. When asked how
pleased they were with their shoulder symptoms, on average 77% of participants were either very or fairly
pleased at 8 months, increasing to 83% by 24 months. All groups responded in a similar manner.
Employment information
Table 19 shows participant employment status at 8, 12 and 24 months. There was no substantial change
in employment status from 8 to 24 months.
Magnetic resonance imaging findings at 12 months post surgery
The findings of those participants undergoing an MRI at 12 months post surgery are displayed in Table 20.
Of the 136 participants randomised to receive arthroscopic repair, 69 (51%) had an MRI scan at 12 months.
For the 137 participants randomised to receive open repair, 83 (61%) had an MRI. The primary reasons for
not receiving were that the patient did not have a tear at initial surgery, it was impossible to repair or the
patient received a revision surgery prior to 12 months.
The rate of re-tear was similar across the randomised groups (46.4% vs. 38.6% for arthroscopic and open
surgery respectively) (relative effect: OR 1.52, 95% CI 0.84 to 2.75; absolute risk difference 9.5%, 95% CI
–6.9% to 25.8%; p= 0.256).
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FIGURE 7 Means and 95% CIs for the MHI-5 score across time for the ITT and non-randomised groups.
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TABLE 18 Change in symptoms and satisfaction ratings at 8, 12 and 24 months
Question
Randomised, n (%)
OR 95% CI p-value
Non-randomised, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Arthroscopic
(n= 91)
Open
(n= 82)
How are the problems related to your shoulder now compared with 8 months ago?
Much better 63 (52.1) 76 (59.8) 0.80 0.41 to 1.58 0.522 55 (64.7) 47 (62.7)
Slightly better 30 (24.8) 22 (17.3) 14 (16.5) 17 (22.7)
No change 18 (14.9) 11 (8.7) 7 (8.2) 1 (1.3)
Slightly worse 3 (2.5) 6 (4.7) 4 (4.7) 4 (5.3)
Much worse 4 (3.3) 4 (3.1) 3 (3.5) 2 (2.7)
Missing 3 (2.5) 8 (6.3) 2 (2.4) 4 (5.3)
How are the problems related to your shoulder now compared with a year ago?
Much better 72 (58.5) 85 (69.1) 0.57 0.31 to 1.03 0.061 51 (60.7) 56 (73.7)
Slightly better 20 (16.3) 18 (14.6) 19 (22.6) 11 (14.5)
No change 12 (9.8) 4 (3.3) 4 (4.8) 6 (7.9)
Slightly worse 9 (7.3) 5 (4.1) 1 (1.2) 1 (1.3)
Much worse 4 (3.3) 7 (5.7) 3 (3.6) 1 (1.3)
Missing 6 (4.9) 4 (3.3) 6 (7.1) 1 (1.3)
How are the problems related to your shoulder now compared with 2 years ago?
Much better 83 (70.9) 81 (68.6) 0.97 0.43 to 2.18 0.939 61 (77.2) 49 (65.3)
Slightly better 16 (13.7) 20 (16.9) 6 (7.6) 14 (18.7)
No change 6 (5.1) 6 (5.1) 6 (7.6) 4 (5.3)
Slightly worse 5 (4.3) 4 (3.4) 3 (3.8) 3 (4.0)
Much worse 3 (2.6) 4 (3.4) 0 (0.0) 2 (2.7)
Missing 4 (3.4) 3 (2.5) 3 (3.8) 3 (4.0)
How pleased are you with your shoulder symptoms at 8 months?
Very pleased 45 (37.2) 51 (40.2) 1.11 0.57 to 2.16 0.769 44 (51.8) 37 (49.3)
Fairly pleased 51 (42.1) 45 (35.4) 26 (30.6) 27 (36.0)
Not very pleased 17 (14.0) 18 (14.2) 6 (7.1) 5 (6.7)
Very disappointed 4 (3.3) 4 (3.1) 7 (8.2) 1 (1.3)
Missing 4 (3.3) 9 (7.1) 2 (2.4) 5 (6.7)
How pleased are you with your shoulder symptoms at 12 months?
Very pleased 59 (48.0) 57 (46.3) 0.57 0.31 to 1.05 0.071 42 (50.0) 45 (59.2)
Fairly pleased 33 (26.8) 47 (38.2) 27 (32.1) 20 (26.3)
Not very pleased 16 (13.0) 8 (6.5) 8 (9.5) 6 (7.9)
Very disappointed 7 (5.7) 7 (5.7) 2 (2.4) 4 (5.3)
Missing 8 (6.5) 4 (3.3) 5 (6.0) 1 (1.3)
How pleased are you with your shoulder symptoms at 24 months?
Very pleased 73 (62.4) 64 (54.2) 1.37 0.73 to 2.60 0.330 47 (59.5) 42 (56.0)
Fairly pleased 26 (22.2) 33 (28.0) 21 (26.6) 19 (25.3)
Not very pleased 7 (6.0) 13 (11.0) 7 (8.9) 7 (9.3)
Very disappointed 6 (5.1) 4 (3.4) 1 (1.3) 4 (5.3)
Missing 5 (4.3) 4 (3.4) 3 (3.8) 3 (4.0)
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TABLE 19 Employment status at 8, 12 and 24 months
Employment status
Randomised, n (%) Non-randomised, n (%)
Arthroscopic
(n= 136)
Open
(n= 137)
Arthroscopic
(n= 91)
Open
(n= 82)
Employed at 8 months
Yes 51 (42.1) 54 (42.5) 29 (34.1) 33 (44.0)
No 67 (55.4) 63 (49.6) 54 (63.5) 38 (50.7)
Missing 3 (2.5) 10 (7.9) 2 (2.4) 4 (5.3)
Employed at 12 months
Yes 50 (40.7) 49 (39.8) 23 (27.4) 32 (42.1)
No 68 (55.3) 70 (56.9) 56 (66.7) 43 (56.6)
Missing 5 (4.1) 4 (3.3) 5 (6.0) 1 (1.3)
Employed at 24 months
Yes 42 (35.9) 42 (35.6) 22 (27.8) 31 (41.3)
No 71 (60.7) 72 (61.0) 54 (68.4) 41 (54.7)
Missing 4 (3.4) 4 (3.4) 3 (3.8) 3 (4.0)
If you are employed, are you off sick or working reduced duties because of your shoulder at 8 months?
Yes, off sick 10 (8.3) 7 (5.5) 5 (5.9) 2 (2.7)
Yes, working reduced hours 4 (3.3) 8 (6.3) 4 (4.7) 7 (9.3)
No, working usual hours/duties 36 (29.8) 36 (28.3) 19 (22.4) 23 (30.7)
Missing 71 (58.7) 76 (59.8) 57 (67.1) 43 (57.3)
Are you currently out of work, off sick or working reduced duties because of your shoulder at 12 months?
Yes 12 (9.8) 10 (8.1) 5 (6.0) 9 (11.8)
No 93 (75.6) 93 (75.6) 63 (75.0) 59 (77.6)
Missing 18 (14.6) 20 (16.3) 16 (19.0) 8 (10.5)
Are you currently out of work, off sick or working reduced duties because of your shoulder at 24 months?
Yes 8 (6.8) 6 (5.1) 4 (5.1) 5 (6.7)
No 99 (84.6) 94 (79.7) 65 (82.3) 60 (80.0)
Missing 10 (8.5) 18 (15.3) 10 (12.7) 10 (13.3)
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The OSS demonstrated a consistent pattern within each group, with the impossible-to-repair participants
having the worst OSS, participants with a re-tear having a slightly better OSS and participants with no tear
having the most improved OSS (see Table 20).
Per-protocol population
For completeness, data on the per-protocol population are included in Appendix 1. These data are from
the 63 participants who were randomised to an arthroscopic procedure and who actually received an
arthroscopic repair and the 85 participants who were randomised to an open procedure and who received
an open repair. Similarly, the data reported also include the 50 arthroscopic repairs and the 40 open
repairs in the non-randomised group.
Recognising that caution must be used when interpreting the per-protocol group, we nevertheless note that
the lack of important differences between the arthroscopic and the open ITT groups was also observed in
the per-protocol data. The similarity is illustrated visually in Figures 8 and 9, where the OSS and EQ-5D
scores, respectively, are contrasted between the ITT population and the per-protocol population.
TABLE 20 Magnetic resonance imaging results
Measure
Randomised, n (%) Non-randomised, n (%)
Arthroscopic (n= 136) Open (n= 137) Arthroscopic (n= 91) Open (n= 82)
MRI scans received, n 69 83 41 40
Result of MRI scan
Re-tear 32 (46.4) 32 (38.6) 15 (36.6) 14 (35.0)
No tear 32 (46.4) 47 (56.6) 23 (56.1) 24 (60.0)
Inconclusive 1 (1.4) 1 (1.2)
Missing 4 (5.8) 3 (3.6) 3 (7.3) 2 (5.0)
Size of tear if MRI scan shows a re-tear
Partial 2 (6.3) 1 (3.1) 1 (6.7)
Small 9 (28.1) 10 (31.3) 1 (6.7) 4 (28.6)
Medium 5 (15.6) 9 (28.1) 6 (40.0) 5 (35.7)
Large 5 (15.6) 3 (9.4) 2 (13.3) 2 (14.3)
Massive 8 (25.0) 7 (21.9) 4 (26.7) 3 (21.4)
Missing 3 (9.4) 2 (6.3) 1 (6.7)
OSS at 24 months, n, mean (SD)
Re-tear 30, 41.8 (8.8) 29, 40.8 (7.6) 15, 38.8 (5.8) 13, 39.8 (7.2)
No tear 30, 44.5 (4.1) 47, 43.6 (5.8) 22, 43.9 (4.2) 20, 44.3 (4.5)
Impossible to repair 7, 37.3 (6.1) 8, 35.1 (9.7) 6, 37.0 (9.8) 8, 32.4 (9.8)
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Statistical between-group analysis
Primary outcome
The pre-chosen primary outcome was the OSS score at 24 months’ follow-up, for which the effect sizes
and 95% CIs are shown in Table 17. Under ITT analysis there was no evidence of a difference between
those randomised to receive an arthroscopic procedure and those randomised to receive an open
procedure (difference –0.76, 95% CI –2.75 to 1.22; p= 0.452). The 95% CI was also small enough to
exclude the prespecified clinically important difference of 3 points.
To test the sensitivity of the primary outcome to the actual procedure received we also performed a
per-protocol analysis of the 24-month OSS using the instrumental variable approach described in Chapter 2.
A similar result to that of the ITT analysis was produced, although the CIs were much wider, as expected
(difference –0.46, 95% CI –5.30 to 4.39; p= 0.854). We are therefore confident that there was no
evidence of important differences between surgical treatments.
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FIGURE 9 Means and 95% CIs for the EQ-5D across time for the ITT and per-protocol groups.
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FIGURE 8 Means and 95% CIs for the OSS across time for the ITT and per-protocol groups.
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Secondary outcomes
The secondary outcomes were the health status measures (EQ-5D, SPADI and MHI-5), the change in
symptom measures (transition items regarding shoulder problems and shoulder symptoms) and satisfaction
ratings (‘How pleased are you with your shoulder symptoms?’) at 8, 12 and 24 months, the OSS at 8 and
12 months and MRI-diagnosed re-tears at 12 months post surgery. Analyses of these outcomes are shown
in Tables 17 and 18.
Health status
There was no evidence of any differences between the randomised groups for any of the health status
measures at all follow-up times (see Table 17).
Change in symptoms and satisfaction
There was no evidence of any differences between the randomised groups for either of the symptom
transition or satisfaction measures at all follow-up times (see Table 18). For example, at 24 months, when
asked how pleased they were with their shoulder symptoms, 84.6% of participants in the arthroscopic
group and 82.4% in the open group were either very or fairly pleased (OR 1.37, 95% CI 0.73 to
2.60; p= 0.330).
Magnetic resonance imaging findings
The rate of re-tear was similar across the randomised groups, at 46.4% in the arthroscopic repair group
and 38.6% in the open surgery group (difference 9.5%, 95% CI –6.9% to 25.8%; p= 0.256).
Subgroup analysis
Two preplanned subgroup analyses on the primary outcome (OSS at 24 months) were conducted: size
of tear at baseline assessment (small or medium vs. large or massive) and age at recruitment (< 65 years vs.
≥ 65 years). Figure 10 displays the means and 95% CIs for the differences in OSS score at 24 months in
the subgroups. There was no evidence that any of the subgroups was statistically significantly different
at the 1% level (p= 0.843 for tear size and p= 0.024 for age).
Learning curve
The statistical model for investigating any trend in OSS at 24 months as surgeon experience increased
during the trial did not demonstrate any significant learning effect (trend in OSS +0.04 per procedure,
95% CI –0.21 to 0.29; p= 0.744).
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FIGURE 10 Prespecified subgroup analysis of the OSS at 24 months (size of tear; age of patient).
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Chapter 5 Rest then exercise
In total, 214 patients were randomised to rest then exercise before the reconfiguration of the trial, with44 randomised within stratum A (arthroscopic surgery vs. open surgery vs. rest then exercise), 90 within
stratum B (arthroscopic surgery vs. rest then exercise) and 80 within stratum C (open surgery vs. rest
then exercise). Data from these participants are presented in this chapter. Reflecting the observational
status of these data, no statistical analysis or formal interpretation of the data is presented.
Description of the rest-then-exercise group at trial entry
All baseline data collected on these patients were presented in Chapter 3. We replicate a subset of the
baseline data here to illustrate that participants randomised to rest then exercise across the three strata
displayed broadly similar characteristics and beliefs at baseline (Tables 21 and 22, respectively).
TABLE 21 Participant characteristics of the rest-then-exercise groups at recruitment
Characteristic Stratum A (n= 44), n (%) Stratum B (n= 90), n (%) Stratum C (n= 80), n (%)
Age (years) 44, 62.9 (7.5) 90, 64.7 (8.0) 80, 61.3 (6.8)
Years with shoulder problem 43, 2.0 (2.7) 87, 2.2 (3.3) 79, 2.3 (2.6)
Sex
Male 28 (63.6) 63 (70.0) 51 (63.8)
Female 16 (36.4) 27 (30.0) 29 (36.3)
Handedness
Right-handed 40 (90.9) 78 (86.7) 66 (82.5)
Left-handed 1 (2.3) 9 (10.0) 8 (10.0)
Both 2 (4.5) 3 (3.3) 5 (6.3)
Missing 1 (2.3) 1 (1.3)
Highest qualification
None 23 (52.3) 37 (41.1) 25 (31.3)
Secondary 16 (36.4) 38 (42.2) 41 (51.3)
Higher 5 (11.4) 12 (13.3) 12 (15.0)
Missing 3 (3.3) 2 (2.5)
continued
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TABLE 21 Participant characteristics of the rest-then-exercise groups at recruitment (continued )
Characteristic Stratum A (n= 44), n (%) Stratum B (n= 90), n (%) Stratum C (n= 80), n (%)
Housing tenure
Home owner 34 (77.3) 78 (86.7) 68 (85.0)
Private rent 3 (6.8) 2 (2.2) 4 (5.0)
Council rent 5 (11.4) 7 (7.8) 2 (2.5)
Other 2 (4.5) 2 (2.2) 5 (6.3)
Missing 1 (1.1) 1 (1.3)
Lives alone
Yes 6 (13.6) 19 (21.1) 12 (15.0)
No 34 (77.3) 67 (74.4) 64 (80.0)
Missing 4 (9.1) 4 (4.4) 4 (5.0)
Employment status
Full-time 12 (27.3) 30 (33.3) 35 (43.8)
Part-time 7 (15.9) 10 (11.1) 8 (10.0)
Homemaker 0 (0.0) 0 (0.0) 0 (0.0)
Retired 22 (50.0) 45 (50.0) 32 (40.0)
Unemployed 3 (6.8) 5 (5.6) 4 (5.0)
Missing 1 (1.3)
Type of work
Manual 12 (63.2) 27 (67.5) 24 (55.8)
Non-manual 6 (31.6) 11 (27.5) 15 (34.9)
Not sure 1 (5.3) 1 (2.5) 3 (7.0)
Missing 1 (2.5) 1 (2.3)
Off sick or working reduced duties
Yes, off sick 3 (15.8) 5 (12.5) 4 (9.3)
Yes, working reduced duties 5 (26.3) 8 (20.0) 8 (18.6)
No, working usual duties 11 (57.9) 27 (67.5) 31 (72.1)
Would you be able to do your job or everyday activities with arm in a sling?
No 18 (40.9) 48 (53.3) 43 (53.8)
Yes, with difficulty 19 (43.2) 35 (38.9) 31 (38.8)
Yes, no difficulty 4 (9.1) 2 (2.2) 5 (6.3)
Missing 3 (6.8) 5 (5.6) 1 (1.3)
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TABLE 22 Attitudes to surgery at recruitment in the rest-then-exercise groups
Attitude Stratum A (n= 44), n (%) Stratum B (n= 90), n (%) Stratum C (n= 80), n (%)
Doctors rely on surgery too much
Agree 3 (6.8) 5 (5.6) 5 (6.3)
Uncertain 26 (59.1) 35 (38.9) 29 (36.3)
Disagree 13 (29.5) 42 (46.7) 39 (48.8)
Strongly disagree 2 (4.5) 7 (7.8) 5 (6.3)
Missing 1 (1.1) 2 (2.5)
Doctors place too much trust in surgery
Strongly agree 1 (2.3)
Agree 9 (20.5) 7 (7.8) 8 (10.0)
Uncertain 22 (50.0) 35 (38.9) 33 (41.3)
Disagree 11 (25.0) 43 (47.8) 33 (41.3)
Strongly disagree 1 (2.3) 4 (4.4) 3 (3.8)
Missing 1 (1.1) 3 (3.8)
Worry about surgery risks
Strongly agree 3 (6.8) 12 (13.3) 4 (5.0)
Agree 20 (45.5) 35 (38.9) 33 (41.3)
Uncertain 8 (18.2) 14 (15.6) 16 (20.0)
Disagree 12 (27.3) 23 (25.6) 20 (25.0)
Strongly disagree 1 (2.3) 4 (4.4) 4 (5.0)
Missing 2 (2.2) 3 (3.8)
Surgery should be only a last resort
Strongly agree 6 (13.6) 12 (13.3) 11 (13.8)
Agree 17 (38.6) 48 (53.3) 36 (45.0)
Uncertain 9 (20.5) 12 (13.3) 13 (16.3)
Disagree 11 (25.0) 15 (16.7) 15 (18.8)
Strongly disagree 1 (2.3) 3 (3.3) 2 (2.5)
Missing 3 (3.8)
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Outcomes in those allocated to rest then exercise
Outcomes of all those allocated to rest then exercise (i.e. by ITT) are presented in Table 23. As with the full
trial data presented in previous chapters, these data show that participants demonstrated substantial
improvements in quality of life from baseline to final follow-up at 2 years.
TABLE 23 Health status by ITT group
Measure
Stratum A (n= 44),
n, mean (SD)
Stratum B (n= 90),
n, mean (SD)
Stratum C (n= 80),
n, mean (SD)
OSS
Baseline 44, 23.7 (8.3) 90, 23.5 (8.0) 80, 26.2 (7.9)
8 months 39, 37.6 (7.0) 69, 34.8 (9.7) 68, 37.1 (8.8)
12 months 37, 39.3 (7.4) 65, 38.7 (8.9) 62, 40.1 (9.0)
24 months 34, 41.1 (7.5) 64, 39.2 (10.8) 56, 41.9 (8.2)
SPADI pain
Baseline 44, 73.0 (22.0) 89, 73.1 (19.4) 80, 69.4 (18.2)
8 months 39, 33.3 (24.5) 68, 37.4 (28.1) 64, 30.0 (26.1)
12 months 35, 26.3 (27.1) 61, 24.3 (26.6) 58, 22.0 (25.2)
24 months 33, 19.1 (23.4) 62, 22.9 (30.1) 54, 16.4 (23.8)
SPADI disability
Baseline 44, 63.0 (23.7) 90, 64.4 (22.1) 77, 57.7 (23.3)
8 months 38, 26.6 (23.5) 66, 33.3 (27.9) 65, 26.3 (25.3)
12 months 35, 21.8 (22.7) 60, 20.7 (24.7) 57, 20.0 (26.8)
24 months 32, 16.2 (22.4) 62, 20.0 (27.6) 54, 13.2 (22.3)
SPADI
Baseline 44, 66.9 (22.1) 90, 67.8 (20.4) 79, 62.3 (20.1)
8 months 38, 29.2 (23.4) 67, 34.9 (27.5) 64, 27.7 (25.0)
12 months 35, 23.5 (23.9) 61, 22.5 (25.2) 57, 21.1 (26.3)
24 months 32, 17.1 (22.5) 62, 21.1 (28.2) 54, 14.7 (22.5)
MHI-5
Baseline 44, 21.5 (5.5) 90, 22.7 (4.9) 80, 22.9 (4.6)
8 months 37, 24.5 (4.3) 68, 23.8 (4.8) 64, 23.8 (4.8)
12 months 35, 22.9 (4.8) 62, 23.8 (5.4) 58, 24.2 (4.6)
24 months 33, 24.1 (3.8) 62, 24.6 (4.6) 54, 25.3 (4.0)
EQ-5D
Baseline 43, 0.448 (0.332) 89, 0.503 (0.287) 79, 0.538 (0.298)
8 months 36, 0.740 (0.143) 68, 0.691 (0.272) 67, 0.722 (0.232)
12 months 35, 0.703 (0.262) 63, 0.750 (0.257) 61, 0.778 (0.257)
24 months 34, 0.797 (0.153) 63, 0.736 (0.291) 57, 0.780 (0.304)
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Outcomes in those allocated to rest then exercise but who did
not complete the 10-week course before progressing to surgery
In total, 77 (36%) of the 214 participants initially randomised to rest then exercise progressed to surgery
before completion of the 10-week rest-then-exercise course. Outcomes at each time point in this specific
subgroup of participants are presented in Table 24.
TABLE 24 Health status in those who did not complete the 10-week rest-then-exercise course before progressing
to surgery
Measure
Stratum A (n= 14),
n, mean (SD)
Stratum B (n= 36),
n, mean (SD)
Stratum C (n= 27),
n, mean (SD)
OSS
Baseline 14, 24.5 (8.8) 36, 23.3 (8.2) 27, 26.3 (8.3)
8 months 14, 39.4 (5.7) 26, 35.8 (9.7) 27, 39.4 (8.5)
12 months 13, 40.0 (8.1) 26, 39.3 (8.1) 25, 41.3 (9.3)
24 months 12, 40.7 (8.0) 25, 39.4 (10.7) 22, 42.1 (9.8)
SPADI pain
Baseline 14, 70.0 (23.7) 35, 74.7 (19.8) 27, 72.1 (16.6)
8 months 14, 28.7 (22.1) 26, 36.0 (29.3) 27, 22.4 (23.6)
12 months 13, 20.2 (24.6) 25, 19.3 (21.4) 24, 17.2 (24.6)
24 months 11, 16.4 (23.8) 24, 25.9 (31.8) 22, 16.2 (29.4)
SPADI disability
Baseline 14, 60.4 (27.3) 36, 65.0 (21.9) 25, 58.4 (22.9)
8 months 14, 26.4 (21.5) 25, 28.8 (27.5) 27, 20.1 (25.6)
12 months 13, 19.7 (22.7) 25, 14.7 (18.8) 25, 17.3 (26.5)
24 months 11, 16.9 (24.1) 24, 19.5 (26.8) 22, 13.6 (26.9)
SPADI
Baseline 14, 64.1 (25.3) 36, 23.3 (8.2) 27, 26.3 (8.3)
8 months 14, 27.3 (21.2) 26, 30.9 (27.7) 27, 21.0 (24.4)
12 months 13, 19.9 (22.8) 25, 16.5 (19.5) 25, 18.3 (26.9)
24 months 11, 16.7 (23.7) 24, 22.0 (28.4) 22, 14.6 (27.6)
MHI-5
Baseline 14, 23.3 (3.9) 36, 23.3 (4.4) 27, 23.0 (5.5)
8 months 14, 24.7 (3.3) 26, 24.1 (4.5) 26, 23.7 (5.2)
12 months 13, 23.1 (5.2) 26, 24.3 (4.1) 25, 23.6 (5.5)
24 months 11, 23.7 (4.2) 24, 24.5 (3.8) 22, 24.7 (5.2)
EQ-5D
Baseline 14, 0.460 (0.343) 36, 0.476 (0.289) 26, 0.525 (0.306)
8 months 13, 0.817 (0.138) 26, 0.735 (0.198) 26, 0.765 (0.239)
12 months 12, 0.813 (0.138) 26, 0.754 (0.241) 25, 0.785 (0.300)
24 months 12, 0.777 (0.171) 25, 0.714 (0.311) 22, 0.812 (0.289)
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Outcomes in those allocated to rest then exercise who
completed the full 10-week course but still progressed to
have surgery
In total, 88 (41%) of those allocated to rest then exercise completed the full 10-week course but despite
this progressed to surgery. Outcomes at each time point in this specific subgroup of participants are
presented in Table 25.
TABLE 25 Health status in those who completed the 10-week rest-then-exercise course before progressing
to surgery
Measure
Stratum A (n= 24),
n, mean (SD)
Stratum B (n= 31),
n, mean (SD)
Stratum C (n= 33),
n, mean (SD)
OSS
Baseline 24, 21.6 (7.6) 31, 22.6 (7.0) 33, 24.8 (7.6)
8 months 20, 35.6 (8.1) 27, 34.6 (9.6) 30, 35.0 (9.5)
12 months 19, 38.3 (7.4) 24, 39.8 (8.3) 27, 39.6 (8.4)
24 months 18, 42.1 (6.8) 24, 41.8 (10.8) 25, 42.1 (7.8)
SPADI pain
Baseline 24, 78.8 (20.2) 31, 74.6 (14.4) 33, 69.9 (18.0)
8 months 20, 39.2 (27.0) 27, 36.4 (25.5) 29, 37.1 (27.3)
12 months 18, 32.3 (30.8) 22, 22.0 (26.6) 25, 23.4 (25.0)
24 months 18, 20.4 (25.6) 24, 12.4 (25.1) 23, 15.3 (21.3)
SPADI disability
Baseline 24, 69.2 (20.2) 31, 68.3 (18.2) 32, 59.4 (23.0)
8 months 19, 31.7 (25.9) 27, 34.5 (28.3) 29, 32.2 (24.4)
12 months 18, 25.0 (24.7) 22, 20.7 (26.2) 24, 20.8 (27.6)
24 months 18, 15.9 (23.2) 24, 13.9 (27.4) 23, 11.8 (20.0)
SPADI
Baseline 24, 73.0 (19.1) 31, 70.8 (16.3) 33, 63.1 (20.2)
8 months 19, 34.7 (26.2) 27, 35.2 (26.8) 29, 34.0 (24.6)
12 months 18, 27.8 (26.8) 22, 21.2 (26.1) 24, 22.2 (26.2)
24 months 18, 17.6 (23.8) 24, 13.3 (26.2) 23, 13.7 (20.2)
MHI-5
Baseline 24, 20.1 (6.4) 31, 22.6 (4.9) 33, 22.8 (4.0)
8 months 18, 24.1 (5.2) 27, 24.9 (3.8) 29, 23.5 (4.7)
12 months 18, 22.8 (4.7) 22, 24.6 (5.6) 24, 24.8 (3.5)
24 months 18, 24.8 (3.4) 24, 26.3 (3.7) 23, 25.2 (2.9)
EQ-5D
Baseline 23, 0.386 (0.323) 30, 0.532 (0.242) 33, 0.518 (0.304)
8 months 19, 0.669 (0.116) 27, 0.726 (0.225) 29, 0.657 (0.250)
12 months 18, 0.603 (0.306) 24, 0.812 (0.165) 27, 0.780 (0.209)
24 months 18, 0.811 (0.141) 23, 0.808 (0.258) 26, 0.717 (0.354)
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Outcomes in those allocated to rest then exercise who
completed the full 10-week course and did not proceed
to surgery
In total, 36 (17%) of those allocated to rest then exercise completed the full 10-week course and had no
surgical intervention. Outcomes at each time point in this specific subgroup of participants are presented in
Table 26. A further 14 rest-then-exercise patients withdrew from the study over the course of the study.
TABLE 26 Health status in those who completed the 10-week rest-then-exercise course and did not proceed
to surgery
Measure
Stratum A (n= 5),
n, mean (SD)
Stratum B (n= 16),
n, mean (SD)
Stratum C (n= 15),
n, mean (SD)
OSS
Baseline 5, 32.0 (6.4) 16, 25.3 (8.4) 15, 27.7 (7.7)
8 months 5, 40.8 (3.4) 15, 35.0 (9.4) 11, 37.4 (6.5)
12 months 5, 41.2 (5.8) 14, 37.8 (9.2) 10, 38.4 (10.1)
24 months 4, 37.5 (9.6) 14, 36.5 (8.5) 9, 40.9 (5.2)
SPADI
Baseline 5, 54.8 (19.2) 16, 69.9 (25.5) 15, 64.7 (21.5)
8 months 5, 22.4 (15.3) 14, 38.4 (30.0) 8, 30.0 (25.8)
12 months 4, 19.5 (10.0) 13, 32.5 (29.2) 9, 30.7 (27.5)
24 months 4, 20.6 (13.9) 13, 31.4 (27.5) 9, 20.0 (15.2)
SPADI disability
Baseline 5, 42.8 (21.9) 16, 59.9 (25.2) 15, 54.3 (26.4)
8 months 5, 7.9 (5.9) 13, 35.5 (26.1) 9, 26.3 (25.7)
12 months 4, 14.1 (12.0) 12, 27.3 (24.1) 8, 26.1 (27.8)
24 months 3, 15.0 (17.4) 13, 28.1 (25.6) 9, 15.6 (16.7)
SPADI
Baseline 5, 47.4 (18.4) 16, 63.8 (24.7) 15, 58.3 (23.4)
8 months 5, 13.5 (7.2) 13, 37.9 (26.9) 8, 27.7 (26.0)
12 months 4, 16.2 (11.1) 13, 30.9 (25.3) 8, 26.5 (27.2)
24 months 3, 15.6 (15.6) 13, 29.3 (25.9) 9, 17.3 (15.1)
MHI-5
Baseline 5, 23.8 (3.3) 16, 22.2 (4.8) 15, 22.5 (4.4)
8 months 5, 25.8 (3.3) 14, 21.0 (6.4) 9, 25.4 (3.8)
12 months 4, 22.6 (5.1) 13, 22.0 (6.9) 9, 24.0 (4.4)
24 months 4, 22.0 (4.7) 13, 21.9 (6.2) 9, 26.8 (2.6)
EQ-5D
Baseline 5, 0.655 (0.335) 16, 0.469 (0.345) 15, 0.603 (0.271)
8 months 4, 0.829 (0.115) 14, 0.548 (0.419) 12, 0.782 (0.116)
12 months 5, 0.800 (0.199) 12, 0.636 (0.392) 9, 0.755 (0.289)
24 months 4, 0.790 (0.187) 14, 0.674 (0.305) 9, 0.883 (0.094)
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Chapter 6 Health economics
Methods: overview
The health economic analyses evaluate the total resource use and costs of rotator cuff repair and quality of
life over the follow-up period of the trial. The primary economic outcome is additional cost per QALY gained
of arthroscopic repair compared with open repair over a time horizon of 24 months, by ITT analysis. This
outcome was assessed using patients allocated to arthroscopic and open repair in stratum A only, although
cost and quality-of-life outcomes from stratum B (arthroscopic repair only) and stratum C (open repair only)
are also reported. Lifetime extrapolation was not conducted for this analysis.
All analyses were conducted from the perspective of the NHS. Cost components included all initial and
subsequent inpatient episodes and outpatient hospital visits, as well as GP, nurse and physiotherapist visits
during follow-up.
Resource-use data collection
Resource-use for initial surgery
Individual patient data on time in theatre and number and type of bone anchors used were collected using
a data collection form completed by health-care staff at the time of surgery. Additional equipment use
during surgery was incorporated as a fixed cost of consumables. Further details of the assumed costs are
given in Tables 27 and 28. The number of nights in hospital immediately following initial surgery was
calculated for each patient as the difference between the date of surgery and the discharge date reported
on the patient questionnaire at 2 weeks (or at 8 weeks if not reported at 2 weeks).
TABLE 27 Unit costs
Cost category
Unit cost
(GB£ 2012/13) Source and description
Rest-then-exercise programme
Cost of rest-then-exercise
programme materials
44.56 Based on actual printing costs for main trial booklets and rest-then-
exercise intervention booklets, cost of envelopes for sending materials
to patients, cost of a sling and set-up costs for a Freephone number
Surgery costs (all patients)a
Cost per minute in theatre 16.43 Mean cost per minute in orthopaedic operating theatre. Average over
15 NHS boards in Scotland, year end March 2013. Information Services
Division Scotland release 17 December 201375
Cost per anchor
Open repair 103.67/105.34 Manufacturers’ list prices with a price discount applied. Costs presented
are the average anchor cost for patients receiving each type of surgery
(stratum A/all patients). The undiscounted list prices for the anchors
ranged from £141 to £262. The illustrative average anchor cost here is
based on the mean total anchor cost divided by the mean number of
anchors (using imputed data)
Arthroscopic repair 107.43/107.31
Other procedures 98.52/102.96
continued
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TABLE 27 Unit costs (continued )
Cost category
Unit cost
(GB£ 2012/13) Source and description
Additional fixed surgical costs
Average cost per suture 7.14 Average of manufacturers’ list prices (discountedb) for each suture type
recorded on theatre forms
Drapesc 16.41 Manufacturers’ list prices (discountedb) for shoulder arthroscopy drape
and video camera drape
Fluid management system
1-day tubingc
20.30 Manufacturers’ list prices, discountedb
90° suction electroded 90.00 Hospital cost obtained (£90 discounted price provided by manufacturerb)
5.5mm full radius resectore 57.51 Manufacturers’ list prices, discountedb
4.0mm oval burre 57.51 Manufacturers’ list prices, discountedb
Monopolar diathermy ESU
pencilf
1.93 Manufacturers’ list prices, discountedb
Arthroscopic suture needleg 157.14 Cost obtained from supplier to the Nuffield Orthopaedic Centre, discountedb
Post-surgery and follow-up costsa
Cost per inpatient bed-day 378.93 Elective inpatient excess bed-day from 2012–13 NHS reference costs
(‘The main schedule’, ‘El_XS’ tab).76 Weighted average of all shoulder
and upper-arm procedures for non-trauma, ‘Trauma and Orthopaedics’
Surgery during follow-up
Repair (open) 1977.68 All calculated from the average cost for each type of procedure within
the trial (cost of time in theatre, anchors and fixed equipment).
The cost of nights in hospital relating to surgery during follow-up was
incorporated separately
Repair (arthroscopic) 2192.80
Repair (unknown type) 2085.24
Reverse shoulder
replacement
3722.11 Elective inpatient excess bed-day from 2012–13 NHS reference costs
(‘The main schedule’, ‘El_XS’ tab).76 Weighted average inpatient cost
for major shoulder and upper-arm procedures with/without CC,
non-trauma, ‘Trauma and Orthopaedics’
Washout procedure 337.48 Elective inpatient excess bed-day from 2012–13 NHS reference costs
(‘The main schedule’, ‘El_XS’ tab).76 Weighted average of minor and
intermediate shoulder and upper arm procedures for non-trauma,
‘Trauma and Orthopaedics’
Cost per appointment with
GP
37.00 Consultation lasting 11.7 minutes, including direct care staff costs,
excluding qualification costs. From Unit Costs of Health and Social Care
2013, Table 10.8b77
Cost per appointment with
nurse
11.34 Based on a 15.5-minute face-to-face consultation. From Unit Costs of
Health and Social Care 2013, Table 10.677
Cost per session with
physiotherapist
43.69 Weighted average of NHS own costs for hospital- and community-
based appointments. From 2012–13 NHS reference costs (‘The main
schedule’, ‘NCL’ and ‘CHSAHP’ tabs)76
Outpatient visits (shoulder) 162.08 Weighted average outpatient cost for major, intermediate and minor
outpatient procedures. From 2012–13 NHS reference costs (OPROC tab)76
ESU, electrosurgery unit.
a Applied to all patients according to resource use for each patient.
b An assumed price discount of 30% has been applied to the list prices to produce the cost to the hospital (as shown)
for surgical items.
c All procedures.
d Mini-open repair, arthroscopic repair and all subacromial decompression, biceps tenotomy and capsular release procedures.
e Mini-open repair, arthroscopic repair and all subacromial decompression procedures.
f Open repair, mini-open repair and open partial-thickness tear procedures.
g Arthroscopic procedures only.
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Resource use during follow-up
Information on health-care resource use after discharge was collected using patient questionnaires that
were administered to all patients at 12 and 24 months, with responses in both questionnaires covering
the 12 months prior to form completion. Data collected included the number of visits to a GP, nurse
or physiotherapist/occupational therapist, the number of hospital outpatient and inpatient admissions and
the number of nights in hospital; data were also collected on employment status, as reported in Chapter 4.
Resource-use data were also available from a questionnaire administered at 8 months; however, the
12-month questionnaire also covered the 8-month follow-up period and so the 8-month responses were
not used in the resource-use analysis (but they were used in the quality-of-life analysis; see later in
this chapter).
Information on use of medications provided by the health-care system (mostly painkillers) was obtained
from the 2-week and 8-week post-surgery questionnaires. It was assumed that the dosages reported on
the questionnaires were the daily doses taken throughout the time period covered by the questionnaire
responses (2 weeks for the 2-week questionnaire, 6 weeks for the 8-week questionnaire).
Data on surgical procedures during follow-up (e.g. revision repair surgery, washout for infection), along
with nights spent in hospital relating to the procedures, were obtained from the 8-, 12-, and
24-month questionnaires.
TABLE 28 Aggregated fixed surgical costs by procedure type (unit costs are presented in Table 27)
Procedure details n (%)a
Fixed procedure costs
(GB£, discountedb)
Open repair
Fully-open 84 (44) 39.96
Mini-open (with arthroscopic SAD) 105 (55) 244.97
Weighted average 153.98
Arthroscopic repair 190 (100) 319.64
Other procedures
Biceps tenotomy 4 (3) 126.71
Capsular release 5 (4) 126.71
Partial-thickness tear (open) 1 (1) 38.64
SAD±ACJ excision (arthroscopic) 112 (81) 241.72
Impossible to repair/no other procedure 6 (4) 36.71
Weighted average 222.29
ACJ, acromioclavicular joint.
a Three (1%) for open repair and 11 (8%) for other procedures were not included in the weighting because procedure
details were unknown.
b An assumed price discount of 30% has been applied to the list prices to produce the cost to the hospital (as shown)
for surgical items.
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Unit costs and application to resource use
Cost of initial treatment
Costs relating to surgical procedures were based on time in theatre, anchors used and nights spent in
hospital after the procedure. Time in theatre was obtained from a surgery data collection form and a unit
cost per minute in theatre was obtained using a national average figure for orthopaedic surgery theatres
reported by the Information Services Division in Scotland.75 List prices for the anchors used in the trial
(identified by brand and product name from the surgery data collection form) were obtained from the
various manufacturers and a 30% price discount was applied to these costs based on the assumption that
the amount paid by the hospital would be less than the list price. The unit cost used for nights in hospital
following surgery was the cost of an orthopaedic inpatient bed-day, obtained from NHS reference costs.76
Additional fixed equipment costs
In addition to patient-specific time in theatre and number of anchors, a fixed cost for consumables was
included in the cost of initial surgery, under the assumption that the same set of single-use consumables
would be used for each procedure (but varying by procedure type). This cost incorporated single-use items
such as drapes, tubing and surgical devices, including bone shavers and needle passers. The surgical items
used were assumed to be the same for each patient receiving a certain type of procedure (open repair,
arthroscopic repair and so on). Further information on these items is given Table 27, with the total fixed
costs given in Table 28. Other surgery-related resource-use items, such as theatre running costs, staffing,
machinery and reusable equipment, were incorporated in the running costs per minute in theatre given in
Table 27, which was applied using time in theatre for each patient.
Cost of revision surgery
Individual patient data on time in theatre and number of anchors were not available for revision surgery.
Therefore, patients returning for a revision repair procedure were assumed to accrue a cost equal to the
total procedure cost observed for the initial procedure (for the reported revision procedure type).
Information on the total number of nights spent in hospital during follow-up was reported separately on
the follow-up form and was assumed to include nights spent in hospital during the revision procedure.
Costs for non-repair procedures during follow-up (e.g. washout for infection, shoulder replacement) were
obtained from NHS reference costs,76 as detailed in Table 27.
Unit costs for other health-care resource use were obtained from national sources,76,77 as summarised in
Table 27.
Costs for the rest-then-exercise arm
Costs for the rest-then-exercise intervention were applied for all patients who had been allocated to the
intervention (and therefore were sent the materials), regardless of their subsequent treatment.
The rest-then-exercise intervention consisted of an A4 colour booklet with information on rotator cuff tears
and a management strategy of relative rest and then subsequent exercises. This was delivered by post with
a sling and an accompanying CD showing moving images of the exercises. A Freephone number giving
access to a shoulder physiotherapist was provided. Information on the costs of preparing, printing and
distributing the booklet and CD was obtained from the trial co-ordinators in Oxford.
Application of unit costs
Unit costs were multiplied by resource use to obtain a total cost for each resource-use component and a
total cost for each patient was obtained by summing all components. No further costs were accrued for
patients who had died.
A discount rate of 3.5% per annum was applied to all costs accrued after 12 months, in line with standard
guidelines for economic evaluations.78 Costs are reported in UK pounds and the cost year is 2012–13.
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Quality of life
Quality of life was measured at baseline and 8, 12 and 24 months using the five domains of the EQ-5D-3L
questionnaire,68,71 with patients reporting levels of mobility, self-care, usual activities, pain/discomfort and
anxiety/depression using a 3-point scale. (For a summary of the proportion of responses at each level of
each domain for each time point of follow-up, see Table 38.) The responses for the domains were
converted to quality-of-life valuations using the Stata command ‘eq5d’ (Stata/SE version 12; StataCorp LP,
College Station, TX, USA), which uses a value set based on the preferences of a large sample of the UK
population to produce a EQ-5D index score for each patient at each time point. The possible range for the
index scores when using the UK value set runs from –0.594 to 1, with a higher index indicating a better
quality of life and an index of zero representing quality of life equivalent to death. An EQ-5D index score
of zero was assumed for patients who had died.
The EQ-5D index scores were used to estimate the total QALYs for each patient between the 8-, 12- and
24-month follow-up points, as well as the total QALYs at 24 months. QALYs were calculated from the area
under the curve after linear interpolation of the EQ-5D index score between time points. A discount rate
was applied to QALYs after 12 months, at a rate of 3.5% per annum.78
Dealing with missing data
Table 29 shows the number of complete cases (individuals with complete data for all resource-use, cost and
QALY outcome variables) at each follow-up point by treatment arm. Missing data were handled using
multiple imputation methods. Imputation via chained equations (with the ‘mi impute chained’ command in
Stata) was used to impute the missing values in the original data set, based on all other variables included in
the imputation model, to produce a specified number of complete data sets. Three imputation models were
constructed for (1) resource-use parameters (number of health-care visits and number of nights in hospital),
(2) reported out-of-pocket costs (medications, transportation, private health care, lost earnings) and (3) the
five EQ-5D-3L domains at each follow-up point. Thirty data sets were produced for this analysis to align with
the greatest level of missingness among the imputed variables. The data sets were then combined using
the ‘mi estimate’ command in Stata, which applies Rubin’s rules when combining estimates from multiple
imputed data sets to account for variation both within and between data sets. Imputation was conducted
separately for initial hospitalisation, follow-up resource-use/costs and quality-of-life data. All imputation
models included variables for patient characteristics (age, sex, size of tear, duration of shoulder problems at
baseline) and indicators for centre and treatment allocation. For quality of life each domain of the EQ-5D-3L
was imputed (rather than the index score directly) and baseline EQ-5D-3L domains were also included in
the imputation model.
TABLE 29 Number (%) of complete cases by follow-up point and treatment arm in the original data
Follow-up point
n (%) with complete data for all outcome variables
Stratum A (n= 317) Stratum B (n= 181) Stratum C (n= 162)
At dischargea 199 (63) 94 (52) 92 (57)
12 monthsb 113 (36) 40 (22) 46 (28)
24 monthsc 104 (33) 36 (20) 42 (26)
a Variables included costs of theatre time, anchors, equipment and nights in hospital.
b Variables included as above plus the cost of revision surgery, out-of-pocket costs (medication, health-care visits, hospital
stays) and QALYs at 12 months.
c Variables included as above plus the cost/resource-use/QALY outcome variables (as for 12 months) at 24 months.
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Incremental analysis
Under conventional decision rules, specifically those used by the National Institute for Health and Care
Excellence (NICE), the cost-effectiveness of a technology is assessed using the incremental cost-effectiveness
ratio (ICER), which is based on the additional cost per QALY gained compared with the current best
practice. The guidance for methods of economic evaluation produced by NICE78 states that a technology
with an ICER below £20,000 per QALY gained is likely to be deemed cost-effective. Technologies with
ICERs above £30,000 are unlikely to be considered cost-effective unless additional justification is provided.
In addition, the likelihood of a technology being accepted as cost-effective decreases as the ICER increases
from £20,000 to £30,000.
Incremental cost-effectiveness ratio
The incremental analysis is presented in terms of the total additional cost per QALY gained for arthroscopic
repair compared with open repair (referred to as the ICER throughout). The ICER was calculated as the
difference in total costs at 24 months divided by the difference in QALYs for arthroscopic repair compared
with open repair.
Analysis of uncertainty
Uncertainty around the ICER was characterised using 1000 non-parametric bootstrap replicates of the
mean total cost and effect differences (adjusted for covariates for certain analyses, as detailed in the results
section) between the arthroscopic repair group and the open repair group in the data. The 30 multiple
imputed data sets were merged to produce one data set prior to bootstrapping.
Results
This section presents the results of the economic analysis. Resource use during initial surgery (implants,
theatre time) and the follow-up period (appointments with health-care professionals, hospital visits and so
on) is presented, along with the associated costs up to 24 months after surgery. Results were adjusted for
covariates when specified [EQ-5D score at baseline (for QALY outcomes only), age, tear size, centre].
All results are based on imputed data unless ‘original data’ is specified.
Four analyses are presented for the economic outcomes:
(a) ITT, no adjustment for covariates – base case
(b) ITT, adjusting for covariates
(c) per protocol (only those patients receiving the allocated treatment), no adjustment for covariates
(d) per protocol (only those patients receiving the allocated treatment), adjusting for covariates.
Covariates for age, tear size and centre were included when calculating mean cost and effect differences
for analyses (b) and (d). Effect differences for analyses (b) and (d) were also adjusted for EQ-5D index score
at baseline.
Resource-use results
Resource-use results for initial surgery and during follow-up are presented in Tables 30–32. There were no
significant differences between the arthroscopic repair group and the open repair group for any of the
resource-use categories for the base-case ITT analysis, apart from outpatient visits, for which there were
0.7 (95% CI –1.5 to 0.0) fewer visits between surgery and the 12-month follow-up for the arthroscopic
repair group (see Table 31). When adjusting for covariates this difference became non-significant.
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For the per-protocol analysis there was a significant difference in theatre time between patients receiving
an arthroscopic repair and patients receiving an open repair, at a mean of 17.8 (95% CI 6.4 to 29.2)
minutes longer for arthroscopic repair when not adjusting for covariates and 14.1 (95% CI 4.0 to 24.3)
minutes longer for arthroscopic repair when adjusting for covariates (see Table 30). However, none of the
other resource-use categories for either initial surgery or follow-up were significantly different between the
two treatment groups (see Tables 30 and 32).
Cost results
Intention-to-treat analysis
Cost outcomes for initial surgery for the base-case ITT analysis are presented in Table 33. For the ITT
analysis the difference in total initial procedure-related costs between treatment groups was not significant
at the p= 0.05 level, whether adjusting for covariates or not.
The difference in total cost of surgery alone (excluding the cost of nights in hospital after the procedure)
was non-significant without covariate adjustment in the base case but significant when adjusted for
covariates, at a mean of £187 (95% CI £35 to £339) more costly for the arthroscopic repair group than
the open repair group. Additional equipment costs were significantly more costly for arthroscopic repair,
being £58 (95% CI £31 to £84) more costly for arthroscopic repair without covariate adjustment and
£77 (95% CI £56 to £97) more costly for arthroscopic repair with covariate adjustment.
Follow-up costs to 24 months for the base-case ITT analysis are presented in Table 34. The only resource-use
category that had a significance cost difference between groups was outpatient visits, which were £121
(95% CI £2 to £240) less costly between surgery and 12 months’ follow-up for the arthroscopic group than
for the open repair group (without adjustment for covariates). When adjusting for covariates this difference
became non-significant. There were no significant differences in mean cost between the arthroscopic repair
group and the open repair group for any other component resource-use category, nor were there any
significant differences in total follow-up costs at 12 months or 24 months. The total time-discounted mean
cost difference between arthroscopic repair and open repair at 24 months for the unadjusted base-case ITT
analysis was negative at –£132 (95% CI –£589 to £324), suggesting that arthroscopic repair is less costly
overall. The difference was positive after adjusting for covariates (£105, 95% CI –£255 to £466), suggesting
that arthroscopic repair is more costly overall, although both results were non-significant.
Per-protocol analysis
For the per-protocol analysis there was a significant difference in the total initial procedure-related cost
between the arthroscopic repair group and the open repair group, at £371 (95% CI £135 to £607) more
costly for arthroscopic repair with no covariate adjustment and £315 (95% CI £93 to £536) more costly for
arthroscopic repair with covariate adjustment (see Table 33).
The total cost of surgery alone (excluding nights in hospital) was also significantly different between the
two groups, at £463 (95% CI £260 to £666) more costly for arthroscopic repair without covariate
adjustment and £410 (95% CI £232 to £589) more costly for arthroscopic repair with covariate
adjustment. This difference was largely driven by the longer theatre time for the arthroscopic repair group.
The cost of theatre time was significantly different between the two treatment groups, in line with the
resource-use outcomes for time in theatre. Theatre time was £292 (95% CI £105 to £479) more costly
for arthroscopic repair without covariate adjustment and £232 (95% CI £66 to £399) more costly for
arthroscopic repair with covariate adjustment.
Follow-up costs to 24 months for the per-protocol analysis are presented in Table 35. There were no
significant differences between the two treatment groups for any of the cost components. The mean total
cost at 24 months was greater for arthroscopic repair by £222 (95% CI –£328 to £773) without covariate
adjustment and by £207 (95% CI –£341 to £754) with covariate adjustment, suggesting that arthroscopic
repair is more costly over the follow-up period, although again neither outcome was significant.
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Quality-of-life results
Table 36 presents a summary of the mean EQ-5D index score at each follow-up point (8, 12 and
24 months). The proportions of responses at each level of the five domains at each time point are
presented in Tables 37–40 for the non-imputed data and in Tables 41–44 for the imputed data. QALYs
from baseline to 24 months’ follow-up are presented in Table 45.
Intention-to-treat analysis
For the base-case ITT analysis, there were no significant differences in total QALYs between the
arthroscopic repair group and the open repair group at 8, 12 or 24 months. The mean difference in total
QALYs between the groups at 24 months with time discounting was negative, both without (0.00, 95% CI
–0.11 to 0.10) and with (–0.04, 95% CI –0.12 to 0.05) adjustment for covariates, suggesting worse
outcomes for the arthroscopic repair group, although both values were non-significant.
Per-protocol analysis
There were no significant differences between the two groups in the per-protocol analysis for any of the
quality-of-life outcomes. Again, the mean difference in total QALYs between the groups was negative for
both the unadjusted analysis (–0.03, 95% CI –0.17 to 0.12) and the adjusted analysis (–0.06, 95% CI
–0.17 to 0.06), suggesting that arthroscopic repair may be less effective, although again both results were
non-significant.
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TABLE 37 Number (%) of responses for each level in each domain of the EQ-5D questionnaire: original data,
all strata
Level Mobility Self-care Activity Pain Anxiety
Baseline
1 505 (77) 358 (54) 90 (14) 16 (2) 427 (65)
2 152 (23) 299 (45) 519 (79) 474 (72) 207 (31)
3 – 2 (0) 51 (8) 169 (26) 25 (4)
Missing 3 (0) 1 (0) – 1 (0) 1 (0)
8 months
1 437 (66) 413 (63) 241 (37) 142 (22) 412 (63)
2 141 (21) 158 (24) 309 (47) 399 (61) 151 (23)
3 – 5 (1) 27 (4) 35 (5) 12 (2)
Missing 80 (12) 82 (12) 81 (12) 82 (12) 83 (13)
12 months
1 414 (63) 443 (67) 290 (44) 194 (29) 408 (62)
2 145 (22) 112 (17) 247 (38) 323 (49) 137 (21)
3 1 (0) 3 (0) 24 (4) 42 (6) 12 (2)
Missing 98 (15) 100 (15) 97 (15) 99 (15) 101 (15)
24 months
1 387 (59) 449 (69) 308 (47) 232 (36) 414 (63)
2 155 (24) 90 (14) 219 (34) 283 (43) 119 (18)
3 – 4 (1) 16 (2) 28 (4) 9 (1)
Missing 111 (17) 110 (17) 110 (17) 110 (17) 111 (17)
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TABLE 38 Number (%) of responses for each level in each domain of the EQ-5D questionnaire: original data,
stratum A
Level Mobility Self-care Activity Pain Anxiety
Baseline
1 244 (77) 176 (56) 45 (14) 9 (3) 209 (66)
2 72 (23) 139 (44) 252 (80) 223 (70) 95 (30)
3 – 2 (1) 20 (6) 84 (27) 12 (4)
Missing 1 (0) – – 1 (0) 1 (0)
8 months
1 216 (68) 210 (66) 115 (36) 72 (23) 194 (61)
2 68 (22) 67 (21) 155 (49) 193 (61) 81 (26)
3 – 5 (2) 15 (5) 19 (6) 8 (3)
Missing 32 (10) 34 (11) 31 (10) 32 (10) 33 (10)
12 months
1 202 (64) 220 (70) 137 (43) 95 (30) 202 (64)
2 75 (24) 55 (17) 129 (41) 161 (51) 70 (22)
3 1 (0) 3 (1) 14 (4) 24 (8) 6 (2)
Missing 38 (12) 38 (12) 36 (11) 36 (11) 38 (12)
24 months
1 191 (61) 224 (71) 151 (48) 107 (34) 203 (65)
2 77 (25) 42 (13) 112 (36) 153 (49) 61 (19)
3 – 2 (1) 5 (2) 8 (3) 4 (1)
Missing 46 (15) 46 (15) 46 (15) 46 (15) 46 (15)
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TABLE 39 Number (%) of responses for each level in each domain of the EQ-5D questionnaire: original data,
stratum B
Level Mobility Self-care Activity Pain Anxiety
Baseline
1 132 (73) 91 (50) 25 (14) 5 (3) 110 (61)
2 48 (27) 90 (50) 141 (78) 127 (70) 65 (36)
3 – – 15 (8) 49 (27) 6 (3)
Missing 1 (1) – – – –
8 months
1 111 (61) 101 (56) 73 (40) 36 (20) 110 (61)
2 39 (22) 49 (27) 71 (39) 101 (56) 37 (20)
3 – – 4 (2) 12 (7) 3 (2)
Missing 31 (17) 31 (17) 33 (18) 32 (18) 31 (17)
12 months
1 105 (58) 112 (62) 70 (39) 49 (27) 103 (57)
2 42 (23) 34 (19) 73 (40) 83 (46) 38 (21)
3 – – 4 (2) 13 (7) 4 (2)
Missing 34 (19) 35 (19) 34 (19) 36 (20) 36 (20)
24 months
1 100 (56) 116 (65) 80 (45) 62 (35) 108 (61)
2 42 (24) 26 (15) 56 (31) 71 (40) 33 (19)
3 – 1 (1) 7 (4) 10 (6) 2 (1)
Missing 36 (20) 35 (20) 35 (20) 35 (20) 35 (20)
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TABLE 40 Number (%) of responses for each level in each domain of the EQ-5D questionnaire: original data,
stratum C
Level Mobility Self-care Activity Pain Anxiety
Baseline
1 129 (80) 91 (56) 20 (12) 2 (1) 108 (67)
2 32 (20) 70 (43) 126 (78) 124 (77) 47 (29)
3 – – 16 (10) 36 (22) 7 (4)
Missing 1 (1) 1 (1) – – –
8 months
1 110 (68) 102 (63) 53 (33) 34 (21) 108 (67)
2 34 (21) 42 (26) 83 (52) 105 (65) 33 (21)
3 – – 8 (5) 4 (2) 1 (1)
Missing 17 (11) 17 (11) 17 (11) 18 (11) 19 (12)
12 months
1 107 (66) 111 (69) 83 (52) 50 (31) 103 (64)
2 28 (17) 23 (14) 45 (28) 79 (49) 29 (18)
3 – – 6 (4) 5 (3) 2 (1)
Missing 26 (16) 27 (17) 27 (17) 27 (17) 27 (17)
24 months
1 96 (60) 109 (68) 77 (48) 63 (39) 103 (64)
2 36 (22) 22 (14) 51 (32) 59 (37) 25 (16)
3 – 1 (1) 4 (2) 10 (6) 3 (2)
Missing 29 (18) 29 (18) 29 (18) 29 (18) 30 (19)
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TABLE 41 Percentage (SE) of responses for each level in each domain of the EQ-5D questionnaire: imputed data,
all strata
Level Mobility Self-care Activity Pain Anxiety
Baseline
1 76.9 (1.6) 54.3 (1.9) 13.6 (1.3) 2.4 (0.6) 64.8 (1.9)
2 23.1 (1.6) 45.4 (1.9) 78.6 (1.6) 71.9 (1.8) 31.4 (1.8)
3
Missing – 0.3 (0.2) 7.7 (1.0) 25.6 (1.7) 3.8 (0.7)
8 months
1 75.3 (1.8) 71.2 (1.9) 41.4 (2.0) 24.4 (1.8) 71.2 (1.9)
2 24.7 (1.8) 27.9 (1.9) 53.8 (2.1) 69.4 (1.9) 26.6 (1.8)
3
Missing – 1.0 (0.4) 4.9 (0.9) 6.2 (1.0) 2.2 (0.6)
12 months
1 73.5 (1.8) 78.7 (1.7) 51.2 (2.1) 34.3 (2.0) 73.1 (1.8)
2 26.2 (1.9) 20.7 (1.7) 44.3 (2.1) 57.7 (2.1) 24.6 (1.8)
3 0.3 (0.3) 0.6 (0.4) 4.5 (0.9) 8.0 (1.1) 2.3 (0.6)
Missing 73.5 (1.8) 78.7 (1.7) 51.2 (2.1) 34.3 (2.0) 73.1 (1.8)
24 months
1 69.9 (1.9) 81.7 (1.7) 55.8 (2.0) 42.6 (2.1) 75.5 (1.8)
2 30.1 (1.9) 17.5 (1.6) 41.0 (2.0) 51.9 (2.2) 22.6 (1.8)
3 – 0.8 (0.4) 3.2 (0.8) 5.5 (1.0) 1.9 (0.6)
Missing 69.9 (1.9) 81.7 (1.7) 55.8 (2.0) 42.6 (2.1) 75.5 (1.8)
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TABLE 43 Percentage (SE) of responses for each level in each domain of the EQ-5D questionnaire: imputed data,
stratum B
Level Mobility Self-care Activity Pain Anxiety
Baseline
1 73.4 (3.3) 50.3 (3.7) 13.8 (2.6) 2.8 (1.2) 60.8 (3.6)
2 26.6 (3.3) 49.7 (3.7) 77.9 (3.1) 70.2 (3.4) 35.9 (3.6)
3 – – 8.3 (2.1) 27.1 (3.3) 3.3 (1.3)
8 months
1 73.7 (3.5) 67.2 (2.2) 47.6 (3.9) 23.7 (3.3) 72.1 (3.5)
2 26.3 (3.5) 32.3 (2.4) 49.0 (4.0) 68.1 (3.8) 25.7 (3.4)
3 – 0.5 (0.7) 3.4 (1.6) 8.2 (2.3) 2.2 (1.2)
12 months
1 71.7 (2.5) 76.9 (1.9) 47.7 (4.2) 33.2 (3.8) 71.2 (3.6)
2 28.1 (2.6) 23.0 (2.0) 49.1 (4.2) 57.6 (4.0) 26.1 (3.4)
3 0.1 (0.5) 0.1 (0.4) 3.2 (1.5) 9.2 (2.3) 2.8 (1.3)
24 months
1 68.5 (3.8) 80.9 (3.2) 55.1 (4.1) 43.4 (4.1) 74.7 (3.5)
2 31.5 (2.8) 18.4 (3.1) 40.2 (4.2) 49.8 (4.2) 23.5 (3.4)
3 – 0.7 (0.7) 4.7 (1.7) 6.7 (2.0) 1.8 (1.2)
TABLE 42 Percentage (SE) of responses for each level in each domain of the EQ-5D questionnaire: imputed data,
stratum A
Level Mobility Self-care Activity Pain Anxiety
Baseline
1 77.2 (2.4) 55.5 (28.0) 14.2 (2.0) 2.8 (0.9) 66.2 (2.7)
2 22.8 (2.4) 43.8 (2.8) 79.5 (2.3) 70.6 (2.6) 30.0 (2.6)
3 – 0.6 (0.4) 6.3 (1.4) 26.6 (2.5) 3.8 (1.1)
8 months
1 75.8 (2.5) 73.9 (2.6) 40.2 (2.9) 25.1 (2.6) 68.6 (2.7)
2 24.2 (2.5) 24.4 (2.6) 54.5 (3.0) 68.3 (2.7) 28.6 (2.7)
3 – 1.6 (0.7) 5.3 (1.3) 6.6 (1.5) 2.8 (0.9)
12 months
1 72.3 (2.7) 78.5 (2.5) 48.9 (2.9) 33.8 (2.8) 72.6 (2.6)
2 27.2 (2.7) 20.5 (2.4) 45.9 (2.9) 57.3 (2.9) 25.1 (25.7)
3 0.5 (0.4) 1.1 (0.6) 5.2 (1.3) 8.9 (1.7) 2.3 (0.9)
24 months
1 69.6 (2.8) 82.0 (2.3) 55.5 (3.0) 39.7 (2.9) 74.7 (2.6)
2 30 4 (2.8) 17.1 (2.3) 42.2 (3.0) 56.4 (3.0) 23.5 (2.5)
3 – 1.0 (0.6) 2.3 (0.9) 3.9 (1.2) 1.7 (0.8)
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TABLE 44 Percentage (SE) of responses for each level in each domain of the EQ-5D questionnaire: imputed data,
stratum C
Level Mobility Self-care Activity Pain Anxiety
Baseline
1 80.1 (3.2) 56.5 (3.9) 12.3 (2.6) 1.2 (0.9) 66.7 (3.7)
2 19.9 (3.2) 43.5 (3.9) 77.8 (3.3) 76.5 (3.3) 29.0 (3.6)
3 – – 9.9 (2.4) 22.2 (3.3) 4.3 (1.6)
8 months
1 76.0 (3.6) 70.2 (2.1) 36.6 (4.0) 23.6 (3.6) 75.3 (3.6)
2 24.0 (3.6) 29.7 (2.0) 57.8 (4.0) 73.1 (3.8) 23.8 (3.5)
3 – 0.1 (0.5) 5.5 (1.9) 3.3 (1.6) 0.9 (0.8)
12 months
1 78.0 (2.1) 81.1 (1.7) 59.6 (4.1) 36.5 (4.1) 76.2 (3.6)
2 21.9 (2.1) 18.8 (1.6) 35.7 (4.1) 58.6 (4.2) 22.1 (3.5)
3 0.0 (0.3) 0.2 (0.7) 4.6 (1.8) 4.9 (1.9) 1.7 (1.2)
24 months
1 72.0 (3.7) 81.9 (3.4) 57.3 (4.1) 47.4 (4.2) 78.0 (3.5)
2 28.0 (3.7) 17.3 (3.3) 39.5 (4.1) 45.5 (4.2) 19.9 (3.4)
3 – 0.8 (0.8) 3.1 (1.5) 7.1 (2.1) 2.2 (1.3)
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Incremental cost-effectiveness results
The incremental cost-effectiveness results are presented in Table 46 for the ITT and per-protocol analyses,
with and without covariate adjustment. To illustrate the uncertainty around the point estimate for
the ICER, Figures 11–14 show 1000 bootstrapped cost and effect differences as a scatter plot on the
cost-effectiveness plane.
When considering only the point estimate of the ICER, negative ICERs resulting from negative cost and
positive effect differences (in the south-east quadrant of the cost-effectiveness plane) are indistinguishable
from negative ICERs resulting from positive cost and negative effect differences (in the north-west quadrant);
this is also the case for positive ICERs (north-east and south-west quadrants). As the uncertainty around the
ICER for each of the four analyses (A–D) spans all four quadrants of the cost-effectiveness plane (more/less
costly and more/less effective), CIs cannot be produced by taking the 25th and 975th value of the ranked
bootstrapped ICER estimates. Instead, the graphs in Figures 15–18 show cost-effectiveness acceptability
curves, which plot the probability that arthroscopic repair is cost-effective compared with open repair at
different levels of willingness to pay for health gains, ranging from £0 to £100,000 per QALY.
The uncertainty around the ICER is also presented in Table 46 in terms of the probability that arthroscopic
repair is more effective, less costly, dominant (more effective and less costly), dominated (less effective and
more costly) and cost-effective at a willingness to pay of £20,000 per QALY compared with open repair.
Intention-to-treat analysis
For the base-case ITT analysis without adjustment for covariates, arthroscopic repair was less costly but less
effective than open repair, resulting in a point estimate for the ICER of £30,001. This value represents the
additional cost per QALY gained for open repair compared with arthroscopic repair. The probability of
arthroscopic repair being less costly than open repair was 74% and the probability of arthroscopic repair
being more effective than open repair was 48%.
When adjusting for covariates the probability of arthroscopic repair being more effective than open repair
decreased to 23% and the probability of it being less costly decreased to 27%. The probability that
arthroscopic repair was dominated by open repair in this analysis was 60%, compared with 16% in the
unadjusted analysis. The probability of arthroscopic repair being cost-effective compared with open repair
at a willingness to pay of £20,000 per QALY gained was 54% in the unadjusted analysis and 21% in the
adjusted analysis.
Per-protocol analysis
In the per-protocol analysis, the point estimate for the ICER suggested that arthroscopic repair was both
more costly and less effective in both the unadjusted and the adjusted analyses, meaning that it was
dominated by open repair. Using the uncertainty results from the bootstrap replicates, the probability that
arthroscopic repair is dominated by (more costly and less effective than) open repair was 55% in the
unadjusted analysis and 63% in the adjusted analysis and the probability that arthroscopic repair is
cost-effective compared with open repair at a willingness to pay of £20,000 per QALY gained was 30% in
the unadjusted analysis and 19% in the adjusted analysis.
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1500
1000
500
– 500
– 1000
0
In
cr
em
en
ta
l c
o
st
s 
(£
) 
o
ve
r 
24
 m
o
n
th
s
– 0.3 – 0.2 – 0.1 0.0 0.1 0.2
Total QALYs gained over 24 months
FIGURE 12 Cost-effectiveness plane, analysis B (ITT, adjusted).
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FIGURE 16 Cost-effectiveness acceptability curve, analysis B (ITT, adjusted). Dotted lines represent 95% CIs.
– 0.3 – 0.2 – 0.1 0.0 0.1 0.2
Total QALYs gained over 24 months
1500
1000
500
– 500
– 1000
0
In
cr
em
en
ta
l c
o
st
s 
(£
) 
o
ve
r 
24
 m
o
n
th
s
FIGURE 14 Cost-effectiveness plane, analysis D (per protocol, adjusted).
1.0
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
Pr
o
b
ab
ili
ty
 o
f 
b
ei
n
g
 c
o
st
-e
ff
ec
ti
ve
0 20 40 60 80 100
Willingness-to-pay threshold (£000)
FIGURE 15 Cost-effectiveness acceptability curve, analysis A (base case: ITT, unadjusted). Dotted lines represent
95% CIs.
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FIGURE 17 Cost-effectiveness acceptability curve, analysis C (per protocol, unadjusted). Dotted lines represent
95% CIs.
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FIGURE 18 Cost-effectiveness acceptability curve, analysis D (per protocol, adjusted). Dotted lines represent
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Conclusion
For the ITT analysis there were no significant differences in mean costs between the arthroscopic repair
group and the open repair group for any of the component resource-use categories, nor for the total
follow-up costs at 12 months or 24 months. For the per-protocol analysis there was a significant difference
in total initial procedure-related costs between the arthroscopic repair group and the open repair group,
with arthroscopic repair being more costly by £371 (95% CI £135 to £607) with no covariate adjustment
and £315 (95% CI £93 to £536) with covariate adjustment. The total cost of surgery alone (excluding
nights in hospital) was also significantly different between the two groups, at £463 (95% CI £260 to
£660) more costly for arthroscopic repair without covariate adjustment and £410 (95% CI £232 to £589)
more costly for arthroscopic repair with covariate adjustment. Total QALYs accrued at 2 years averaged
1.34 (SE 0.04) in the arthroscopic group and 1.35 (SE 0.04) in the open repair group. The overall
treatment cost at 2 years was £2567 (SE £176) for arthroscopic surgery and £2699 (SE £149) for open
surgery, according to ITT analysis. This difference was not statistically significant.
For quality-of-life outcomes there was no statistically significant difference between the arthroscopic repair
group and the open repair group, either for the ITT analysis or for the per-protocol analysis. The difference
remained non-significant after adjusting for covariates.
In terms of incremental cost-effectiveness, arthroscopic repair was less costly but less effective than open
repair in the ITT analysis, resulting in a point estimate for the ICER of £30,001 (without adjustment for
covariates). The probability of arthroscopic repair being less costly than open repair was 74% and the
probability of it being more effective than open repair was 48%. When adjusting for covariates,
the probability of arthroscopic repair being more effective than open repair decreased to 23% and the
probability of it being less costly decreased to 27%. For both the unadjusted and adjusted per-protocol
analyses the point estimate for the ICER suggested that arthroscopic repair was both more costly and less
effective, meaning that it was dominated by open repair.
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Chapter 7 Discussion
The results of this RCT involving patients aged > 50 years with a symptomatic degenerative rotator cuff tearindicate that there are no significant differences in effectiveness, health-care costs or cost-effectiveness
between arthroscopic repair and open repair. Both surgical techniques resulted in a significant improvement
in the primary outcome, change in OSS between baseline and 2 years, and in all of the prespecified
secondary outcome measures, which included the SPADI, the EQ-5D and the MHI-5. At 2 and 8 weeks post
surgery an assessment was also carried out of analgesic use, return to activities and return to work. Patients
improved from a baseline OSS of 25.7 to 41.5 at 24 months. All groups followed a similar pattern.
Response rates during follow-up
The protocol specified follow-up at times equivalent to 2 and 8 weeks after surgery. The success of this
approach can be assessed in Table 5. Data were also collected through self-completed postal questionnaires,
backed up by postal and telephone reminders and occasional completion of the questionnaire over the
telephone. The standard rule in most trials is to time follow-up from randomisation. This was not appropriate
for the early outcomes in this trial because of the variable time between randomisation and surgery. This
variability occurred because of differences in NHS waiting times between centres. The overall response rates
for the post-randomisation postal questionnaires were 408 out of 446 (91.5%) at 8 months, 406 out of
446 (91.0%) at 12 months and 389 out of 446 (87.2%) at 24 months. Response analysis showed that
responders at 24 months had similar characteristics to non-responders.
Telephone questionnaires at 2 and 8 weeks post surgery
At 2 and 8 weeks there were no differences between groups for reported pain, levels of painkiller use or
return to work. At 2 weeks, 131 out of 446 (29.4%) had no or mild pain, 232 out of 446 (52.0%) were
taking painkillers and 80% of those in work were off sick. At 8 weeks 161 out of 446 (36.1%) had no or
mild pain, 171 out of 446 (38.3%) were taking painkillers and 45% of those in work were off sick.
These findings are broadly in line with advice given to patients before surgery.
Postal questionnaires at 8, 12 and 24 months
At 8 months, 77% of participants reported that their symptoms were much or slightly better; this had
improved to 85% at 24 months, with no differences found between the groups. Operation time and time
in theatre were both significantly lower (by approximately 12 minutes) in the open surgery group than in
the arthroscopic group. The difference, however, was not observed in the non-randomised group. It may
be the case that surgeons, when performing their preferred procedure, can undertake the procedures
equally efficiently. One reason why we continued to follow-up the stratum B and stratum C participants
after the rest-then-exercise arm was discontinued (see Rest-then-exercise programme) was to gather more
information on surgical outcomes of the arthroscopic and open procedures. To that end we obtained data
on another 142 surgical procedures from the non-randomised arms. Taken at face value it would appear
that the procedures had a similar rate of complications and were safe.
Health economics
Follow-up at 24 months revealed no significant differences in costs or QALYs between arthroscopic and
open treatment of rotator cuff tears (for either the ITT or the per-protocol analysis). There was no
significant difference in time in theatre between arthroscopic and open surgery in the base-case ITT
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analysis using multiple imputed data (see Table 30). The cost of surgery and the total overall procedure
costs were significantly more for arthroscopic repair than for open repair in the per-protocol analysis but
not in the ITT analysis (see Table 33). There was no significant difference in QALYs accruing to each group
at 24 months, with a mean of 1.34 and 1.35 QALYs per patient for arthroscopic repair and open repair,
respectively, in the base-case ITT analysis (see Table 45). There was also no significant different between
the groups when the results were analysed per protocol. As a result, the incremental cost-effectiveness of
arthroscopic repair compared with open repair is subject to a great deal of uncertainty. The probability that
arthroscopic repair is cost-effective compared with open repair when the willingness to pay for health
benefits is set at £20,000 per QALY was 54% in the base case (when not adjusting results for covariates)
and only 21% when incorporating covariate adjustment (see Table 46).
Complications
The number of patients suffering significant complications was very low and less than the rate described
by Moosmayer et al.,60 but similar to that described by Kukkonen et al.59 The infection rate in this study
was 0.7% and the rate of revision surgery was 1.5%.
Cuff repair integrity at 12 months
During surgery, 72 out of 356 participants (20.2%) randomised to surgery and who underwent surgery were
found not to have a tear (see Table 11). This rate of false-positive reporting of tears potentially indicates
the relatively inaccurate diagnostic work-up of the participants. The majority (68%) of tears were diagnosed
by ultrasound and the remainder by MRI (see Table 6). A Cochrane systematic review of the use of MRI, MRI
arthrography and ultrasound for assessing rotator cuff tears in people for whom shoulder surgery is being
considered analysed 20 studies.79 For full-thickness tears they reported a sensitivity and specificity of 94%
(95% CI 85% to 98%) and 93% (95% CI 83% to 97%), respectively, for MRI and 92% (95% CI 82% to
96%) and 93% (95% CI 81% to 97%), respectively, for ultrasound. These results do not seem to be
reflected in the real-world setting of the NHS. At baseline, 321 out of 446 tears (72.0%) were classified as
small/medium and 125 out of 446 tears (28.0%) were classified as large/massive, whereas at surgery 152 out
of 330 tears (46.1%) were judged by the surgeon to be small/medium, 125 out of 330 tears (37.9%) were
judged by the surgeon to be large/massive and 72 out of 356 participants (20.2%) were judged to have no
tear (see Table 11). It is possible that tears had changed in size between the preoperative scan and surgery;
however, it is more likely that these differences reflect inaccuracies in the interpretation of preoperative
imaging. The operative findings should be used as the standard.79
In the randomised comparison, the mean difference in OSS at 2 years between healed tears and re-tears
was 3 OSS points. The mean difference in OSS at 2 years between retears and unrepairable tears was also
3 OSS points. Healed repairs therefore fared best and unrepairable tears worst (see Table 20). A healed repair
resulted in the greatest improvement in OSS. In the randomised group the OSS improved from 26.3 (SD 8.2)
at baseline to 44.5 (SD 4.1) for the arthroscopic group and from 25.0 (SD 8.0) at baseline to 43.6 (SD 5.8) for
the open group. The next best results were for the repaired tears that re-tore, which improved to 41.8
(SD 8.8) for the arthroscopic group and 40.8 (SD 7.6) for the open group. The worst results were seen for
tears that were impossible to repair, which improved to 37.3 (SD 6.1) for the arthroscopic group and 35.1
(SD 9.7) for the open group. The results were similar for the non-randomised preference groups.
This improvement may be a result of the subacromial decompression surgery and tissue debridement that
was invariably performed in these cases. Alternative reasons for the treatment effect include a period of
rest after surgery, physiotherapy after surgery, spontaneous resolution or a placebo effect. It is clear that
patients’ symptoms can improve even after a protracted course, with 22 out of 81 participants (27.2%)
who withdrew from the trial while on the waiting list for surgery also reporting resolution of symptoms
(see Table 10).
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Comparison with other randomised clinical trials
A Cochrane review of treatment for rotator cuff tears was published in 2008 in which no clear evidence in
support of any particular intervention was reported.16 A systematic review was conducted in May 2014
(see Chapter 1) and found one trial53 of arthroscopic repair compared with mini-open repair in 100
patients published since the UKUFF trial started. Patients were followed for 1 year using the DASH
questionnaire, with no treatment difference found for small and medium tears.53 We found two further
trials of surgery compared with conservative care published since the trial began. In the single-centre trial
of small and medium tears by Moosmayer et al.,60 the surgical group had better outcomes at 1 year. This
study reported a full-thickness re-tear rate of 8% and a partial-thickness re-tear rate of 12%. In this study
14 out of 103 (13.6%) patients had previously received glucocorticoid injections, 49 out of 103 (47.6%)
had received physiotherapy and the mean duration of symptoms was 9 and 12 months in the two groups,
respectively. It would appear that, in this trial, patients were being advised to have surgery after a much
shorter duration of symptoms and after a less comprehensive course of conservative therapies than is the
case in the UK. In the Kukkonen et al.59 study of small and medium tears the duration of symptoms was
similar to that in this study at 26–28 months. Only 103 out of 167 (61.7%) had previously received
conservative treatment in the form of cortisone injections. The waiting list for surgery in this Finnish study
was < 4 weeks. There was no postoperative imaging and so repair integrity could not be assessed.
Strengths and weaknesses
This study was carried out in a large number of centres in the UK with wide geographical representation.
Despite the length of time that has elapsed since the trial began, uncertainty still exists in the global
surgical community regarding surgery for rotator cuff tear and the results of this trial are likely to influence
care in the UK and globally.
Previous studies comparing surgery with conservative care have treated patients at an earlier stage with a
shorter duration of symptoms and less, or no, previous experience of conservative care programmes,
particularly physiotherapy and glucocorticoid injections. One reason why the original study design failed
was that a high proportion of patients had already received and failed to respond to physiotherapy
treatment (91.5%) and so it is not surprising that they were reluctant to pursue a further programme of
conservative care.
Testing surgical interventions against non-operative treatments in a randomised trial is often challenging.
This is particularly the case for chronic conditions with indolent onset that cause pain and reduce quality of
life. If patients are recruited at the conventional stage of the treatment pathway they will invariably have
already received conservative care (as was the case with this study). We involved patients during both the
design and the conduct of the trial. The consistent feedback was that patients would be reluctant to try
more conventional conservative care. For this reason experienced physiotherapy leaders within BESS
designed the rest-then-exercise programme as a novel conservative programme that could be delivered
to patients across the UK. An important consideration was the wide variation in conservative care
programmes across the UK and the absence of standardisation of physiotherapy treatments. The
rest-then-exercise programme was designed so that it could be delivered remotely and in the same way to
all patients. We did consider the option of bringing surgery forward in the treatment pathway to try and
recruit patients who had not yet received physiotherapy but this was not supported by either our patient
representatives or our independent surgical advisers.
A second reason for crossover was that patients in the non-operative arm were put on the waiting list for
surgery at the time of randomisation. At the time the trial was commissioned and designed NHS waiting
lists for this type of surgery were > 12 months on average. This design was proposed in an attempt to
improve recruitment by not disadvantaging patients randomised to the conservative arm who subsequently
needed surgery in the belief that with 12 months on the waiting list the conservative programme could be
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evaluated fairly. Feedback from patient representatives during the study design process was that patients
would not agree to participate in the rest-then-exercise programme if they were not also put on the NHS
waiting list. During the course of the trial the introduction of waiting list targets reduced waiting times
in the NHS and this adversely affected the trial.
The rate of withdrawal from the planned surgery was 81 out 446 (18.2%) for the surgical groups. We
believe that this is likely to be a real NHS phenomenon. The reasons for withdrawal were not different
between the groups and included the patient becoming asymptomatic and the development of other
medical conditions that prevented surgery taking place (see Table 10). It is important to note that the levels
of withdrawal were equal in all groups, including the non-randomised groups.
The reasons why patients did not receive a surgical repair were because no tear was found (scan false positive)
or because the tear was impossible to repair. The relative inaccuracy of preoperative scanning in a real-world
NHS setting compared with the accuracy reported in the literature is worthy of further investigation.
We have considered these issues further in the design of the CSAW (Can Shoulder Arthroscopy Work) trial
[see https://clinicaltrials.gov/ct2/show/NCT01623011 (accessed 25 August 2015)], which has also been led
from Oxford with the same chief investigator. This trial uses the same network of shoulder surgeons and
centres and compares arthroscopic subacromial decompression with placebo surgery and active monitoring
in patients with subacromial shoulder pain but no rotator cuff tear. It has successfully completed
recruitment of 300 patients without any significant crossover between the randomised groups. Various
factors have contributed to the success of this trial compared with the UKUFF trial. First, the trial works
within accepted patient pathways and does not attempt to offer to patients treatments that have already
been tried and which have failed to result in improvement, nor does it offer surgical treatment too early;
all patients in the CSAW trial had a minimum duration of symptoms and had received well-delivered
conservative care. In the CSAW trial 30 surgeons were involved in recruiting participants, all of whom were
provided with instruction in recruiting before the trial and feedback from site visits during the trial. This
feedback included the recording of patient consultations with advice about how individual surgeons might
improve recruitment.
Patient and public involvement and engagement
Patients were involved in the interpretation of the trial findings and in the preparation of the monograph
through patient representation on the TSC. The results were discussed with patient groups associated with
BESS and with priority-setting forums, including the James Lind Alliance.
Generalisability of the results
We designed the trial with the aim of making the management policies as similar as possible to normal NHS
care. In the first configuration the trial involved 47 centres and then, after the rest-then-exercise programme
was closed, 19 centres. The centres were widely dispersed across the UK and included teaching hospitals
and district general hospitals. Recruitment was performed by surgeons and surgeons chose the specific
aspects of the procedure once a patient had been allocated to either arthroscopic repair or open repair.
There was no requirement for extra tests or hospital visits and simple entry criteria identified people eligible
for the study. The results should therefore be easily generalisable to standard NHS care. No single centre
recruited > 10% of the total patients, which significantly enhances the generalisability of the results. All
participating surgeons had been trained in the techniques, had undergone at least 2 years of independent
practice as a consultant surgeon and undertook a minimum of five rotator cuff repair operations
per annum.
DISCUSSION
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Rest-then-exercise programme
The rest-then-exercise programme was designed by a group of leading shoulder physiotherapists
representing the physiotherapy section of BESS. All members of the group had considerable experience in
the non-operative management of patients with shoulder pain and with rotator cuff tears in particular. The
programme was designed to be delivered remotely using an information booklet and CD, with access to
physiotherapy guidance on a free telephone line. The same programme was provided to patients recruited
to all 47 centres participating in the trial. All patients were provided with a sling, which they were advised
to wear for up to 4 weeks with the aim of reducing pain levels to, or below, 4/10 on a VAS. In addition to
information regarding rotator cuff tears (e.g. lack of correlation between pain and structure), a variety of
exercises were detailed with advice to perform them for a further 6–12 weeks.
As described in the approved grant application and required by the ethics committee, patients in
the rest-then-exercise arm were put on the NHS waiting list to prevent disadvantaging them should the
rest-then-exercise programme fail to adequately resolve their symptoms. When the trial was designed
NHS waiting lists were around 12 months, giving more than sufficient time to determine whether the
conservative programme was effective. During the course of the study additional funding was made
available to the NHS and waiting lists shortened to an average of 2–4 months, which may have played a part
in the problems encountered with the rest-then-exercise programme.
Because of the reconfiguration of the trial, data from participants allocated to the rest-then-exercise arm of
the original UKUFF study no longer contribute to the formal comparisons being reported within this
monograph. However, it is important to record the details of all patients randomised across the totality of
the study for completeness and transparency of reporting (but also in accordance with the expectation
provided to participants as part of the consent process).
The outcomes of those allocated to rest then exercise were presented in Table 23. In total, 77 of the
214 participants (36%) did not complete the 10-week course of treatment and progressed to surgery
(see Table 24), 88 (41%) completed the course before progressing to surgery (see Table 25) and 36 (17%)
completed the full course and did not have surgery (see Table 26). A further 14 patients withdrew. As this
component of the trial was stopped, no formal comparisons can be or have been made. All patients
appeared to improve but it is not possible to determine why improvements were made. The number of
patients previously having received non-operative care (including physiotherapy and cortisone injections)
was high [604/660 (91.5%)]. In total, 401 out of 660 (60.8%) had received a cortisone injection in the last
5 years, 414 out of 660 (62.7%) had received physiotherapy and 87 out of 660 (13.2%) had received any
other treatment. Of those randomised to rest then exercise, 141 out of 214 (65.9%) had received
physiotherapy, 129 out of 214 (60.3%) had received a cortisone injection and 20 out of 214 (9.3%) had
received some other treatment, such as acupuncture. Only 19 out of 214 (8.9%) patients randomised
to rest then exercise [56/660 (8.5%) of the total trial participants] had not received treatment prior to
randomisation. The mean duration of symptoms at baseline is shown in Table 7 and ranged from
2.0 to 2.7 years across the groups, with no significant differences between them.
Data across all subgroups show that participants’ assessments of their disease-specific and generic
quality-of-life scores improved markedly from baseline to final outcomes. However, because of the sizeable
rates of surgical intervention in this cohort of participants, it is difficult to dissect the specific gains that
could be attributed to the rest-then-exercise programme and to surgery.
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Chapter 8 Conclusion
In patients aged > 50 years with a degenerative rotator cuff tear there were no significant differences inthe primary outcome (OSS) and all other prespecified secondary outcomes between open repair and
arthroscopic repair at 2 years. Rotator cuff surgery resulted in a significant improvement in symptoms
(OSS 25.7/48 at baseline to 41.5/48 at 2 years). Improvement occurred despite the relatively small number
of patients who underwent a rotator cuff repair. Patients who had an unrepairable tear at surgery and
those in whom the repair subsequently re-tore also improved from baseline.
In total, 1.34 (SE 0.04) QALYs accrued at 2 years in the arthroscopic repair group and 1.35 (SE 0.04)
QALYs accrued at 2 years in the open repair group, whereas the overall treatment cost at 2 years was
£2567 (SE £176) for arthroscopic surgery and £2699 (SE £149) for open surgery, according to ITT analysis;
neither cost nor QALY differences were statistically significant.
The incidence of complications and serious adverse events was low, with only 0.7% of deep infections and
1.5% of revision repair operations.
Only 162 out of 273 (59%) patients randomised to surgery underwent a rotator cuff repair. In total,
59 out of 273 (22%) patients withdrew while on the waiting list. The most common reasons for this were
improvement in symptoms and the development of another medical condition. A total of 52 out of 273
(19%) patients underwent subacromial decompression and no rotator cuff repair. The most common
reasons for this were that no tear was found or that the tear was impossible to repair. The best outcome
was seen in patients in whom the repair had healed; strategies to improve tendon healing are likely to
improve outcomes for all tear sizes and ages. This was followed by a repair that subsequently re-tore.
The worst outcome was seen in patients whose tear was unrepairable at surgery. Re-tears were found in
93 out of 233 (40%) patients who underwent repair surgery, with no difference between the open and
arthroscopic groups. Re-tears occurred after repairs to all tear sizes and the risk of re-tear was not
influenced by age. Previous studies have been small and either single-centre or in a small number of
centres and have not had the same generalisability as this trial.
It proved impossible to test a rest-then-exercise programme in the context of a pragmatic trial in the
47 centres during routine NHS care. In total, 91.5% of patients randomised had previously received
conservative care and the mean duration of symptoms was 2.5 years.
Implications for health care
Clinical
i. Suitably selected patients can benefit equally well from either open or arthroscopic rotator cuff repair
with a low risk of complications.
ii. In the subset of patients for whom repair was possible the greatest benefit is seen in patients in whom
the rotator cuff repair is successful and remains intact.
iii. A significant improvement was seen in all randomised and non-randomised groups, including in those
in whom a repair was not possible or in whom there was a postoperative re-tear, suggesting that there
are other treatment effects.
iv. No evidence of an effect of age or tear size on outcome was found.
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Health economics
i. There is no significant cost difference at 2 years between open and arthroscopic rotator cuff repair.
ii. Per protocol the costs of arthroscopic surgery are significantly greater than the costs of open surgery.
This is largely because of the longer operating time for arthroscopic surgery.
Recommendations for future research
Clinical
i. There is a case to continue follow-up of the patients who underwent surgery and who had a repair that
healed, who had a repair that re-tore, who had a tear that was impossible to repair or who had no
tear. There is early evidence at 2 years’ follow-up that these groups have different outcomes.
This unique study cohort provides the opportunity to determine the longer-term consequences of
rotator cuff tear and repair.
ii. There is a need to explore the basis of the treatment effect seen with a RCT of rotator cuff repair
compared with placebo surgery.
Health economics
i. With enforced restrictions on surgical training time there is also a need to understand both the costs
and the time required for surgeons to learn arthroscopy and open surgery, including the volume of
cases that needs to be performed to maintain skills. If the time required for training and maintaining
either arthroscopic or open skills differs then this will have cost implications for surgical training
programmes and workforce planning.
ii. There is a need to evaluate cost-effectiveness over a longer period than 24 months using further
follow-up data from this study and elsewhere on the longer-term consequences of rotator cuff tear
and repair.
CONCLUSION
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Appendix 1 Per-protocol data tables
TABLE 47 Assessment data
Assessment
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
Size of tear
Small/medium 49 (77.8) 66 (77.6) 23 (46.0) 28 (70.0)
Large/massive 14 (22.2) 19 (22.4) 27 (54.0) 12 (30.0)
Method of diagnosing tear
MRI 18 (28.6) 22 (25.9) 9 (18.0) 11 (27.5)
Ultrasound 43 (68.3) 56 (65.9) 36 (72.0) 27 (67.5)
Missing 2 (3.2) 7 (8.2) 5 (10.0) 2 (5.0)
Received physiotherapy on affected shoulder in the last 5 years
Yes 35 (55.6) 54 (63.5) 34 (68.0) 29 (72.5)
No 19 (30.2) 24 (28.2) 11 (22.0) 4 (10.0)
Missing 9 (14.3) 7 (8.2) 5 (10.0) 7 (17.5)
Duration of physiotherapy (weeks)
≤ 4 8 (22.9) 11 (20.4) 3 (8.8) 7 (24.1)
5–12 12 (34.3) 14 (25.9) 11 (32.4) 10 (34.5)
> 12 5 (14.3) 17 (31.5) 14 (41.2) 7 (24.1)
Missing 10 (28.6) 12 (22.2) 6 (17.6) 5 (17.2)
Received an injection in affected shoulder in the last 5 years
Yes 35 (55.6) 52 (61.2) 31 (62.0) 26 (65.0)
No 23 (36.5) 22 (25.9) 13 (26.0) 7 (17.5)
Missing 5 (7.9) 11 (12.9) 6 (12.0) 7 (17.5)
Number of injections
1 14 (40.0) 20 (38.5) 13 (41.9) 11 (42.3)
2 10 (28.6) 17 (32.7) 10 (32.3) 7 (26.9)
3 1 (2.9) 8 (15.4) 6 (19.4) 7 (26.9)
4 2 (5.7) 1 (1.9)
5 2 (5.7) 1 (1.9)
6 1 (2.9) 2 (3.8)
7
9 1 (3.8)
10 1 (3.2)
Missing 5 (14.3) 3 (5.8) 1 (3.2)
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TABLE 47 Assessment data (continued )
Assessment
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
Received other treatment on the affected shoulder in the last 5 years
Yes 7 (11.1) 19 (22.4) 2 (4.0) 7 (17.5)
No 33 (52.4) 41 (48.2) 28 (56.0) 15 (37.5)
Missing 23 (36.5) 25 (29.4) 20 (40.0) 18 (45.0)
Other treatment
Acupuncture 1 (14.3) 3 (15.8) 1 (50.0) 3 (42.9)
Analgesics 2 (28.6) 9 (47.4) 1 (14.3)
Chiropractor 1 (14.3) 2 (10.5) 1 (14.3)
Exercises 1 (5.3)
Massage 1 (14.3)
Osteopathy 1 (5.3) 1 (14.3)
TENS 1 (14.3)
Ultrasound 1 (5.3)
Missing 2 (28.6) 2 (10.5) 1 (50.0)
Received no previous treatment on shoulder
in the last 5 years
9 (14.3) 5 (5.9) 6 (12.0) 2 (5.0)
Are there any problems with patient’s other shoulder?
No problems 41 (65.1) 51 (60.0) 27 (54.0) 23 (57.5)
Mild problems 12 (19.0) 21 (24.7) 14 (28.0) 10 (25.0)
Moderate problems 6 (9.5) 7 (8.2) 7 (14.0) 6 (15.0)
Severe problems 2 (3.2) 3 (3.5) 1 (2.0) 1 (2.5)
Missing 2 (3.2) 3 (3.5) 1 (2.0)
TENS, transcutaneous electrical nerve stimulation.
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TABLE 48 Baseline data
Characteristic
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
Age (years), n, mean (SD) 63, 61.7 (6.5) 85, 62.2 (7.3) 50, 65.3 (6.7) 40, 61.1 (6.2)
Years with shoulder problem, n,
mean (SD)
63, 2.8 (4.6) 85, 2.6 (4.9) 49, 2.5 (3.3) 40, 3.3 (6.3)
OSS, n, mean (SD) 63, 25.6 (8.4) 85, 24.6 (7.8) 50, 25.5 (8.5) 40, 24.8 (7.7)
SPADI, n, mean (SD) 63, 63.7 (22.7) 85, 62.8 (21.6) 50, 61.5 (22.9) 40, 64.6 (17.7)
SPADI pain, n, mean (SD) 63, 71.2 (19.9) 85, 71.7 (19.6) 50, 72.1 (21.4) 40, 74.6 (17.1)
SPADI disability, n, mean (SD) 63, 59.0 (25.8) 84, 57.4 (24.8) 50, 54.9 (26.2) 40, 58.4 (20.1)
MHI-5, n, mean (SD) 63, 21.9 (5.0) 85, 22.8 (4.5) 49, 22.9 (5.1) 40, 22.3 (4.7)
EQ-5D, n, mean (SD) 62, 0.529 (0.315) 84, 0.509 (0.285) 50, 0.505 (0.320) 39, 0.472 (0.306)
Sex
Male 36 (57.1) 55 (64.7) 33 (66.0) 26 (65.0)
Female 27 (42.9) 30 (35.3) 16 (32.0) 14 (35.0)
Missing 1 (2.0)
Highest qualification
None 26 (41.3) 34 (40.0) 22 (44.0) 20 (50.0)
Secondary 21 (33.3) 33 (38.8) 21 (42.0) 9 (22.5)
Higher 16 (25.4) 17 (20.0) 5 (10.0) 11 (27.5)
Missing 1 (1.2) 2 (4.0)
Housing tenure
Home owner 49 (77.8) 76 (89.4) 46 (92.0) 35 (87.5)
Private rent 4 (6.3) 1 (2.5)
Council rent 7 (11.1) 3 (3.5) 4 (8.0) 3 (7.5)
Other 3 (4.8) 6 (7.1) 1 (2.5)
Lives alone
Yes 13 (20.6) 6 (7.1) 7 (14.0) 5 (12.5)
No 46 (73.0) 73 (85.9) 42 (84.0) 34 (85.0)
Missing 4 (6.3) 6 (7.1) 1 (2.0) 1 (2.5)
Employment status
Full-time 22 (34.9) 36 (42.4) 15 (30.0) 17 (42.5)
Part-time 10 (15.9) 12 (14.1) 10 (20.0) 6 (15.0)
Homemaker 2 (3.2) 4 (4.7) 1 (2.5)
Retired 26 (41.3) 29 (34.1) 25 (50.0) 15 (37.5)
Unemployed 3 (4.8) 3 (3.5) 1 (2.5)
Missing 1 (1.2)
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TABLE 48 Baseline data (continued )
Characteristic
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
Type of work
Manual 17 (53.1) 30 (62.5) 17 (68.0) 14 (60.9)
Non-manual 13 (40.6) 15 (31.3) 8 (32.0) 9 (39.1)
Not sure 2 (6.3) 2 (4.2)
Missing 1 (2.1)
Off sick or working reduced duties
Yes, off sick 2 (6.3) 6 (12.5) 2 (8.0) 1 (4.3)
Yes, working reduced duties 6 (18.8) 5 (10.4) 5 (20.0) 5 (21.7)
No, working usual duties 22 (68.8) 36 (75.0) 18 (72.0) 17 (73.9)
Missing 2 (6.3) 1 (2.1)
Handedness
Right-handed 57 (90.5) 76 (89.4) 48 (96.0) 33 (82.5)
Left-handed 3 (4.8) 6 (7.1) 2 (4.0) 5 (12.5)
Both 3 (4.8) 3 (3.5) 2 (5.0)
Would you be able to do your job or everyday activities with arm in a sling?
No 38 (60.3) 55 (64.7) 29 (58.0) 21 (52.5)
Yes, with difficulty 25 (39.7) 30 (35.3) 21 (42.0) 19 (47.5)
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TABLE 49 Operative details
Operative detail
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
Procedure side
Left 26 (41.3) 26 (30.6) 11 (22.0) 12 (30.0)
Right 37 (58.7) 59 (69.4) 39 (78.0) 28 (70.0)
Missing
Ease of repair
Easy 18 (28.6) 39 (45.9) 12 (24.0) 11 (27.5)
Moderate 28 (44.4) 25 (29.4) 19 (38.0) 12 (30.0)
Difficult 12 (19.0) 12 (14.1) 11 (22.0) 11 (27.5)
Impossible 2 (2.4) 1 (2.0) 2 (5.0)
Missing 5 (7.9) 7 (8.2) 7 (14.0) 4 (10.0)
Size of tear
Small 22 (34.9) 25 (29.4) 11 (22.0) 6 (15.0)
Medium 25 (39.7) 32 (37.6) 10 (20.0) 11 (27.5)
Large 10 (15.9) 18 (21.2) 16 (32.0) 13 (32.5)
Massive 5 (7.9) 9 (10.6) 13 (26.0) 10 (25.0)
Missing 1 (1.6) 1 (1.2)
Surgical opinion of completeness of repair
Poor 6 (9.5) 6 (7.1) 4 (8.0) 5 (12.5)
Good 37 (58.7) 42 (49.4) 29 (58.0) 20 (50.0)
Excellent 16 (25.4) 33 (38.8) 9 (18.0) 11 (27.5)
Missing 4 (6.3) 4 (4.7) 8 (16.0) 4 (10.0)
Total minutes in theatre, n, mean (SD) 48, 107.5 (33.3) 74, 87.8 (30.1) 32, 99.2 (25.8) 30, 99.9 (52.6)
Operation time, n, mean (SD) 48, 76.4 (30.5) 72, 58.1 (22.8) 24, 70.4 (23.5) 25, 75.4 (38.3)
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TABLE 50 Intraoperative complications
Complication
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic (n= 63) Open (n= 85) Arthroscopic (n= 50) Open (n= 40)
Intraoperative problem
Anaesthetic 1 (1.2)
Equipment 3 (4.8) 1 (1.2) 2 (4.0)
Implant 1 (1.2) 1 (2.0)
Surgical 5 (7.9) 1 (1.2) 3 (6.0)
Other 2 (3.2) 4 (4.7) 3 (6.0) 2 (5.0)
Staff problems 2 (5.0)
Any intraoperative problems 7 (11.1) 6 (7.1) 2 (4.0) 7 (14.0)
Did the procedure change as a result of an intraoperative problem?
Yes 2 (28.6)
No 7 (100.0) 4 (66.7) 4 (57.1) 2 (100.0)
Unsure 1 (14.3)
Missing 2 (33.3)
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TABLE 51 Two-week follow-up
Question
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
Completed follow-up forms 56 (88.9) 77 (90.6) 42 (84.0) 36 (90.0)
Within the last 24 hours, have you been wearing a sling at all?
Yes 49 (87.5) 64 (83.1) 40 (95.2) 32 (88.9)
No 6 (10.7) 12 (15.6) 2 (4.8) 4 (11.1)
Missing 1 (1.8) 1 (1.3)
If yes, how long have you worn the sling for?
> 12 hours 45 (91.8) 61 (95.3) 36 (90.0) 23 (71.9)
> 6 hours but < 12 hours 3 (6.1) 2 (3.1) 1 (2.5) 6 (18.8)
> 3 hours but < 6 hours 1 (2.0) 1 (2.5) 1 (3.1)
< 3 hours 1 (1.6)
Missing 2 (5.0) 2 (6.3)
Within the last 24 hours, how would you describe the worst pain from your shoulder?
None 4 (7.1) 3 (3.9) 2 (4.8) 2 (5.6)
Mild 16 (28.6) 19 (24.7) 13 (31.0) 12 (33.3)
Moderate 22 (39.3) 38 (49.4) 17 (40.5) 17 (47.2)
Severe 11 (19.6) 15 (19.5) 8 (19.0) 5 (13.9)
Unbearable 2 (3.6) 1 (1.3) 2 (4.8)
Missing 1 (1.8) 1 (1.3)
Within the last 24 hours, how much has pain from your shoulder interfered with your usual work?
Not at all 9 (16.1) 7 (9.1) 9 (21.4) 7 (19.4)
A little bit 6 (10.7) 8 (10.4) 7 (16.7) 6 (16.7)
Moderately 14 (25.0) 26 (33.8) 7 (16.7) 7 (19.4)
Greatly 16 (28.6) 22 (28.6) 7 (16.7) 11 (30.6)
Totally 10 (17.9) 13 (16.9) 12 (28.6) 5 (13.9)
Missing 1 (1.8) 1 (1.3)
Were you troubled by pain from your shoulder in bed last night?
No, not at all 14 (25.0) 13 (16.9) 8 (19.0) 10 (27.8)
Yes, just at first 5 (8.9) 5 (6.5) 4 (9.5)
Yes, during some of the night 25 (44.6) 28 (36.4) 19 (45.2) 14 (38.9)
Yes, throughout the night 11 (19.6) 30 (39.0) 11 (26.2) 12 (33.3)
Missing 1 (1.8) 1 (1.3)
Within the last 24 hours, have you taken any painkillers because of your shoulder?
Yes 40 (71.4) 56 (72.7) 31 (73.8) 28 (77.8)
No 15 (26.8) 20 (26.0) 11 (26.2) 8 (22.2)
Missing 1 (1.8) 1 (1.3)
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TABLE 51 Two-week follow-up (continued )
Question
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
If yes, how many painkillers have you taken in the last 24 hours?
1 18 (45.0) 25 (44.6) 15 (48.4) 14 (50.0)
2 15 (37.5) 25 (44.6) 11 (35.5) 8 (28.6)
3 5 (12.5) 3 (5.4) 5 (16.1) 3 (10.7)
4 1 (1.8) 2 (7.1)
5 1 (2.5) 1 (1.8) 1 (3.6)
Missing 1 (2.5) 1 (1.8)
During the (last 2 weeks) time since the completion of surgery or rest then exercise, have you received any
additional treatment on your shoulder?
Yes 3 (5.4) 14 (18.2) 5 (11.9) 2 (5.6)
No 50 (89.3) 60 (77.9) 36 (85.7) 32 (88.9)
Missing 3 (5.4) 3 (3.9) 1 (2.4) 2 (5.6)
If yes, what was the additional treatment?
Injection
Antibiotics 1 (7.1)
Physiotherapy 1 (33.3) 2 (14.3) 2 (40.0) 1 (50.0)
Wound or dressing 5 (35.7) 2 (40.0)
Not for shoulder problem 1 (33.3) 1 (7.1) 1 (50.0)
Pain relief 1 (33.3) 5 (35.7) 1 (20.0)
Are you currently employed?
Yes 28 (50.0) 40 (51.9) 22 (52.4) 24 (66.7)
No 27 (48.2) 36 (46.8) 20 (47.6) 12 (33.3)
Missing 1 (1.8) 1 (1.3)
If employed, are you currently off sick or working reduced duties because of your shoulder?
Yes, off sick 24 (85.7) 36 (90.0) 18 (81.8) 19 (79.2)
Yes, working reduced duties 3 (10.7) 2 (5.0) 3 (13.6) 4 (16.7)
No, working usual hours/duties 1 (3.6) 2 (5.0) 1 (4.5)
Missing 1 (4.2)
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TABLE 52 Eight-week follow-up
Question
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
Completed follow-up forms 55 (87.3) 78 (91.8) 41 (82.0) 32 (80.0)
Within the last 24 hours, have you been wearing a sling at all?
Yes 5 (9.1) 13 (16.7) 5 (12.2) 6 (18.8)
No 50 (90.9) 65 (83.3) 36 (87.8) 26 (81.3)
If yes, how long have you worn the sling for?
> 12 hours 1 (20.0) 3 (23.1) 2 (40.0) 1 (16.7)
> 6 hours but < 12 hours 4 (30.8) 1 (16.7)
> 3 hours but < 6 hours 1 (20.0) 6 (46.2) 1 (20.0) 1 (16.7)
< 3 hours 3 (60.0) 2 (40.0) 1 (16.7)
Missing 2 (33.3)
Within the last 24 hours, how would you describe the worst pain you have had from your shoulder?
None 4 (7.3) 6 (7.7) 3 (7.3) 3 (9.4)
Mild 26 (47.3) 38 (48.7) 13 (31.7) 12 (37.5)
Moderate 18 (32.7) 19 (24.4) 16 (39.0) 11 (34.4)
Severe 7 (12.7) 14 (17.9) 9 (22.0) 6 (18.8)
Unbearable 1 (1.3)
Within the last 24 hours, how much has pain from your shoulder interfered with your usual work?
Not at all 16 (29.1) 13 (16.7) 8 (19.5) 7 (21.9)
A little bit 15 (27.3) 23 (29.5) 14 (34.1) 10 (31.3)
Moderately 17 (30.9) 27 (34.6) 11 (26.8) 9 (28.1)
Greatly 5 (9.1) 12 (15.4) 6 (14.6) 5 (15.6)
Totally 2 (3.6) 3 (3.8) 2 (4.9) 1 (3.1)
Were you troubled by pain from your shoulder in bed last night?
No, not at all 24 (43.6) 25 (32.1) 14 (34.1) 10 (31.3)
Yes, just at first 3 (5.5) 5 (6.4) 4 (9.8) 1 (3.1)
Yes, during some of the night 19 (34.5) 27 (34.6) 16 (39.0) 13 (40.6)
Yes, throughout the night 9 (16.4) 21 (26.9) 7 (17.1) 8 (25.0)
Within the last 24 hours, have you taken any painkillers for your shoulder?
Yes 28 (50.9) 44 (56.4) 23 (56.1) 20 (62.5)
No 27 (49.1) 34 (43.6) 18 (43.9) 12 (37.5)
If yes, how many painkillers have you taken?
1 19 (67.9) 26 (59.1) 12 (52.2) 8 (40.0)
2 7 (25.0) 15 (34.1) 6 (26.1) 4 (20.0)
3 1 (3.6) 3 (6.8) 2 (8.7) 1 (5.0)
4 1 (3.6) 1 (5.0)
Missing 3 (13.0) 6 (30.0)
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TABLE 52 Eight-week follow-up (continued )
Question
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
During the time (last 6 weeks) since we spoke to you last, have you had any additional treatment for your shoulder?
Yes 5 (9.1) 8 (10.3) 3 (7.3) 5 (15.6)
No 47 (85.5) 69 (88.5) 38 (92.7) 27 (84.4)
Missing 3 (5.5) 1 (1.3)
If yes, what additional treatment did you receive?
Injection 1 (12.5)
Antibiotics 2 (25.0) 1 (20.0)
Physiotherapy 5 (100.0) 2 (25.0) 2 (66.7) 4 (80.0)
Wound or dressing 1 (12.5)
Hospital admission 1 (33.3)
Surgery and antibiotics 2 (25.0)
Are you currently employed?
Yes 28 (50.9) 42 (53.8) 17 (41.5) 18 (56.3)
No 27 (49.1) 35 (44.9) 22 (53.7) 13 (40.6)
Missing 1 (1.3) 2 (4.9) 1 (3.1)
If yes, are you currently off sick or working reduced hours because of your shoulder?
Yes, off sick 13 (46.4) 23 (54.8) 11 (64.7) 11 (61.1)
Yes, working reduced duties 7 (25.0) 10 (23.8) 4 (23.5) 3 (16.7)
No, working usual hours/duties 8 (28.6) 8 (19.0) 2 (11.8) 4 (22.2)
Missing 1 (2.4)
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TABLE 53 Symptoms at 8, 12 and 24 months
Question
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
8-month follow-up forms completed 60 (95.2) 82 (96.5) 50 (100.0) 38 (95.0)
12-month follow-up forms completed 62 (98.4) 83 (97.7) 47 (94.0) 38 (95.0)
24-month follow-up forms completed 58 (92.1) 81 (95.3) 45 (90.0) 36 (90.0)
How are the problems related to your shoulder now compared with 8 months ago?
Much better 40 (66.7) 55 (67.1) 34 (68.0) 23 (60.5)
Slightly better 12 (20.0) 11 (13.4) 11 (22.0) 6 (15.8)
No change 3 (5.0) 5 (6.1) 1 (2.0) 1 (2.6)
Slightly worse 3 (5.0) 4 (4.9) 2 (4.0) 4 (10.5)
Much worse 2 (3.3) 2 (2.4) 1 (2.0) 2 (5.3)
Missing 5 (6.1) 1 (2.0) 2 (5.3)
How are the problems related to your shoulder now compared with a year ago?
Much better 43 (69.4) 61 (73.5) 34 (72.3) 30 (78.9)
Slightly better 10 (16.1) 16 (19.3) 9 (19.1) 4 (10.5)
No change 1 (1.6) 2 (5.3)
Slightly worse 3 (4.8) 1 (1.2) 1 (2.1)
Much worse 2 (3.2) 5 (6.0) 1 (2.6)
Missing 3 (4.8) 3 (6.4) 1 (2.6)
How are the problems related to your shoulder now compared with 2 years ago?
Much better 48 (82.8) 58 (71.6) 39 (86.7) 25 (69.4)
Slightly better 5 (8.6) 16 (19.8) 2 (4.4) 5 (13.9)
No change 1 (1.7) 1 (1.2) 1 (2.2) 2 (5.6)
Slightly worse 2 (3.4) 2 (2.5) 1 (2.2) 2 (5.6)
Much worse 1 (1.7) 2 (2.5)
Missing 1 (1.7) 2 (2.5) 2 (4.4) 2 (5.6)
How pleased are you with your shoulder symptoms at 8 months?
Very pleased 29 (48.3) 37 (45.1) 28 (56.0) 21 (55.3)
Fairly pleased 24 (40.0) 32 (39.0) 17 (34.0) 12 (31.6)
Not very pleased 6 (10.0) 5 (6.1) 2 (4.0) 2 (5.3)
Very disappointed 1 (1.7) 3 (3.7) 2 (4.0) 1 (2.6)
Missing 5 (6.1) 1 (2.0) 2 (5.3)
How pleased are you with your shoulder symptoms at 12 months?
Very pleased 33 (53.2) 42 (50.6) 26 (55.3) 26 (68.4)
Fairly pleased 18 (29.0) 33 (39.8) 18 (38.3) 9 (23.7)
Not very pleased 6 (9.7) 3 (3.6) 1 (2.1)
Very disappointed 2 (3.2) 5 (6.0) 2 (5.3)
Missing 3 (4.8) 2 (4.3) 1 (2.6)
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TABLE 53 Symptoms at 8, 12 and 24 months (continued )
Question
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
How pleased are you with your shoulder symptoms at 24 months?
Very pleased 44 (75.9) 46 (56.8) 27 (60.0) 25 (69.4)
Fairly pleased 9 (15.5) 23 (28.4) 13 (28.9) 6 (16.7)
Not very pleased 1 (1.7) 6 (7.4) 3 (6.7) 1 (2.8)
Very disappointed 3 (5.2) 3 (3.7) 2 (5.6)
Missing 1 (1.7) 3 (3.7) 2 (4.4) 2 (5.6)
TABLE 54 Employment status at 8, 12 and 24 months
Employment status
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
Employed at 8 months
Yes 27 (45.0) 38 (46.3) 21 (42.0) 20 (52.6)
No 33 (55.0) 37 (45.1) 28 (56.0) 16 (42.1)
Missing 7 (8.5) 1 (2.0) 2 (5.3)
Employed at 12 months
Yes 29 (46.8) 34 (41.0) 16 (34.0) 20 (52.6)
No 31 (50.0) 48 (57.8) 29 (61.7) 17 (44.7)
Missing 2 (3.2) 1 (1.2) 2 (4.3) 1 (2.6)
Employed at 24 months
Yes 25 (43.1) 30 (37.0) 16 (35.6) 19 (52.8)
No 32 (55.2) 48 (59.3) 27 (60.0) 15 (41.7)
Missing 1 (1.7) 3 (3.7) 2 (4.4) 2 (5.6)
If you are employed, are you off sick or working reduced duties because of your shoulder at 8 months?
Yes, off sick 7 (11.7) 6 (7.3) 4 (8.0) 1 (2.6)
Yes, working reduced hours 1 (1.7) 6 (7.3) 3 (6.0) 4 (10.5)
No, working usual hours/duties 18 (30.0) 24 (29.3) 14 (28.0) 14 (36.8)
Missing 34 (56.7) 46 (56.1) 29 (58.0) 19 (50.0)
Are you currently out of work, off sick or working reduced duties because of your shoulder at 12 months?
Yes 6 (9.7) 8 (9.6) 3 (6.4) 3 (7.9)
No 44 (71.0) 64 (77.1) 37 (78.7) 29 (76.3)
Missing 12 (19.4) 11 (13.3) 7 (14.9) 6 (15.8)
Are you currently out of work, off sick or working reduced duties because of your shoulder at 24 months?
Yes, off sick 4 (6.9) 4 (4.9) 2 (4.4) 2 (5.6)
No, working usual hours/duties 48 (82.8) 64 (79.0) 38 (84.4) 28 (77.8)
Missing 6 (10.3) 13 (16.0) 5 (11.1) 6 (16.7)
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TABLE 55 Health status at 8, 12 and 24 months
Measure
Stratum A, n, mean (SD)
Stratum B, n,
mean (SD)
Stratum C, n,
mean (SD)
Arthroscopic
(n= 63) Open (n= 85)
Arthroscopic
(n= 50) Open (n= 40)
OSS
Baseline 63, 25.6 (8.4) 85, 24.6 (7.8) 50, 25.5 (8.5) 40, 24.8 (7.7)
8 months 60, 35.9 (10.3) 81, 37.1 (8.4) 50, 37.6 (8.3) 38, 35.5 (10.6)
12 months 61, 38.6 (9.9) 82, 40.3 (8.2) 46, 40.0 (5.9) 38, 41.1 (6.9)
24 months
(primary outcome)
57, 42.9 (7.1) 79, 42.0 (7.5) 45, 41.9 (5.9) 36, 42.7 (5.9)
SPADI
Baseline 63, 63.7 (22.7) 85, 62.8 (21.6) 50, 61.5 (22.9) 40, 64.6 (17.7)
8 months 59, 30.4 (28.2) 80, 30.1 (27.4) 49, 28.6 (23.2) 36, 31.7 (26.1)
12 months 93, 23.1 (26.1) 83, 22.4 (25.5) 65, 21.5 (22.8) 37, 18.8 (21.6)
24 months 91, 15.2 (21.3) 81, 16.9 (22.7) 61, 13.8 (17.5) 34, 15.0 (22.2)
SPADI pain
Baseline 63, 71.2 (19.9) 85, 71.7 (19.6) 50, 72.1 (21.4) 40, 74.6 (17.1)
8 months 60, 34.0 (27.9) 81, 32.8 (27.6) 50, 31.4 (24.8) 36, 35.9 (27.7)
12 months 61, 24.3 (26.8) 82, 24.4 (26.4) 46, 21.6 (17.3) 37, 21.9 (24.6)
24 months 57, 13.4 (18.0) 81, 18.7 (24.4) 42, 15.6 (15.3) 34, 16.9 (23.4)
SPADI disability
Baseline 63, 59.0 (25.8) 84, 57.4 (24.8) 50, 54.9 (26.2) 40, 58.4 (20.1)
8 months 59, 28.2 (29.0) 80, 28.2 (27.9) 49, 26.5 (23.1) 37, 31.0 (28.3)
12 months 61, 21.0 (26.7) 83, 21.0 (26.0) 46, 16.9 (17.8) 37, 16.7 (20.3)
24 months 58, 11.5 (20.7) 81, 15.7 (22.4) 43, 14.1 (19.0) 34, 13.7 (22.2)
MHI-5
Baseline 63, 21.9 (5.0) 85, 22.8 (4.5) 49, 22.9 (5.1) 40, 22.3 (4.7)
8 months 60, 23.5 (4.9) 81, 23.9 (4.4) 48, 24.1 (4.5) 38, 24.1 (4.1)
12 months 60, 23.3 (5.0) 82, 23.3 (4.9) 45, 25.0 (4.3) 37, 24.4 (3.9)
24 months 58, 24.7 (3.7) 81, 24.6 (4.6) 43, 23.9 (5.0) 34, 24.1 (4.9)
EQ-5D
Baseline 62, 0.529 (0.315) 84, 0.509 (0.285) 50, 0.505 (0.320) 39, 0.472 (0.306)
8 months 59, 0.669 (0.332) 80, 0.713 (0.258) 45, 0.717 (0.233) 37, 0.668 (0.236)
12 months 61, 0.712 (0.308) 81, 0.715 (0.288) 45, 0.767 (0.212) 35, 0.748 (0.181)
24 months 57, 0.773 (0.236) 81, 0.782 (0.218) 45, 0.771 (0.223) 36, 0.788 (0.222)
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TABLE 56 Magnetic resonance imaging results
Measure
Stratum A, n (%) Stratum B, n (%) Stratum C, n (%)
Arthroscopic (n= 63) Open (n= 85) Arthroscopic (n= 50) Open (n= 40)
MRI scans received 60 79 39 36
Result of MRI scan
Re-tear 29 (48.3) 30 (38.0) 14 (35.9) 13 (36.1)
No tear 28 (46.7) 46 (58.2) 22 (56.4) 21 (58.3)
Inconclusive 1 (1.7) 1 (1.3)
Missing 2 (3.3) 2 (2.5) 3 (7.7) 2 (5.6)
Size of tear if MRI scan shows a re-tear
Partial 2 (6.9) 1 (3.3) 1 (7.1)
Small 8 (27.6) 9 (30.0) 1 (7.1) 3 (23.1)
Medium 5 (17.2) 8 (26.7) 6 (42.9) 5 (38.5)
Large 5 (17.2) 3 (10.0) 2 (14.3) 2 (15.4)
Massive 7 (24.1) 7 (23.3) 3 (21.4) 3 (23.1)
Missing 2 (6.9) 2 (6.7) 1 (7.1)
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Appendix 2 Health economics complete
case analysis
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Appendix 3 Trial protocol
Protocol for the UKUFF study: a pragmatic multi-centre randomised controlled trial of 
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ABSTRACT 
This protocol describes a pragmatic multi-centre randomised controlled trial (RCT) to assess 
the clinical and cost-effectiveness of arthroscopic surgery and open surgery in the 
management of rotator cuff tears.  This trial began in 2007 and was modified in 2010 with the 
removal of a non-operative arm due to high rates of early cross-over to surgery. 
 
KEYWORDS 
Shoulder, Rotator cuff, tendon, tears, surgery, arthroscopy 
 
BACKGROUND AND RATIONALE 
In 2000, an assessment of the prevalence and incidence of consultations for shoulder 
problems in UK primary care estimated the annual prevalence to be 2.4%, with the rate 
increasing linearly with age [1]. It is estimated that disorders of the rotator cuff account for 
between 30 and 70% of the shoulder pain cases that are reported [2, 3].  The clinical evidence 
available, regarding both the natural history and management of rotator cuff tears, is limited 
and conflicting, most reports are small scale, (<50 cases), single centre, retrospective cohort 
studies [4-11].    
Rotator cuff tears can be treated both surgically (arthroscopic and open) and non-surgically 
(for example by injection and exercises). Traumatic tears are uncommon: most patients 
present through age related degeneration of tendon attachment to bone at the proximal 
humerus. Surgical repair may be considered for patients with persistent symptoms who fail to 
respond to rest and conservative care. Such non-operative care will usually include 
physiotherapy and glucocorticoid injections into the shoulder.  
A rotator cuff repair operation aims to re-attach the tendons to the bone. The repair may also 
include an acromioplasty where overhanging bone and soft tissue above the tendon are 
excised with the aim of creating more space for the rotator cuff tendons to move freely.  
In general, two approaches are available for surgical repair.  
• Open/mini-open surgery involves the rotator cuff being repaired under direct vision 
through an incision in the skin. 
APPENDIX 3
NIHR Journals Library www.journalslibrary.nihr.ac.uk
128
• Arthroscopic surgery involves the repair being performed through arthroscopic 
portals.  
Proponents of arthroscopic rotator cuff surgery suggest that the procedure may have 
advantages over standard open techniques by causing less trauma to the deltoid muscle and 
overlying soft tissue. Arguably this causes less post-operative patient discomfort together 
with earlier return of movement. However, the success of the repair depends on the ability of 
the surgeon to achieve a secure attachment of tendon to bone. This may be more easily and 
reliably achieved by open/mini-open surgery. Other potential disadvantages of the 
arthroscopic approach include increased technical difficulty and longer time in theatre. Only 
a few, small, non-randomised controlled trials have directly compared procedures and, 
therefore, there is a need to compare the outcome of the two surgical techniques [12].  
The primary objective of this study is to conduct a pragmatic multicentre randomised clinical 
trial to obtain good quality evidence of the effectiveness and cost-effectiveness of 
arthroscopic versus open surgical repair for the treatment of degenerative rotator cuff tears.  
 
METHODS 
Design 
At the outset of the UKUFF trial in 2007 a 3 way parallel group randomised trial began 
comparing arthroscopic rotator cuff repair surgery with open or mini-open rotator cuff repair 
surgery with a rest then exercise programme of non-operative care [UKUFF Original REC 
Version Number Version 07/Q1606/49]. Figure 1 presents the original version as a flowchart. 
The trial was adapted and reconfigured by the funder in 2009, (after consultation with the 
trial steering and data monitoring committees), into a 2 way parallel group RCT, due to a 
high rate of cross-over of patients (77%) from the rest then exercise programme to surgery 
(UKUFF Reconfigured REC Reference Number 10/H0402/24). 87 patients were carried 
through to the subsequent reconfigured trial. After the reconfiguration, it was calculated a 
further 180 patients be recruited and followed-up for two years as per the original protocol. 
(providing a total of 267 patients treated with surgery).  It is the reconfigured design that is 
presented in this protocol. 
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UKUFF (reconfigured) is a pragmatic multi-centre study involving 20 surgeons from 16 UK 
centres. It includes patients over 50 years of age, with a diagnosis of a full thickness rotator 
cuff tear who are deemed eligible for surgery.  Patients are randomised to either open or 
arthroscopic repair while the surgeons perform their usual and preferred surgical technique 
using one of these approaches. Patients are followed up with telephone and postal 
questionnaires for 24 months, and an MRI (Magnetic Resonance Scan) or USS (Ultrasound 
Scan) 12 months after their surgery.  The primary outcome is the Oxford Shoulder Score at 
24 months [13].  The study is led by clinicians (both surgeons and physiotherapists), 
methodologists, statisticians and health economists. 
Surgeon eligibility  
Participating surgeons require a ‘minimum level of expertise’ for the types of surgery 
undertaken. For both surgical techniques only consultant orthopaedic shoulder surgeons with 
a minimum of two years experience in consultant practice can participate. For those surgeons 
performing both arthroscopic surgery and open surgery, only those who have performed a 
minimum of 5 cases per year are considered eligible. The participating surgeons represent a 
cross-section of high, medium and low volume practitioners undertaking both arthroscopic 
and open surgery.  
Recruitment and treatment allocation 
Support from local research networks is used, where possible, to help with patient 
identification, recruitment and with obtaining any required data from patient notes. The 
eligibility of the patient is confirmed by the local consultant orthopaedic surgeon.  
Patient eligibility  
The patient is eligible for the study if they are:  
• Aged at least 50 years  
• Suffer from a degenerative rotator cuff tear  
• Have a full thickness rotator cuff tear  
• Rotator cuff tear diagnosed using MRI or Ultrasound scan  
• Able to consent  
 
The patient is excluded if ANY of the following apply:  
• Previous surgery on affected shoulder  
APPENDIX 3
NIHR Journals Library www.journalslibrary.nihr.ac.uk
130
• Dual shoulder pathology  
• Traumatic Tear 
• Significant problems in the other shoulder  
• Rheumatoid arthritis/Systemic disease  
• Significant osteoarthritis problems  
• Significant neck problems  
• Cognitive impairment or language issues  
• Unable to undergo an MRI scan for any reason  
 
There is no formal age limit. However, patients aged 85 years and over are not expected to be  
eligible to participate.  Consent is obtained either locally, by a research nurse, or remotely by 
the study office in Oxford.   Only when the consent form and the baseline questionnaire have 
been returned is the participant entered into the trial and randomised to one of the surgical 
options.  Randomisation is by computer allocation at the Health Services Research Unit, 
University of Aberdeen. Allocation was minimised using surgeon, age and size of tear. After 
randomisation the participant is considered irrevocably part of the trial for the purpose of the 
research, irrespective of what occurs subsequently.  
Patients are free to withdraw at any time without consequence to the health care they receive. 
Randomised Surgery 
Details of the surgical technique used (including method of repair and theatre equipment used 
e.g. types of suture) are recorded on a standard form, as well as the size of the tear, the 
appearance of the tendons involved, the ease of repair and the completeness of the repair. If 
circumstances dictate that the allocated surgical technique cannot be carried out then any 
alternative procedure is recorded. The surgeon contacts the study office if their patient is 
unwilling or unable to have the operation on the arranged date. Patient progress through the 
study is detailed in Figure 2. UKUFF Flow Chart. 
DATA COLLECTION AND PROCESSING  
Outcome assessments involve patient completed questionnaires and 12 month post-surgery 
imaging.    
Questionnaires  
A combination of the Oxford Shoulder Score (OSS) [13], the Shoulder Pain and Disability 
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Index (SPADI) [14], the Mental Health Inventory (MHI-5) [15] and the EQ-5D [16] is used 
to assess functional outcome and patient-reported quality of life. These assess a range of 
symptoms often experienced with rotator cuff tears e.g. pain, weakness and a loss of function. 
Outcome assessments are conducted by participant self-completion questionnaires and as 
such, interviewer bias and clinical rater bias are avoided. This form of outcome measurement 
has consistently performed well in comparison to clinician based assessments and general 
health status measures. All participants, including those who withdraw from their allocated 
intervention but who still wish to be involved in the study, are followed up, with analysis 
based on the intention to treat principle.    
Participants will receive questionnaires at the following time points:  
• Baseline questionnaire – completed before randomisation  
• 2 and 8 weeks post treatment – questionnaire completed over the phone  
• 8, 12 and 24 months post randomisation  
 
The baseline, 12 and 24 month post randomisation questionnaires also collect information to 
inform a cost-effectiveness element. Questions relating to information on primary care 
consultations, other consultations, out-of-pocket costs and work-impact of the intervention 
received are included. The study office in Aberdeen will contact and follow-up participants 
whose questionnaires have not been returned. 
 
4.2 Post-operative Imaging  
A number of authors have reported high rates of re-rupture of the rotator cuff tear (20-54%) 
after surgery, with some reporting a significant correlation between re-rupture and poor 
outcome [17]. Rates of re-rupture or repair failure may differ between the two surgical 
techniques. For this reason, participants will undergo an MRI or USS at 12 months post 
operation to assess the state of the rotator cuff repair. These are arranged by the study office 
in Oxford and performed locally. The images are collected centrally and read by an 
independent consultant radiologist blind to the type of surgery performed. The results of the 
scan are not reported to the participating surgeons. Incidental abnormalities of clinical 
significance are reported to the surgeon.    
5. ANALYSIS  
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Statistical analyses are based on all people randomised, irrespective of subsequent 
compliance with the randomised intervention.  The principal comparisons will be all those 
allocated arthroscopic surgery versus all those allocated open surgery.  The analyst will be 
blinded to the allocation.  
 
Measure of outcome  
Primary outcome measure:  
• Oxford Shoulder Score at 24 months after randomisation  
Primary measure of cost-effectiveness:  
• Incremental cost per quality-adjusted life year gained 
 
Secondary outcome measures include:  
• Oxford Shoulder Score (OSS) at 12 months after randomisation  
• EQ-5D at 8, 12, 24 months after randomisation  
• MHI-5 at 8, 12, 24 months after randomisation  
• Shoulder pain and disability index (SPADI) at 8, 12, 24 months after randomisation  
• Participant’s rating of how pleased they are with shoulder symptoms at 12, 24 months 
after randomisation  
• Participant’s view of state of shoulder at 8, 12, 24 months after randomisation  
• Surgical complications (intra and post-operative) at 2 and 8 weeks post surgery and at 
12 and 24 months after randomisation  
• Net health care costs at 2 weeks, 12 and 24 months after randomisation; out of pocket 
costs and work impact. 
 
Planned subgroup analyses  
(i) Size of tear (small versus medium/large);  
(ii) Age < or equal to 65 or >65;  
Stricter levels of statistical significance (p<0.01) will be used in subgroup analyses reflecting 
their exploratory nature and the multiple testing involved.    
Statistical analysis  
Reflecting the possible clustering in the data, the outcomes will be compared using multilevel 
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models, with adjustment for minimisation variables and participant baseline values. Statistical 
significance is set at the 2.5% level with corresponding confidence intervals. All participants 
will remain in their allocated group for analysis (intention to treat). Per-protocol analysis will 
also be performed. 
Economic evaluation  
A cost-effectiveness analysis will be performed. A simple patient resource use questionnaire 
at baseline and at 12 and 24 months post randomisation is used to obtain information on 
primary care consultations, other consultations, out-of pocket costs, work-impact of the 
intervention received and return to work. Unit costs will come from national sources and 
participating hospitals. The patient questionnaire is also used to administer the EQ-5D. The 
main health economic outcome is within-trial and extrapolated quality adjusted life-years, 
estimated using the EQ-5D.   
 
Incremental cost-effectiveness will be calculated as the net cost per quality-adjusted life year 
gained, for arthroscopic surgery versus open surgery. Power calculations (see following 
section) have been based on clinical rather than cost-effectiveness outcomes, which will be 
estimated rather than used in hypothesis testing. Cost-effectiveness ratios and net-benefit 
statistics will be calculated. We will report within-trial cost-effectiveness and explore if the 
trial produces sufficient evidence to plausibly model future quality of life or costs (e.g. based 
on projected failure rates). We will also extrapolate long-term cost-effectiveness beyond the 
trial period.  
An important component of this trial will be assessment of cost. Therefore, an accurate record 
of procedures at each of the proposed centres is essential.  To evaluate costs of each type of 
surgery, information from the operating theatres will be collected. Theatre managers will be 
contacted and visited at each site. Resources used, equipment costs and standard procedures 
for rotator cuff repairs will be recorded. Per case information will also be analysed during the 
final analysis. A checklist of equipment, consumables, implants, time and staff utilized during 
each case will be completed by theatre staff. Information from theatres will be collected by 
the Oxford UKUFF office and will be used in a cost comparison between the arthroscopic and 
open surgery.  
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SAMPLE SIZE AND FEASIBILITY  
Sample size sought  
The sample size was designed to detect a difference in OSS score of 0.38 of a SD for the 
comparison of arthroscopic versus open surgery. This was based on our experience of using 
and developing the OSS score in a variety of settings, from which a 3 point difference (0.33 
of a SD) would be deemed a clinically important change.  Attrition is expected to be low 
(10%), as are the effects of clustering of outcomes [18, 19]
 
(intra cluster correlation (ICC) less 
than 0.03). Whilst we did not have a direct estimate from a shoulder trial, other orthopaedic 
datasets available to our team supported this low ICC estimate. Both these factors required the 
sample size to be inflated; however, the primary analysis will be adjusted for baseline OSS 
score which conversely allowed the sample size to be decreased by a factor of 1-correlation 
squared [20]. Our previous studies showed that the correlation in the OSS score pre surgery to 
6 months post surgery in patients similar to potential trial participants was 0.57. Assuming a 
conservative correlation of 0.5 implied that the sample size could be reduced by 25% and still 
maintains the same power. Therefore, a study with a total of 267 participants was considered 
sufficiently powered to detect a clinically important change in each comparison, assuming 
attrition and clustering accounted for approximately 25% of variation in the data.  
ORGANISATION  
Trial Timeline 
The trial began in December 2007 and was stopped in December 2009 to allow for 
reconfiguration. Funding approval of the reconfiguration was given in January 2010 and 
revised research ethics approval was granted in April 2010. In May 2010 recruitment 
started to the reconfigured design. The final follow-up assessment is planned for December 
2013. Analysis and write up are planned for January to July 2014, with publication and 
dissemination from August 2014 onwards. 
Central organisation of the study  
Oxford coordinates the site specific and clinical concerns while Aberdeen houses the 
database and randomisation systems. The study is overseen by an independent Trial 
Steering Committee and an independent Data Monitoring Committee.   
Protocol Amendments 
DOI: 10.3310/hta19800 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 80
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Carr et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
135
Small changes have been made to the protocol over time, to reflect changes in points of 
outcome data collection and recruitment procedures.  Some changes have been made in 
response to alterations in waiting times for surgery in the NHS that occurred during the trial 
period. Support for individual centres also changed after the inception of the NIHR in the 
UK and the provision of a regional network of research support through the UK 
Comprehensive Research Network (UKCRN). 
 
PUBLICATION  
The Investigators will be involved in reviewing drafts of the manuscripts, abstracts, press 
releases and any other publications arising from the study.  Authors will acknowledge that the 
study was funded by the NIHR HTA programme.  Authorship will be determined in 
accordance with the ICMJE guidelines and other contributors will be acknowledged. The 
main report will be drafted by the UKUFF Management Group, and the final version will be 
agreed by the Trial Steering Committee before submission for publication, on behalf of the 
UKUFF collaborators.  
 
 
Trial Status 
UKUFF completed recruitment in February 2012 and follow up will be completed by January 
2014.  Production of the monograph is planned for July of 2014. 
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FIGURE 2. RECONFIGURED FLOW CHART     
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Appendix 4 Search terms used in the
literature review
MEDLINE (OVID platform): 1946 to March Week 4 2014
Using the Cochrane sensitivity- and precision-maximising version RCT filter (2008 version).
1. exp Shoulder/
2. shoulder$.tw.
3. exp Shoulder Joint/
4. exp Shoulder Pain/
5. exp Rotator Cuff/
6. rotator cuff$.tw.
7. exp Acromion/
8. acromion$.tw.
9. exp Scapula/
10. musculotendinous cuff$.tw.
11. (degenerative adj tear$).ti,ab.
12. or/1-11
13. exp Joints/
14. exp Tendons/
15. exp Tendinopathy/
16. exp Bursitis/
17. exp Calcinosis/
18. exp Calcium/
19. exp Joint Diseases/
20. or/13-19
21. 12 and 20
22. exp Shoulder Impingement Syndrome/
23. subacromial impingement.tw.
24. ((shoulder$ or rotator cuff or scapula or subacromial or acromion) adj5 (joint$ or tendon$ or bursitis or
calcinosis or calcium or impinge$)).tw.
25. or/21-24
26. exp General Surgery/
27. surg$.tw.
28. su.fs.
29. exp Decompression, Surgical/
30. decompress$.tw.
31. bursectom$.tw.
32. acromioplast$.tw.
33. (calcium adj remov$).tw.
34. exp Debridement/
35. debrid$.tw.
36. exp Arthroscopy/
37. arthroscop$.tw.
38. Orthopedics/
39. (open adj procedure$).ti,ab.
40. (open adj technique$).ti,ab.
41. mini-open.ti,ab.
42. or/26-41
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43. 25 and 42
44. Randomised controlled trial.pt.
45. controlled clinical trial.pt.
46. Randomised.ab.
47. placebo.ab.
48. clinical trials as topic.sh.
49. randomly.ab.
50. trial.ti.
51. or/44-50
52. exp animals/ not humans.sh.
53. 51 not 52
54. 43 and 53
55. Limit 54 to yr=”2006-2014”
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Appendix 5 Operation record
Lateral
Impossible
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Appendix 6 Patient information sheet
 
 
 
 
PATIENT INFORMATION SHEET 
This study is about the clinical and cost effectiveness of surgical (arthroscopic or open) repairs for 
management of the rotator cuff tears.     (10/H0402/24) 
 
We are inviting you to take part in a research study.  Before you decide whether to participate or not it is 
important for you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully and to decide whether or not you wish to be involved.  
 
1. What is the purpose of this study? 
The rotator cuff is a group of muscles that control movements within the shoulder.  Tears of the rotator cuff 
are one of the most common causes of shoulder pain and dysfunction.  Many patients require surgery to 
repair the tear, as non-surgical treatment like physiotherapy may not have helped restore shoulder function 
satisfactorily.    Operations to repair the tendon can be done via an: 
· Arthroscopic technique – where the tear is repaired through key-hole surgery, or a 
· Mini-open/Open technique – where a longer skin incision is made to complete the repair procedure. 
 
This study was designed to assess the best surgical technique for rotator cuff tears both in terms of 
recovery for patients and the costs involved. 
 
2. Why have I been chosen? 
You have been chosen because you are 50 years of age or older and have been diagnosed with a rotator 
cuff tear, deemed suitable for surgical repair. 
   
3. Do I have to take part? 
It is up to you to decide whether or not to take part.  You are free to withdraw at any time and without giving 
a reason.   
 
4. What will happen if I take part? 
Sometimes we don’t know which way of treating patients is best.  To find out, we need to make 
comparisons between different treatments.  To do this we will randomly allocate you to one of the following 
surgical options:   
1. Arthroscopic Surgical Repair 
2. Mini-open/Open Surgical Repair 
Your surgeon routinely performs both these operations.  Whichever one you are allocated to will be 
performed in the usual way by your surgeon.  The benefits and problems associated with each treatment 
will be compared. This is called a randomised study. 
 
5. What do I have to do? 
If you agree to participate in the UKUFF trial, we may ask you for a blood sample.  We hope to identify 
genes responsible for tears of the rotator cuff.  We will provide you with the blood sample tubes and ask 
you take the equipment with you to your outpatients or pre-admission clinic appointment and ask to have 
the samples taken there.  Due to the genetic nature of the blood analysis, only patients who identify as 
White British will be asked to give a blood sample. 
 
You will also be asked to give a tissue sample.  The tissue sample will be taken during your operation and 
is a very small amount which is routinely excised during rotator cuff repairs.  The samples will be used to 
examine the condition of the tendon. 
 
Involvement in the UKUFF trial will include completing questionnaires.  These are specialised 
questionnaires, recognised as a means of assessing shoulder pain and function, and they also cover other 
health related questions.   These will all be sent to you in the post with a free post envelope for them to be 
returned to our data centre.  Follow up questionnaires will occur as follows: 
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· At two and eight weeks after the completion of the Rest then Exercise Programme/or two and 
eight weeks after your surgery, a member of the research team will ask you questions over the 
telephone.   
· 8 months, 12 months and 24 months after you first agreed to participate in the study a 
questionnaire will be sent to you in the post 
· 12 months after your operation you will be asked to undergo an MRI scan. The MRI scan is a 
detailed method of assessing the clinical and physical result of the operation. 
. 
A diagram illustrating your involvement in the study is attached at the end of this information sheet.  
 
6. Expenses and payments 
If you are asked to attend an MRI scan 12 months after your operation, the costs incurred during this extra 
appointment will be reimbursed on request.   
 
7. What are the possible benefits of taking part? 
Your rotator cuff tear will be treated by experienced surgeons using widely recognised treatments.  The 
information we get from this study will help improve the future treatment of people with rotator cuff tears.   
 
8. What are the possible risks of taking part? 
MRI is a safe and non-invasive technique, which does not involve ionising radiation.  An MRI safety 
questionnaire will be asked at the time of arranging the scan appointment to help identify and minimise any 
possible risks. 
 
9. Will my taking part be kept confidential? 
All patient information is stored on password protected computer databases or in locked filing cabinets.  
You will be allocated a study number and staff not directly involved with you will know you only by this 
number.  When the results of the study are reported, individuals who have taken part will not be identified 
in any way. 
 
10. What if I change my mind about taking part? 
If you decide to withdraw from the study, your standard of care will not be affected.  You will still be asked 
to attend the usual follow-up clinics required by your surgeon and hospital.   These will not be part of the 
study.     
 
11. What if there is a problem? 
Complaints If you wish to complain formally, you can do this through the NHS Complaints Procedure, 
(details can be obtained from your hospital) or you can find further information on ethics in 
research on the National Research Ethics Service website (www.nres.npsa.nhs.uk).  
 
Harm If you are harmed and this is due to someone’s negligence then you may have grounds for legal 
action or compensation against the University of Oxford (in respect of any harm arising out of the 
participation in the Clinical Trial) or the NHS (in respect of any harm which has resulted from the 
clinical procedure being undertaken). 
 
12. Will my GP be informed of my involvement in the study? 
With your consent your GP will be notified of your participation in the UKUFF study. 
 
13. What will happen to any samples I give? 
The tissue and blood samples collected for the UKUFF trial will be sent to the Nuffield Department of 
Orthopaedic Surgery, in Oxford, for analysis.   
 
14. How will the information I provide be used? 
We plan to publish the results in a health journal so others can read about and learn from the results of the 
study. 
 
15. Who is organising and funding the research? 
This nationwide trial is being funded through the Heath Technology Assessment (HTA) Programme, which 
is part of the Department of Health.   You can access information about them on the HTA website 
(www.hta.nhs.uk).    
APPENDIX 6
NIHR Journals Library www.journalslibrary.nihr.ac.uk
146
  
The Nuffield Department of Orthopaedic, Rheumatology & Musculoskeletal Sciences 
(www.ndorms.ox.ac.uk) a department of the University of Oxford, in Oxford will undertake the day to day 
running of the trial, under the supervision of Professor Andrew Carr.   The University of Oxford will act as a 
sponsor for the study and will be responsible for the governance of the trial. 
 
The Centre for Healthcare and Randomised Trials (CHaRT), Health Services Research Unit in the 
University of Aberdeen (www.charttrials.abdn.ac.uk) in Aberdeen will be responsible for collecting and 
monitoring the information generated. 
 
16. Who has reviewed this study? 
A Research Ethics Committee, the UK Comprehensive Research Network, each hospital’s Research and 
Development Committee/Department and your local Orthopaedic Consultant have reviewed this study.  
 
17. Further Information 
If you require more information about this study please call one of the telephone numbers provided to 
speak to a clinical member of the research team or, alternatively look at the study website 
www.charttrials.abdn.ac.uk/ukuff.  
 
 
 
 
Thank you for reading this. 
If you have any questions or would like any more information please contact the UKUFF Study 
Office by phone: 
XXXXX 
Or email XXXXX 
 
Please keep this information sheet for your records. 
 
If you agree to enter the study, please sign the enclosed consent form and we will return a copy to 
you.  
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Appendix 7 Baseline questionnaire
Study Number:
UKUFF SHOULDER TRIAL
PATIENT ASSESSMENT
BASELINE QUESTIONNAIRE
Thank you for helping us with our research into rotator cuff tears.
We would be very grateful if you could complete and return this questionnaire in the enclosed 
freepost envelope.
CONFIDENTIAL
ISRCTN No: 97804283
Version 1 01/02/07
B
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el
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HOW TO FILL IN THIS QUESTIONNAIRE
Most questions can be answered by putting numbers or a tick in the 
appropriate box or boxes. Please print your answers carefully within the 
boxes like this:
Please try to complete the whole questionnaire.
There are no right or wrong answers.
Sometimes the box you tick tells you to skip forward so that you miss out 
questions which do not apply to you.
In some questions, we would like you to think about different time periods, 
such during the last 4 weeks. Please check the time periods carefully.
Some of the questions ask for answers in your own words, please write 
these in the boxes provided.
Thank you for your help.
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Please tick ONE box for EACH question
Please tick ONE box for EACH question
2. Gender:  Are you Male Female
3. Education: Which of these best describes your highest qualification?
          Secondary/further education Higher education
             (eg: GCSE, ‘O’ Level,                (eg: diploma, degree, 
No formal qualifications vocational qualification)     postgraduate qualification)       
If you are unemployed:
6c. Are you currently unable to work because of your shoulder?
1. How old are you? years old
Section 1 - Demographics
4. Housing tenure:  Which best applies to you?
Home owner
        (including mortgage/loan) Private rent Council rent Other
    
5. Do you live on your own?    Yes No
6. What is your current employment status?
      Employed full time Employed part time         
(including self-employed)      (including self-employed)         Homemaker/Car
        Retired        Student Unemployed
If you are employed:
6a. How would you describe your work?
        Manual     Non-manual    Not sure
6b. Are you currently ‘off sick’ or working reduced duties because of your shoulder?
          Yes            Yes           No 
       ‘off-sick’    working reduced hours/duties      working usual hours/duties
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· We would like to ask you about your personal views about surgery in general
· Below are 4 statements other people have made about surgery in general
· Please indicate the extent to which you agree or disagree with them by putting a tick 
( ) in the appropriate box
There are no right or wrong answers.  We are interested in your personal views.
Strongly
agree Agree Uncertain Disagree
Strongly 
disagree
Doctors rely on surgery too much
Doctors place too much trust in 
surgery
I worry about the risks of surgery
Surgery should only be taken as a 
last resort
Everyone
7. Are you right or left-handed?
Right-handed Left-handed Both
            
8. For how long (approximately) have you had this problem with your shoulder?
Years Months
9. Would you be able to do your job OR essential everyday activities, if you had your 
‘bad’ arm in a sling?
        No      Yes, but with difficulty Yes, with no difficulty
Section 3 – Shoulder Pain
Section 2 – Your Views About Surgery
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Please tick ONE box for EACH question
During the past 4 weeks
1. How would you describe the worst pain you had from your shoulder?
None                Mild              Moderate              Severe          Unbearable
                                                            
During the past 4 weeks
2. Have you had any trouble dressing yourself because of your shoulder?
No trouble         A little bit           Moderate             Extreme       Impossible 
    at all              of trouble              trouble              difficulty           to do
            
During the past 4 weeks
3. Have you had any trouble getting in and out of a car or using public transport 
because of your shoulder?
No trouble        A little bit            Moderate             Extreme           Impossible 
                 at all              of trouble              trouble               difficulty              to do
During the past 4 weeks
4. Have you been able to use a knife and fork - at the same time?
Yes,           With little     With moderate       With extreme        No,
easily         difficulty          difficulty               difficulty          impossible
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During the past 4 weeks 
Please tick ONE box for EACH question
During the past 4 weeks 
During the past 4 weeks
5. Could you do the household shopping on your own?
Yes,             With little       With moderate With extreme           No,
              easily            difficulty             difficulty               difficulty          impossible
         
During the past 4 weeks
6. Could you carry a tray containing a plate of food across a room? 
Yes,           With little        With moderate     With extreme          No,
           easily         difficulty                difficulty             difficulty      impossible
During the past 4 weeks
7. Could you brush/comb your hair with the affected arm?
      Yes,          With little       With moderate      With extreme            No,
easily         difficulty           difficulty            difficulty         impossible
          
During the past 4 weeks
8. How would you describe the pain you usually had from your shoulder?
None            Very mild                Mild                 Moderate            Severe
      
APPENDIX 7
NIHR Journals Library www.journalslibrary.nihr.ac.uk
154
Please tick ONE box for EACH question
During the past 4 weeks
9. Could you hang your clothes up in a wardrobe, - using the affected arm?
      Yes,         With little       With moderate      With great         No,
easily       difficulty            difficulty            difficulty          impossible
During the past 4 weeks
10. Have you been able to wash and dry yourself under both arms?
      Yes,             With little       With moderate      With extreme       No,
easily            difficulty           difficulty              difficulty         impossible
   
During the past 4 weeks
11. How much has pain from your shoulder interfered with your usual work (including 
housework)?
         Not at all        A little bit           Moderately             Greatly             Totally
During the past 4 weeks
12. Have you been troubled by pain from your shoulder in bed at night?
No             Only 1 or 2         Some                 Most               Every
nights               nights                  nights               nights             night
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Please ring round ONE number to EVERY question where
0 = no pain and 10 = worst pain imaginable
PAIN SCALE DURING THE PAST WEEK
How severe is your shoulder pain 
1. At its worst? No pain 0 1 2 3 4 5 6 7 8 9 10 Worst painimaginable
2. When lying on involved 
side? No pain 0 1 2 3 4 5 6 7 8 9 10
Worst pain
imaginable
3. Reaching for something 
on a high shelf? No pain 0 1 2 3 4 5 6 7 8 9 10
Worst pain
imaginable
4. Touching the back of 
your neck? No pain 0 1 2 3 4 5 6 7 8 9 10
Worst pain
imaginable
5. Pushing with the 
involved arm? No pain 0 1 2 3 4 5 6 7 8 9 10
Worst pain
imaginable
Please ring round ONE number to EVERY question where 
0 = no difficulty and 10 = so difficult required help
DISABILITY SCALE DURING THE PAST WEEK
How much difficulty do you have .
1. Washing your hair? No difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
2. Washing your back? No difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
3. Putting on an undershirt 
or pullover sweater?
No 
difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
4. Putting on a shirt that
buttons down the front?
No 
difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
Section 4 – Shoulder Pain and Disability
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Please ring round ONE number to EVERY question where
0 = no difficulty and 10 = so difficult required help
How much difficulty do you have .
5. Putting on your pants? No difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
6. Placing an object on a 
high shelf?
No 
difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
7. Carrying a heavy 
object ( > 10 pounds)?
No 
difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
8. Removing something 
from your back pocket?
No 
difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult
required help
State of Mind
Please tick ONE box for EACH question
1. How much time during
the past month:
All
of the
time
Most
of the 
time
A good 
bit of 
the time
Some
of the
time
A little
of the
time
None
of the
time
a) Have you been a very nervous 
person?
b) Have you felt downhearted and low?
c) Have you felt calm and peaceful?
d) Have you felt so down in the dumps
that nothing could cheer you up?
e) Have you been a happy person?
Your Health Today
Section 5 - Your General Health
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Please indicate which statement describes your own health state today.
Please tick ONE box for EACH question.
a) Mobility
I have no problems in walking about
I have some problems in walking about
I am confined to bed
b) Self-care
I have no problems with self care
I have some problems with washing or dressing myself
I am unable to wash and dress myself
c) Usual activities
I have no problem in performing my usual activities 
(eg: work, study, housework, leisure activity)
I have some problems in performing my usual activities
I am unable to perform my usual activities
d) Pain / Discomfort
I have no pain or discomfort
I have moderate pain or discomfort
I have extreme pain or discomfort
e) Anxiety / Depression
I am not anxious or depressed
I am moderately anxious or depressed
I am extremely anxious or depressed
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We would like to know how much contact you have had with the health service over the last 12
months. If you are not exactly sure, we would rather have your best guess than no information at 
all. Please answer every question, even if the answer is "0".
Please fill in both boxes, for example: if seen three times.
Over the last 12 months, how many times have you:
Over the last 12 months, approximately how much (to the nearest £) did the following 
items cost you?  If there was no cost, please write “0”.
Section 6 – Health Service Use, and Costs
0     3
1. Seen your GP about your shoulder? ..      
2. Seen a practice nurse about your shoulder?   .       
3. Seen a physio or occupational therapist about your shoulder?        
4. Visited a hospital out-patient clinic about your shoulder?     
5. Been in hospital overnight because of your shoulder? 
5a.  If you have been in hospital overnight because of your shoulder,
for how many nights were you there ? .
6. Visited a private practitioner such as an osteopath or chiropractor about 
your shoulder? .
7. Buying painkillers, creams and lotions, dressings or slings as a 
result of your shoulder
8. Transport, parking, or other costs of visiting the GP or physio, 
attending exercise clinics, or other health service visits about your 
shoulder .. 
9. Paying for private practitioners such as osteopaths or chiropractors 
about your shoulder
10. Losing earnings as a result of your shoulder .. 
£
£
£
£
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THANK YOU
Thank you for completing this questionnaire. The information you have given us will be 
extremely useful.
It will be treated with the strictest confidence and kept securely.
Please send the questionnaire back to us in Oxford in the envelope 
provided.
Thank you again for your help.
If you would like any further information or have any queries about the study, please contact:
This study is taking place in centres across the UK but the questionnaires are being processed in Aberdeen 
at the Centre for Healthcare Randomised Trials (CHaRT), Health Sevices Research Unit, University of 
Aberdeen, Health Sciences Building, Foresterhill, ABERDEEN, AB25 2ZD
Finally:
     D    D        M    M        Y   Y   Y     Y
Date you filled in this questionnaire            /          /
The UKUFF Study Office in Oxford 
or visit our website at www.charttrials.abdn.ac.uk/ukuff
Please could you inform us of any
changes to your phone number:
And inform us of any changes to your contact details: .
.
.
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Appendix 8 Two- and 8-week telephone
assessments
UKUFF SHOULDER TRIAL 2 & 8 WEEKS POST-TREATMENT 
C. TELEPHONE ASSESSMENT 
 
Version 2 01/09/2007   
 
 
 
Today's date:  (day/month/year)   /         /        /20     .   Telephone number    
 
Good morning/afternoon Mr/Ms/Mrs    
 
 
My name is    and I am working on the UKUFF shoulder study that you agreed to take 
part in.  
 
I am phoning you today, just to ask you a small number of questions, which should take less 
than 5 minutes. Is now a convenient time for you? (Pause)  If not, I could ring you back 
later today - or tomorrow? 
 
     IF NO - RECORD AGREED DAY/TIME TO CALL BACK:  
 
       date/day . Time .. 
 
IF YES, CONTINUE WITH INTERVIEW BELOW: 
 
 
 
Good. I’m now going to start by asking you a few questions - all relating to your shoulder. 
 
 
1. 
 
 
Within the last 24 hours Have you been wearing a sling at all?    Yes      No  
                                                                                                                                                                                          
                                                                                                                        If no go to  
                                                                                                                      QU. 2 below 
IF YES, Have you worn your sling for  More than 12 hours?  
                                                                                                                                                                                                         
                                                                           Between 6 and 12 hours?  
                                                                                                                                                                                                         
                                                 More than 3, but less than 6 hours?  
                                                                                                                                                                                                         
                   Or less than 3 hours?  
                                                                                                             
 
2. 
 
 
Within the last 24 hours  
How would you describe the worst pain you had from your shoulder? 
  
         None                   Mild                    Moderate              Severe             Unbearable 
                                                                                    
 
3.  
 
Within the last 24 hours . 
How much has pain from your shoulder interfered with your usual work 
(including housework)? 
  
    Not at all             A little bit               Moderately            Greatly                Totally 
                                                                                                                  
 
4. 
 
Were you troubled by pain from your shoulder in bed last night? 
 
 
         Yes, during some        Yes, throughout 
 No, not at all     Yes, just at first         of the night            the night 
 
                                                                                                                                   
  
 
Study ID: 
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Thank you very much. That is all I need to ask you today.  
 
We will be in touch again, by post, in around 2 weeks’ time. 
 
 
5. 
 
Within the last 24 hours . 
Have you taken any painkillers or anti-inflammatory drugs - because of your 
shoulder? 
                                                      Yes          No  
                                                           
IF YES, 5a. could you tell me which types you have used? (within last 24 hours) 
 
 
MEDICATION 
 
Dose 
(mgs) 
OR NO. OF 
TABS 
 
HOW OFTEN? 
(how many times) 
 
BOUGHT ‘over the counter’ 
OR  PRESCRIPTION 
    
    
    
 
6. During the last 2 weeks (since your surgery/completion of Rest & Exercise Programme): 
Have you had any additional treatment (for example: injection into the shoulder, 
antibiotics or surgery) for your shoulder?    
 
               Yes         No IF NO, GO TO QUESTION 7  
                                                                                                                                                                                                              
     IF YES, 6a. please tick all that apply: 
 
   Injection into the shoulder             Surgery      Antibiotics          
                                                                           
   Any other unexpected treatment  
               please give details  
 
     IF ‘any other treatment’ included admission to hospital: 
  
    6b. What was the reason for your hospital admission?.................................................. 
  
    IF this admission included surgery: 
 
    6c. What kind of surgery did you have?........................................................................ 
 
    6d. What was the name of the hospital?......................................................................... 
 
    6e. How many nights did you stay in hospital?............................................................... 
 
 
7.  What date were you discharged from hospital after your shoulder rotator cuff 
repair operation?     ___/___/____ (dd/mm/yyyy) 
 
 
 
8. 
 
Finally, could you tell me, are you currently employed?  Yes                       No  
                                                                                                                                                                                                                                                                                                                                 
 IF YES, 8a. Are you currently ‘off sick’ or working reduced duties  
           because of your shoulder? 
 
 
 Yes - ‘off sick’      Yes - working reduced duties   No - working usual hours/duties  
                                                                         
   
  
  
 
Thank you very much. That is all I need to ask you today.  
 
We will be in touch again. 
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Appendix 9 Eight-, 12- and 24-month
questionnaires
Study Number:
UKUFF SHOULDER TRIAL
PATIENT ASSESSMENT
8, 12, 24 MONTHS POST RANDOMISATION
Thank you for helping us with our research into rotator cuff tears.
We would be very grateful if you could complete and return this questionnaire in the enclosed 
freepost envelope.
CONFIDENTIAL
ISRCTN No: 97804283
Version 2 27/05/08
8 
M
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HOW TO FILL IN THIS QUESTIONNAIRE
Most questions can be answered by putting numbers or a tick in the 
appropriate box or boxes. Please print your answers carefully within the 
boxes like this:
Please try to complete the whole questionnaire.
There are no right or wrong answers.
Sometimes the box you tick tells you to skip forward so that you miss out 
questions which do not apply to you.
In some questions, we would like you to think about different time periods, 
such as during the last 4 weeks or during the last 8, 12, 24 months. Please 
check the time periods carefully.
Some of the questions ask for answers in your own words, please write 
these in the boxes provided.
Thank you for your help.
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Please tick ONE box for EACH question
Section 1 – Shoulder Problems And Treatments
2. Have you been unwell for a reason other than your shoulder (during the past 8 
months)?
                                              Yes          No        IF NO, GO TO QUESTION 3
If YES, 2a. What was the reason? 
If YES, 2b. Were you admitted to hospital? Yes          No
If YES, 2c. Did you have an operation? Yes          No
5. Are you currently employed? Yes           No
If YES, 5a. Are you currently ‘off sick’ or working reduced duties because of your 
shoulder?
       Yes          Yes              No 
     ‘off-sick’            working reduced hours/duties      working usual hours/duties
3. How are the problems related to your shoulder NOW, compared with 8 months ago
(at the start of this study)?
       Much        Slightly    No    Slightly         Much 
       better         better            change     worse         worse
4. Overall, how pleased are you with your shoulder symptoms so far?
        Very         Fairly       Not very         Very
     Pleased       pleased       pleased              disappointed
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Please tick ONE box for EACH question
Section 2 – Questions About Your Shoulder
During the past 4 weeks
1. How would you describe the worst pain you had from your shoulder?
None                Mild              Moderate              Severe          Unbearable
      
During the past 4 weeks
2. Have you had any trouble dressing yourself because of your shoulder?
No trouble          A little bit            Moderate             Extreme         Impossible 
   at all              of trouble              trouble            difficulty          to do
During the past 4 weeks
3. Have you had any trouble getting in and out of a car or using public transport 
because of your shoulder?
No trouble         A little bit            Moderate             Extreme           Impossible 
                 at all              of trouble              trouble               difficulty                to do
During the past 4 weeks
4. Have you been able to use a knife and fork - at the same time?
Yes,           With little     With moderate       With extreme        No,
easily         difficulty          difficulty               difficulty          impossible
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During the past 4 weeks 
Please tick ONE box for EACH question
During the past 4 weeks
5. Could you do the household shopping on your own?
Yes,             With little       With moderate With extreme           No,
              easily            difficulty             difficulty               difficulty          impossible
         
During the past 4 weeks
6. Could you carry a tray containing a plate of food across a room? 
Yes,           With little        With moderate     With extreme          No,
           easily         difficulty                difficulty             difficulty        impossible
During the past 4 weeks
7. Could you brush/comb your hair with the affected arm?
      Yes,          With little       With moderate      With extreme            No,
easily         difficulty           difficulty                difficulty         impossible
          
During the past 4 weeks
8. How would you describe the pain you usually had from your shoulder?
None            Very mild                Mild                 Moderate            Severe
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During the past 4 weeks 
Please tick ONE box for EACH question
During the past 4 weeks
10. Have you been able to wash and dry yourself under both arms?
      Yes,             With little       With moderate     With extreme            No,
easily            difficulty           difficulty            difficulty         impossible
   
During the past 4 weeks
9. Could you hang your clothes up in a wardrobe, - using the affected arm?
      Yes,         With little       With moderate         With great            No,
easily       difficulty            difficulty                difficulty         impossible
During the past 4 weeks
11. How much has pain from your shoulder interfered with your usual work (including 
housework)?
         Not at all        A little bit           Moderately              Greatly            Totally
During the past 4 weeks
12. Have you been troubled by pain from your shoulder in bed at night?
No             Only 1 or 2       Some                 Most               Every
nights               nights                  nights               nights             night
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Please ring round ONE number to EVERY question where
0 = no pain and 10 = worst pain imaginable
PAIN SCALE DURING THE PAST WEEK
How severe is your shoulder pain 
1. At its worst? No pain 0 1 2 3 4 5 6 7 8 9 10 Worst painimaginable
2. When lying on involved
side? No pain 0 1 2 3 4 5 6 7 8 9 10
Worst pain
imaginable
3. Reaching for something 
on a high shelf? No pain 0 1 2 3 4 5 6 7 8 9 10
Worst pain
imaginable
4. Touching the back of 
your neck? No pain 0 1 2 3 4 5 6 7 8 9 10
Worst pain
imaginable
5. Pushing with the 
involved arm? No pain 0 1 2 3 4 5 6 7 8 9 10
Worst pain
imaginable
Please ring round ONE number to EVERY question where 
0 = no difficulty and 10 = so difficult required help
DISABILITY SCALE DURING THE PAST WEEK
How much difficulty do you have .
1. Washing your hair? No difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
2. Washing your back? No difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
3. Putting on an undershirt 
or pullover sweater?
No 
difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
4. Putting on a shirt that
buttons down the front?
No 
difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
Section 3 – Shoulder Pain and Disability
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Please ring round ONE number to EVERY question where
0 = no difficulty and 10 = so difficult required help
How much difficulty do you have .
5. Putting on your pants? No difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
6. Placing an object on a 
high shelf?
No 
difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
7. Carrying a heavy 
object (more than 10
pounds)?
No 
difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult 
required help
8. Removing something 
from your back pocket?
No 
difficulty 0 1 2 3 4 5 6 7 8 9 10
So difficult
required help
State of Mind
Please tick ONE box for EACH question
1. How much time during
the past month:
All
of the
time
Most
of the 
time
A good 
bit of 
the time
Some
of the
time
A little
of the
time
None
of the
time
a) Have you been a very nervous 
person?
b) Have you felt downhearted and low?
c) Have you felt calm and peaceful?
d) Have you felt so down in the dumps
that nothing could cheer you up?
e) Have you been a happy person?
Section 4 - Your General Health
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Your Health Today
Please indicate which statement describes your own health state today.
Please tick ONE box for EACH question.
a) Mobility
I have no problems in walking about
I have some problems in walking about
I am confined to bed
b) Self-care
I have no problems with self care
I have some problems with washing or dressing myself
I am unable to wash and dress myself
c) Usual Activities
I have no problems in performing my usual activities 
(eg: work, study, housework, leisure activity)
I have some problems in performing my usual activities
I am unable to perform my usual activities
d) Pain / Discomfort
I have no pain or discomfort
I have moderate pain or discomfort
I have extreme pain or discomfort
e) Anxiety / Depression
I am not anxious or depressed
I am moderately anxious or depressed
I am extremely anxious or depressed
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THANK YOU
Thank you for completing this questionnaire. The information you have given us will be 
extremely useful.
It will be treated with the strictest confidence and kept securely.
Please send the questionnaire back to us in Aberdeen in the envelope 
provided.
Thank you again for your help.
If you would like any further information or have any queries about the study, please contact:
This study is taking place in centres across the UK but the questionnaires are being processed in Aberdeen 
at the Centre for Healthcare Randomised Trials (CHaRT), Health Sevices Research Unit, University of 
Aberdeen, Health Sciences Building, Foresterhill, ABERDEEN, AB25 2ZD
The UKUFF Study Office in Aberdeen 
or visit our website at www.charttrials.abdn.ac.uk/ukuff
Finally:
     D    D         M    M         Y     Y     Y     Y
Date you filled in this questionnaire            /          /
Please could you inform us of any
changes to your phone number:
And inform us of any changes to your contact details: .
.
.
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Appendix 10 Rest-then-exercise programme
Rest then exercise
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UK Rotator Cuff Surgery Trial
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This booklet will guide you through the Rest then Exercise
programme. 
This booklet was written by: Jane Moser (Clinical
Physiotherapy Specialist – Shoulders) and Andy Carr (Nuffield
Professor of Orthopaedic Surgery) with help from specialist
physiotherapy colleagues (Dr Jeremy Lewis, Dr Bobbie Ainsworth
and Jo Gibson). 
Help and feedback was gratefully received from people with
shoulder problems related to their rotator cuff muscles. 
Design and Illustration: Oxford Designers & Illustrators
Cover Illustration: Angela Walters
FEBRUARY 2007 V ERSION 1. 
www .charttrials.abdn.ac.uk/ukuff 
Disclaimer:
The information contained here is intended solely for the general 
information of the reader, not intending to diagnose or take the place of
professional medical care.
The information is neither intended to dictate what constitutes reasonable, 
appropriate or best care for people with rotator cuff tears of the shoulder, 
nor is it intended to be used as a substitute for professional medical care.
This programme was designed for use in the United Kingdom Rotator Cuff 
Surgery Trial (UKUFF)  ISRCTN 97804283 for people with diagnosed rotator 
cuff tears and as yet,  is unevaluated.  All content, including text, graphics, 
images and the information contained within is general information.
It is unable to take into account unique person- specific issues. If you have 
persistent or worsening problems with your shoulder, please consult your 
doctor or physiotherapist to access individual medical advice and treatment 
options.   The information in this programme  is not a substitute for a
medical assessment.
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Introduction 
You have a tear in your rotator cuff tendon(s). This is a ver y common
problem which affects many people, especially over the age of 50. What
is interesting is that many of your friends and family of a similar age may
also have this tear and yet are NOT affected by a troublesome shoulder .
A resear ch study has shown that 28% of people over the age of 60 had a
tear of the tendon, but reported no problems with their shoulder . We
know that you have a tear and you ARE having problems with your
shoulder .
This programme aims to 
decrease the pain 
increase movement 
increase strength 
in your shoulder .
So, even though you still have a tear in your tendon, it does not cause a
problem in your daily life. We  know that these improvements are
definitely possible, even when a tear has been found. Research studies
have shown that people who have a tear in the tendon can have a
satisfactory outcome without surgery. The Rest then Exercise Programme
can be viewed as an extra treatment, of very low risk and some potential
benefit. 
This is a summary of  the Rest then Exercise Programme 
4 weeks of relative rest & modification of activities to reduce the pain
8-12 weeks of exer cises to work all the muscles around your shoulder 
The exercises are used widely and have been recommended by shoulder
rehabilitation experts. 
The first section of this booklet explains what the rotator cuff muscles are
and do. It also includes frequently asked questions.
If you just want to know what we are suggesting you do, please go
straight to page 5. 
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3REST THEN EXERCISE
SECTION 1 
Frequently asked questions
What are the rotator cuff muscles/tendons?
• They are a group of four deep muscles*, think of them as ‘undercoat
muscles’ 
• They attach from your shoulder blade (scapula) to the arm bone
(humerus) 
• They form a hood around the arm bone
• Commonly there is a problem with one tendon (supraspinatus)
*supraspinatus, infraspinatus, subscapularis and teres minor
What do the rotator cuff tendons do? 
Tendons connect your muscle to the bone 
The four muscles work together and act like ‘guy ropes’, keeping the ball
positioned well against the socket
• The rotator cuff muscles (and tendons) work when you take your arm
away from your side and/or overhead 
• They work harder when you are lifting or carrying a weight 
• They work together with other muscles around your shoulder 
• They work with ‘overcoat’ or ‘outside’ muscles to move your shoulder 
• They stabilize the ball in the socket and help your power muscles to
move your arm 
• They work as a group together 
Arm bone
Three of the four rotator cuff muscles
attach from the back of the shoulder
blade to the arm bone.
Usually it is the top muscle that is
damaged. It is called ‘supraspinatus’
Rotator cuff tendon
Arm bone
Shoulder blade
Rotator cuff tendon
with tear
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What happens to the tendons as I get older?
The supraspinatus tendon ‘wears ’ with ever yday life and may
eventually split and tear
This does not always lead to pain or loss of function
Torn rotator cuff tendons are common with older age
Not ever yone with a torn tendon has problems with the shoulder
The torn tendon does not repair itself
There is a genetic link which means that some people are more at risk
of developing this than others  
If my tendon is torn, surely I will not be able to move my arm?
There are people who have a tear in the tendon and can move their
arm without pain or apparent weakness. We  don’t know why this is or
what is different about them
In fact many people over the age of 50 who do not have any pain or
symptoms have torn tendons
Your shoulder may improve with this simple programme
There is absolutely no guarantee that you will have a reduction in pain
or increase in strength or function following Rotator Cuff repair
surgery
Your arm may not be as strong as it used to be, especially when your
arm is out to the side
For some people this lack of strength can also remain after surgical
repair (an operation)    
If my tendon is torn, will it hurt until it is repaired?
There does not always appear to be a direct relationship between the
pain and a tear in the tendon
A big tear does not mean you will have a lot of pain and many big
tears cannot be repaired with surgery
Some people can have a torn tendon and have little or no pain
Pain can vary even though the tear in the tendon is present all the
time
Pain can stop muscles working so that your arm feels weaker still
Pain can be eased with methods other than an operation (tablets, heat,
injections, rest, exer cise etc.)
The Rest then Exercise Programme is a method of treatment and has
been shown in at least ten resear ch studies to be an effective way of
reducing pain and increasing functional ability
The Rest then Exercise Programme
4 weeks of relative rest & modification of activities to reduce the pain
8-12 weeks of exercises to work all the muscles around your shoulder
to compensate for the damaged tendon. The non-damaged
muscles/tendons can be trained to take a greater ‘share ’ of the work
which may result in less pain and more movement and strength.
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SECTION 2 
Relative rest phase – 4 weeks     
Some of the feeling of ‘weakness ’ in the arm may be due to the 
pain ‘stopping ’ the undamaged muscles working normally around 
the shoulder . 
Therefore to start your treatment, we would like you to avoid doing
things that make the pain worse. To  begin this process, we would like
you to give your shoulder a ‘rest ’. 
This is also what we would advise you to do if you had an operation on
your shoulder . It may be that resting the shoulder is an important factor
in improving your symptoms.  
We  appreciate that this ‘rest ’ for your shoulder will affect your ability to
per form your normal activities, which may be ver y annoying! 
However if the rest helps reduce the pain, you may then find 
it more comfortable to move your arm. This, in the long term, 
may help you with your daily tasks. 
What to do
We  would like you to REALL Y rest your shoulder for 4
weeks 
We  want you to try and keep your pain levels as LOW as 
possible
You can use a sling to help you do this (available at
chemists or online). 
Make sure the weight of your arm is fully supported by 
the sling 
When to wear the sling
Give your shoulder pain a score between 0–10 
Imagine a score where 0 is ‘no pain’ and 10 is the ‘worst pain
imaginable ’ in your shoulder 
If you taking medication think of your pain score while you are taking
them
We  would like you to AVOID all activities and movements that
consistently increase your pain above 4 
Therefore we would advise you to wear the sling for activities that
would increase your pain above 4 
If your pain is always above 4 then you need to wear the sling ALL DAY 
This may  be a real nuisance but we would like you to do this for 4
weeks
It may take 4 weeks for pain to settle down once you have stopped
aggravating activities 
This MAY mean that you will NOT be able to do your usual activities! 
No pain 0 1 2 3 4 5 6 7 8 9 10 Worst pain imaginable
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If the pain increases above 4 on the scale we would advise you to
STOP or CHANGE the way you do that particular thing
Usually the pain is worse when you reach with your arm, so try and
avoid activities that involve this
It may mean that you will have to move things that you use everyday
to a lower height or closer to you
Sometimes using a step can help raise you up but make sure you 
are safe!  
If possible, ask other people to do certain difficult tasks
If moving your arm out sideways is painful (eg for washing armpit and
putting on deodorant), try placing your hand (or elbow) on a surface
and move your body away 
Remember , it is just for four weeks to see if the pain will reduce with rest. 
If you feel it would help, write down some things that often/usually make
your shoulder pain worse. In the opposite column, record possible ways
of avoiding the aggravating activities for the next four weeks.
Today’s date is ……………… 4 weeks’ time the date is ………………
What things make my  How can I do this differently
?lla ta ton ro?truh redluohs
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Gardening, pruning, 
hedge clipping, mowing
Cooking, hoovering, ironing, 
hanging out washing
DIY, changing light bulb, 
hammering, painting
Dressing, hair washing, 
unexpected movements
Reaching to side and
overhead, lifting, driving
ACTIVITIES WHICH CAN 
INCREASE SHOULDER PAIN
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What to do at night/resting 
• Take the sling off at night unless it is very helpful at this time
• Try different resting positions at night
- When lying on your back, place a folded towel or pillow under
your upper arm
- When lying on your good side, place a pillow or two in front of
you so that your arm cannot drop across your body 
• When sitting, try propping your arm on a cushion
What else to do 
• Research has shown a healthy diet may have an effect on tendon
health and improve symptoms 
• A healthy diet includes 
- reducing/stopping smoking
- eating more fruit and vegetables (increases anti-oxidants) 
- increasing omega 3 essential fatty acid intake (eg.oily fish,
flaxseeds, walnuts, kidney beans, winter squash) 
7PAGE
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Don’t let the shoulder get stiff! 
Although we want you to rest the shoulder tendons, we do not want
the shoulder to stiffen 
It may be easier to do the exer cises with someone the first time
The person can read the instructions whilst you try the actions 
These are  gentle exercises that we recommend you to do 
Remember! 
The exercises do not make the muscle/tendon work hard 
The exercises should feel ‘easy ’ and ‘sliding ’ without the feeling of
muscles working with effort 
Do the exercises once or twice a day
Do not do them if it is a struggle 
Do not force the arm to move if it does not want to 
Do not let the pain rise over 4 
All exercises are shown for the right arm. 
Set A Keeping the shoulder moving – for four weeks
A1) Shoulder blade exercise
Sitting or standing 
Keep your arms relaxed by your sides 
Shrug shoulders up and forwards 
Roll shoulders down and back 
Relax 
Repeat 5 times for each movement 
START FINISH
APPENDIX 10
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A2) Elbow exercise
Standing
Straighten arm fully
Bend elbow so hand is coming towards shoulder 
Repeat 5 times
A3) Shoulder elevation stretch
Stand facing a flat horizontal surface at waist height
e.g. table, work surface
Place both hands on a slippery towel, on the surface 
Bend your knees and push your backside away from the table; 
at the same time let your arms slide forwards
Then stand up again, sliding your hands back towards you 
As you repeat, try and stretch forwards as far as you comfortably can
Repeat 5–10 times
9PAGE
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A4) Shoulder rotation stretch
Sit back in chair
Bend elbows to right angle 
Place cushion/towel in-between elbow and waist on the bad shoulder side
Using both hands, hold a stick/umbrella/rolling pin 
Using the stick, push your hand on the bad side outwards
Keep the elbow against the cushion/towel
Your hand should be now outside your elbow
Do the movement gently , use the stick rather than your muscles around
the bad shoulder
Feel a stretch, hold the stretch for 20 seconds
Relax
Repeat 3–5 times
If the movement is painful rather than stretchy  DO NOT CONTINUE
with THIS exercise
If you prefer you can do this lying down, with a folded towel under your
upper arm 
START FINISH
APPENDIX 10
NIHR Journals Library www.journalslibrary.nihr.ac.uk
184
11PAGE
REST THEN EXERCISE
SET B General fitness exercises
There is evidence that general exercise can help reduce pain levels. Your
ability will be dependent on your general health. Consult your GP if you
are unsure of your suitability to exercise or if you experience any unusual
symptoms during the programme. However, we would encourage you to
remain as active as possible without increasing the shoulder pain above 4 
If you are not usually active, here are some ideas
• Walking
• Step ups
• Standing up from a chair without using your arms (the lower the chair
the more your legs work)
• Using an exercise bike
In all these activities you can wear the sling to keep the shoulder
tendon/muscle relatively still.
• If you enjoy swimming, 
- still go to the pool 
- make your legs and body work 
- avoid arm movements if they increase your pain over 4 
Please concentrate on RESTING the arm and doing these few
maintenance/general fitness exercises for 4 weeks.
It may feel like a long time, but compared with the work and activity
your muscle/tendon has done in your lifetime it is only a short rest! 
AFTER 4 WEEKS
MOVE ON TO THE EXERCISES IN THE NEXT SECTION
Remember the date which will be
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SECTION 3 
EXERCISE PHASE – for twelve weeks
After 4 weeks we would like you to start to exercise your shoulder
muscles
You can exercise in a lying (set C) or upright position (set D, sitting or
standing)
When you start these exercises, we suggest you try both set C and 
set D. There is no right or wrong exercise, try them and see which 
suits you
The exercises are in a certain order (or progression), so that most
people find the exercises at the beginning are easier than the ones at
the end of each session
IF AN EXERCISE INCREASES YOUR PAIN ABOVE 4, THEN STOP
THAT PARTICULAR EXERCISE
Do not do any exercise which makes the pain worse
Choose the exercise or position that is the LEAST painful for your
shoulder and do THIS exercise daily
You may feel that your shoulder or arm muscles are working and the
exercise feels ‘hard work ’ or ‘difficult to control ’. When this happens
the exercise is often helpful and we would encourage you to do it!
Ideally we want you to find an exercise from those shown, which is
relatively pain-free that you will be able to practise regularly
If you find an exercise which you can do, and it becomes easier (which
may take 6 weeks or longer) try the progressions that are suggested
(e.g. light weights) or try an exercise in a different position. Please
experiment with the exercises shown. 
Repetition rates are given as a guide only. You may well find that your
muscles get tired and that you will have to build up the number of
times you can do the exercise. For example start with 3–5 repetitions.
Sensations of ‘hard work ’, ‘stiffness ’, uncomfortable ’ and muscle ‘ache ’
are all expected and will tend to improve over 6–8 weeks
Try to do the exercises once every day. You need to do them at least
4 times a week to make a change.
All exercises are shown for the right arm 
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SET C LYING DOWN EXERCISES
You will need:
• A pillow  
• A hand towel folded
• A weight (possibly) – see exercise C3 
The first two exercises start with your arm up in a vertical position. You
may have to find your ‘own way’ to get your arm into this position. If
you cannot tolerate the vertical position – do not do THIS exercise.
Getting into the start position
Many people find this the easiest way to get into the start position
• Lying on your back with knees bent up, feet flat on the floor, pillow
under your head
• Folded towel under your upper arm
• Use your good arm to lift your bad arm up in the air
• Keep your bad arm as ‘relaxed’ and ‘floppy’ as possible. It will feel
heavy to lift!
• When your upper arm is vertical, still support your bad arm but bend 
the elbow, you are ready to start!
Note: If you have problems with both sides you may find getting into
this start position difficult. If you cannot support your bad arm with the
other, as both hurt or are weak, move on to the exercises in the next
section (Set D), page 18.
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HSINIF TRATS
C1) Balancing exer cises
1. Try and keep this position (elbow of the bad arm bent (90 °) and upper
arm vertical), as you let go with the other hand
2. Balance the arm in this position, using your muscles
3. Sway your elbow gently up and down 
4. Rest the shoulder muscles by holding the bad arm with your other
hand again 
5. Aim to repeat this balancing, swaying movement 10 times and build it
up to do 3 sets (i.e. 30 repetitions in total)
If this arm position is painful, try with your hand nearer the opposite ear!
Try and find a position/angle which does not increase the pain.
b)a)
rest balance sway balance rest
START FINISH
6. Progress this exercise by 
a) straightening your arm and moving your arm in small circles
b) tr ying the swaying movement with your elbow straight
APPENDIX 10
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C2) Controlling your arm moving 
1. Get into the start position (see above), let go with good arm 
2. Move the elbow so you are trying to reach up overhead, towards the
pillow 
3. You may only be able to move a small amount to begin with 
4. Keep the pain below 4 
5. Allow your arm to straighten as it moves overhead 
6. You may need to experiment with your elbow or hand in different
positions to find the ‘painless route’ or ‘best route’ for YOU to get
your arm overhead. There is not a right or wrong way. If you find a
way to get your arm up overhead - do that! 
7. Then return your arm back to the vertical start position with elbow
bent or straight 
8. Aim to repeat this 10 times and build it up to do 3 sets 
(i.e.30 repetitions in total) 
9. Progress this exercise by 
a) Gradually lowering your arm, with elbow bent, back down towards
your side 
b) Eventually you may be able to touch the folded towel with your
elbow and stretch up overhead again
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Note: If it is painful to lower your arm towards the folded towel, try this
trick. If possible, place the hand of your good arm, under the elbow or
grip your wrist. When you start to lower your arm, resist the movement
with your good arm so that you are pushing down against the good
arm, rather than just lowering. If this helps, continue to do the exercise
using this trick. Over time you may find that you can reduce the
resistance and eventually you can imagine you are pushing down against
something.  
HSINIF TRATS
START FINISH
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C3) Controlling your arm moving with a weight 
1. If exercise C2 becomes easy, progress it by holding a weight in your
hand 
2. Choose a weight that you can control (e.g. start with 100g or 1lb) 
3. Gradually increase the weight, but always keep the pain less than 4 
4. You may be able to build this to 1.5 kg (3lbs 5oz).
Suitable things to use for weights include 0.5 litre plastic water bottles
(with different amounts of water in), sealed bags of rice etc. 
n.b. 0.5 litres = 500gms/1lb 2oz.
Small hand-held weights can be bought from sports shops and retail
outlets.
Please be careful and make sure that you use something that you can
grip safely. 
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SET D STANDING & SITTING EXERCISES
These two exer cises are similar . Try them both and choose which you
prefer or find easier to do in your daily routine. It will also be fine to do
both. 
D1) Regaining arm movement while standing 
You will need a 
a) ‘blank ’ wall or back of a door that you can stand close to. Ideally it
needs to have a smooth surface 
b) drying-up cloth or small towel – something slippery or which will slide 
1. Stand facing the wall/back of the door 
2. Using your bad side take a cloth/towel and place it against the
wall/door 
3. Now slide your arm up the wall supporting it with your other hand 
4. Bend your knees a little and then straighten them as you HELP the
bad arm slide up the wall with the good one 
5. Stretch up as high as you comfortably can
6. Then slide the hands down 
7. Keep the hand in contact with the wall all the time 
8. Give as much help as is needed to make the
movement seem smooth and relatively easy. Do
NOT struggle 
9. If it is painful lowering your arm, try resisting the
movement  so that you are PUSHING down against
the pressure of the other arm. If this reduces the
pain continue doing this. Over a period of weeks
you may find that you can gradually reduce the
amount of resistance you are giving 
10. Repeat 10 times and build it up to do 3 sets 
(i.e. 30 repetitions in total) 
HSINIF TRATS
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11. Progress this exercise by 
a) Reducing the help given by your good arm 
b) Eventually try and slide your arm up and down the wall by itself 
c) Lifting your hand off the wall when the arm is overhead 
START FINISH
START FINISH
b) b) b) b) b)
D2) Regaining arm movement while sitting (or standing) 
You can sit or stand for these exercises. (If you stand make sure you do
not ‘cheat’ too much by leaning back or over-arching your back.) If you
do these exercises sitting down, you will need a firm chair (kitchen type).
If you get low back pain, or feel unsteady on
your feet, we suggest that you do these
exercises sitting down. 
1. Support the elbow or wrist of your bad
arm with the good 
2. Start with your elbows bent and then
stretch your arms overhead 
3. Help support the weight of the bad arm
as you lift 
4. Lower your arm bringing your elbow into
your side
5. If able, gradually reduce the amount of
help (on the way up) you are giving with
the other arm 
6. Try and ‘find the painless route’ with
your elbow or hand at slightly different
angles 
7. You are aiming to move the bad arm up
and down without needing both arms 
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8. Then build the repetitions to 10 times, 
3 sets 
9. ‘Tricks ’ to try:
lifting the elbow first then straightening
the arm
doing the movement fast (almost like
you are throwing your elbow forwards
and up).
If it is painful lowering your arm, try
resisting the movement so that you are
PUSHING down. If this reduces the pain
continue doing this. Over a period of
weeks you may find that you can
gradually reduce the amount of
resistance you are giving 
10. To  progress this exercise 
a) Add a small weight and continue the
exercise 
b) You may find there is a point beyond
which you cannot increase the weight.
Stop when you get to this stage. 
Using your arm for daily activities
We  hope that this programme will have eased the pain and improved
movement and strength in your shoulder . Use your arm for daily tasks
but avoid things that ‘stir-up ’ your pain. You may still have several
restrictions and may need to continue to modify your lifestyle. However
this result may be the best you can achieve. You have taught your
‘over coat ’ muscles to compensate to the best of their ability . You may
find that you do not need to keep doing the exer cises. If you have found
them helpful, keep this information  in a safe place for future use.
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Appendix 11 Original trial protocol
UKUFF STUDY 
The Clinical and cost- effectiveness of surgical (arthroscopic or open) 
versus Rest then Exercise management for tears of the rotator cuff. 
PROTOCOL 
A UK Collaborative Study funded by the 
NHS HTA Programme 
Version 2 08 September 2008 1 ISRCTN97804283 
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PROTOCOL SUMMARY 
AIM  
To assess the clinical and cost effectiveness of three forms of management of rotator cuff 
tears – arthroscopic surgery, open surgery and a non-surgical/conservative treatment. 
 
DESIGN  
Multi-centred, parallel group, randomised control trial 
 
PATIENT ELIGIBILITY  
Full thickness, degenerative rotator cuff tear 
Tear diagnosed by MRI or Ultrasound scan 
Tear suitable for surgical repair 
≥50 years old with the ability to consent 
 
RECRUITMENT  
The eligibility of the patients will be assessed by the consultant orthopaedic surgeon, with 
full consent being obtained either locally by a research nurse or remotely by the study office 
in Oxford. The aim would be to recruit over 600 patients from 70 centres throughout the 
United Kingdom. 
 
INTERVENTIONS  
Open surgery 
Arthroscopic surgery 
Rest then Exercise Programme 
 
OUTCOME ASSESSMENT 
Telephone questionnaire at 2 and 8 weeks post treatment 
Postal questionnaire at 8, 12 and 24 months post randomisation 
MRI scan at 12 months post surgery (for those randomised to surgical arm only)  
 
ORGANISATION  
Local: by Consultant Orthopaedic Surgeon 
Central: by Study Office in Oxford (clinical co-ordination and health economic evaluation) 
and Study Office in Aberdeen (data entry and statistical analysis) 
Overall: by the UKUFF Management Group and overseen by the Trial Steering Committee 
and the Data Monitoring Committee 
 
FUNDING NHS Health Technology Assessment Programme 
Start date: July 2007 
Planned finish date: June 2012 
Planned reporting date: July 2012 
 
UKUFF PERSONNEL 
Grant Holders 
Andrew Carr, Raymond Fitzpatrick, Alastair Gray, Jill Dawson, John Norrie, Marion 
Campbell, Craig Ramsay, Jonathan Rees and Jane Moser 
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UKUFF Management Group 
Andrew Carr, Raymond Fitzpatrick, Alastair Gray, Jill Dawson, John Norrie, Marion 
Campbell, Craig Ramsay, Jonathan Rees, Jane Moser, Alison McDonald, Gladys 
McPherson, Jonathan Cook, Cushla Cooper and Suzanne Breeman 
 
Trial Steering Committee Independent Members 
Chair Jeremy Fairbank, Professor of Orthopaedic Surgery, Oxford 
Others Jo Gibson, Physiotherapist, Liverpool 
Dair Farrar-Hockley, patient representative, Oxford 
 
DataMonitoring Committee Members 
Chair Roger Emery, Reader in Orthopaedic Surgery, London 
Others Jeremy Lewis, Reader in Physiotherapy, London 
Richard Morris, Senior Lecturer in Medical Statistics, London 
 
UKUFF Study Team in Oxford 
Andrew Carr, Raymond Fitzpatrick, Alastair Gray, Jill Dawson, Jonathan Rees, Jane 
Moser, Cushla Cooper and Claire Pumfrey 
 
UKUFF Study Team in Aberdeen 
John Norrie, Marion Campbell, Craig Ramsay, Alison McDonald, Gladys McPherson, 
Jonathan Cook, Suzanne Breeman and Margaret MacNeil 
 
Other Information 
International Standard Randomised 
Controlled Trial Number (ISRCTN) ISRCTN97804283 
REC Reference Number 07/Q1606/49 
REC Version Number Version 1, April 2008 
HTA Project Number 05/47/02 
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The clinical and cost-effectiveness of surgical (arthroscopic or open) 
versus Rest then Exercise management for tears of the rotator cuff 
This protocol describes a major multi-centre UK trial to assess the clinical and cost 
effectiveness of arthroscopic surgery, open surgery and a Rest then Exercise program in the 
management of rotator cuff tears. For the surgical arms the surgeons will undertake their 
usual and preferred surgical techniques while the conservative management arm will 
comprise of a month of rest and then up to 12 weeks of specialised shoulder exercises. This 
conservative programme has been designed specifically for the trial with the help of 
consumers, physiotherapists and shoulder surgeons. 
 
The eligibility of the patient will be assessed by the local consultant orthopaedic surgeon, 
with consent being obtained either locally by a research nurse or remotely by the study office 
in Oxford. Only when the consent form and the baseline questionnaire are returned will the 
participant enter the trial and be randomised to one of the three management arms. The 
patients will continue to be followed up at 2 and 8 weeks post treatment and 8, 12, and 24 
months post randomisation. 
 
1. BACKGROUND OF ROTATOR CUFF TEARS AND TREATMENT 
In 2000, an assessment of the prevalence and incidence of consultations for shoulder 
problems in UK primary care (based on a three year longitudinal study of over 650,000 
patients aged 18 and over) estimated the annual prevalence to be 2.4%, with the rate 
increasing linearly with age1. In addition, it is estimated that disorders of the rotator cuff 
account for between 30 and 70% of the shoulder pain cases that are reported2,3. 
 
1.1 The problem 
The clinical evidence available, regarding both the natural history and management of 
rotator cuff tears, is limited and conflicting4,5,6,7,8,9,10,11. Most reports are small scale, 
(<50 cases), single centre, retrospective cohort studies. 
 
In one recent report, the surgical management of rotator cuff tears was reviewed by Dunn et 
al12. They surveyed members of the American Academy of Orthopaedic Surgeons (AAOS) 
and found there to be considerable variation in their surgical decision making. This included 
the type of surgery, the surgical techniques (for example, use of anchors, and type of suture) 
and also the type and duration of conservative treatment (including cortisone injections, 
physiotherapy, rest, advice, and analgesia and home exercises). They also found that higher 
volume surgeons were generally less enthusiastic about conservative care. 
 
1.2 Treatment for rotator cuff tears 
Rotator cuff tears can be treated both surgically (arthroscopic and open) and nonsurgically 
(for example by injection and exercises). In the UK there is wide variation in the treatment 
practice for rotator cuff tears and it is unclear which approach provides the best results for the 
patient. 
 
1.2.1 Treatment by surgery 
A rotator cuff repair operation aims to re-attach the tendons to the bone. The repair involves 
sewing the torn tendon into a groove on the bone, releasing a ligament and excising a 
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prominence on the bone (sub-acromial decompression) to give the repaired muscle more 
space in which to move. 
 
In general three approaches are available for surgical repair. These include: 
(a) Open   
Open surgery involves the rotator cuff being repaired under direct vision (through 
an incision in the skin). During this procedure the deltoid muscle in the shoulder is 
detached from the bone. 
(b) Mini-open  
Mini-open surgery is an arthroscopically assisted repair. The sub-acromial 
decompression is performed arthrscopically and the repair is performed under 
direct vision (through a longer incision in the skin). During this procedure the 
deltoid muscle is split but not detached from the bone. 
(c) Arthroscopic 
Arthroscopic surgery involves both the sub-acromial decompression and the repair 
being performed through arthroscopic portals inserted into the shoulder. 
 
For the purposes of the UKUFF trial, the open and mini-open surgical techniques are 
classified together as open surgery. 
 
1.2.1.1 Arthroscopic v open surgery 
Proponents of arthroscopic rotator cuff surgery suggest that the procedure may have 
advantages over standard open procedures in terms of less trauma to shoulder muscles 
(smaller incisions and theoretically less soft tissue damage), less post-operative patient 
discomfort together with decreased morbidity and early return of movement. The success of 
the repair, however, depends on the ability of the surgeon to achieve a secure attachment of 
tendon to bone. This may be more easily and reliably achieved by open surgery. Other 
potential disadvantages of the arthroscopic approach include increased technical difficulty 
and longer time in theatre. Only a few, small, randomized controlled trials directly compare 
procedures and, therefore, there is a need to compare the outcome of the two surgical 
techniques13. 
 
1.2.2 Non-surgical treatment 
In 2007 a systematic review was conducted by Ainsworth and Lewis14 to review the  
evidence for the effectiveness of therapeutic exercises for the treatment of full thickness tears 
of the rotator cuff. They concluded that there was some evidence to support the use of 
exercise in the management of full thickness rotator cuff tears but that there was a definite 
need for a well planned randomised controlled trial to investigate this further. 
 
2. STUDY DESIGN 
2.1 Aim 
The aim of this study is to assess the clinical and cost effectiveness of arthroscopic 
surgery, open surgery and a Rest then Exercise program in the management of rotator 
cuff tears. There are two complementary components: 
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A  A parallel group randomised controlled comparison of three forms of  management of 
Rotator Cuff injuries (arthroscopic surgery, open surgery, and Rest then Exercise 
management), to assess their relative clinical effectiveness. 
 
B  An economic evaluation of these three forms of treatment to compare the cost 
effectiveness of the three management policies, to identify the most efficient 
provision of future care, and to describe the resource impact that various policies for 
rotator cuff repair would have on the NHS. 
 
2.2 Design 
A detailed survey of 126 surgeons from the British Elbow & Shoulder Society (BESS), 
carried out in preparation for this study, showed that the majority of surgeons practice only 
open surgery for rotator cuff repairs. A number of surgeons did indicate a willingness to 
randomise between arthroscopic and open surgery although the majority showed no equipoise 
for the two different techniques. Reflecting this lack of individual uncertainty around certain 
comparisons, randomisation will be organised within three strata depending on the surgeons’ 
preparedness to randomise. The three strata are: 
 
StratumA  arthroscopic surgery versus open surgery versus Rest then Exercise 
StratumB  arthroscopic surgery versus Rest then Exercise 
StratumC  open surgery versus Rest then Exercise  
 
3. TRIAL RECRUITMENT 
3.1 Surgeons eligibility 
The study will require a ‘minimum level of expertise’ for the types of surgery undertaken. 
For both surgical techniques only consultant orthopaedic surgeons with a minimum of two 
years experience in consultant practice can participate. For those surgeons performing 
arthroscopic surgery, only those who have been trained to the levels defined by the education 
committee of BESS will be eligible. As such training standards do not exist for open surgery, 
only those who perform a minimum of 5 cases per year will be considered. The participating 
surgeons will represent a crosssection of high, medium and low volume practitioners 
undertaking both arthroscopic and open surgery. 
 
3.2 Patient eligibility 
3.2.1 Inclusion criteria 
The patient must satisfy all the following criteria to be eligible for the study: 
· Aged over 50 years 
· Suffer from a degenerative rotator cuff tear 
· Have a full thickness rotator cuff tear 
· Rotator cuff tear diagnosed using MRI or Ultrasound scan 
· Patient able to consent 
 
3.2.2 Exclusion criteria 
The patient may not enter the study if ANY of the following apply: 
· Previous surgery on affected shoulder 
· Dual shoulder pathology 
· Significant problems in the other shoulder 
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· Rheumatoid arthritis/Systemic disease 
· Significant osteoarthritis problems 
· Significant neck problems 
· Cognitive impairment or language issues 
· Unable to undergo an MRI scan for any reason 
 
Although there is no formal age limit, it is expected patients aged 85 years and over might not 
be eligible to participate. 
 
Patients are free to withdraw at any time without consequence to the health care they receive. 
 
3.3 Recruitment 
Patients attending out-patient clinics with a rotator cuff tear diagnosed using either an MRI 
scan or an ultrasound scan, which is deemed suitable for surgical repair, will be approached. 
The patient must also have agreed to be placed on the NHS waiting list for surgery. 
 
3.3.1 Remote recruitment 
In most of the clinical centres, recruitment of the participants will be a two-step process. The 
patient’s eligibility will be assessed by the local consultant orthopaedic surgeon who will 
introduce the trial to the patient using the prompt sheet and complete an eligibility check-list 
(Appendix I). If the patient is interested then the surgeon will provide them with a copy of the 
Patient Information Sheet (PIS Appendix I), which summarises what the study involves and 
answer any questions they may have. 
 
If the patient is willing to enter the trial then the initial consent form (Appendix I) will be 
signed, which allows the patients details to be forwarded to the study office in Oxford. The 
office will then issue an invitation letter (Appendix II), the full Patient Information Sheet 
(Appendix I), a full consent form (Appendix I), a baseline questionnaire (Appendix IV) and a 
pre-paid return envelope to the participant by post, encouraging them to contact the office or 
their surgeon if they have any further questions or concerns. Patients who have not returned 
their questionnaire and consent form within a week will be telephoned by a member of the 
UKUFF team in Oxford. This contact will allow the patient to ask questions about the study 
and allow the team to assess if the patient is still willing to participate. When the full consent 
form and baseline questionnaire have been returned to the Oxford office the patient will then 
officially enter the trial and be randomised to one of the management programmes. A copy of 
the signed consent form will be returned to the patient. It is anticipated that some surgeons 
will have an extended scope practitioner or a research nurse working with them to help with 
this initial consenting process. Under these circumstances the participants may receive the 
invitation letter, the full Patient Information Sheet, a full consent form, a baseline 
questionnaire and a pre-paid return envelope from the clinical centre to return to the study 
office in Oxford. 
 
3.3.2 Local recruitment 
At some of our clinical centres a research nurse is available to complete the full consent 
process. The eligibility of the patient will initially be assessed by the local consultant 
orthopaedic surgeon who will introduce the trial to the patient using the prompt sheet and 
complete an eligibility check-list. If the patient is interested a research nurse will provide 
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them with a copy of the Patient Information sheet, which summarises what the study involves 
and answer any questions they may have. 
 
The research nurse will organise a time for the patient to come back in to the clinic to sign the 
full consent form and complete the patient assessment form. The patient will also receive a 
baseline questionnaire to complete at home and return to the study office in Oxford. When 
these details have been returned to the study office in Oxford the patient will officially enter 
the trial and be randomised to one of the management programmes. A copy of the signed 
consent form will be returned to the patient. 
 
3.4 Randomisation procedures 
When the full consent form and the baseline questionnaire have been received by the study 
office in Oxford the participant will be randomised to one of the management programmes. 
Randomisation will be by computer allocation using the service provided by the Health 
Services Research Unit, University of Aberdeen. Allocation will be stratified by the surgical 
technique performed by the surgeon (open and/or arthroscopic) and minimised using centre, 
age and size of tear. After randomisation the participant is considered irrevocably part of the 
trial for the purpose of the research, irrespective of what occurs subsequently. 
 
3.4.1 Randomisation to surgical arm 
The study office in Oxford will send an allocation letter to the participant (Appendix II), 
detailing the surgical procedure they have been randomised too, along with the Post 
Operation Guideline Booklet (Appendix II) (unless instructed otherwise by the local 
consultant surgeon). The consultant surgeon and the participants GP (Appendix II) will also 
receive letters outlining which surgical procedure their patient has been randomised too. It is 
expected that the intervention will be undertaken within four months of randomisation. 
 
The participating surgeon will be expected to perform the type of surgery that the patient has 
been randomised to. Details of the surgical technique used (including method of repair and 
theatre equipment used e.g. types of suture) will be recorded, as well as the size of the tear, 
the appearance of the tendons involved, the ease of repair and the completeness of the repair 
(Appendix IV). If circumstances dictate that the allocated surgical technique can not be 
carried out then an alternative procedure should be conducted, in accordance with the 
UKUFF intention to treat principle. The surgeon is also asked to contact the study office if 
their patient is unwilling or unable to have the operation on the arranged date. 
 
3.4.2 Randomisation to conservative arm 
The study office in Oxford will send an allocation letter to the participant along with an 
information pack containing a self-help CD, self-help booklet and a sling (Appendix II). The 
participants will be asked if they have access to a DVD player or computer, although the 
information contained on the CD is identical to the information in the booklet. To ensure the 
participants receive the information pack, a reply slip will be enclosed with the pack asking 
the participants to check the contents and then return the slip to the study office in Oxford. 
The consultant surgeon and the participants GP will also receive letters outlining that their 
patient has been randomised to the conservative management programme (Appendix II). 
All participants randomised to the conservative arm will receive the same information and 
advice. If they require further information about non-surgical care they will have access to a 
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telephone free-call help-line where clinical staff and/or the research physiotherapist will be 
available to answer questions and provide advice. The patients GPs will also be asked to 
inform the study office if the patient consults them regarding any physiotherapy treatments. 
This information is important as attending a physiotherapy session may alter the outcomes of 
the programme and so all sessions need to be documented. 
 
The Rest then Exercise participants will be placed on the NHS waiting list for surgery at the 
same time as the surgical arm participants. Due to the length of most of the Trust’s NHS 
waiting lists, they should be able to complete the Rest then Exercise programme before they 
would be due for surgery. However, it is anticipated that a few participants may have their 
date of surgery delayed while they complete the programme, although this is not anticipated 
to be a regular occurrence. Surgeons are asked to contact the study office if their patients 
decline surgery after the completion of the Rest then Exercise Programme. 
 
4. DATA COLLECTION AND PROCESSING 
Outcome assessments are primarily from patient based questionnaires and the 12 
month post surgeryMRI scan. 
 
4.1 Questionnaires 
A combination of the Oxford Shoulder Score (OSS), the shoulder pain and disability index 
(SPADI), the mental health inventory (MHI-5) and the EQ-5D will be used to assess 
functional outcome and patient quality of life. These will assess a range of symptoms often 
experienced with rotator cuff tears e.g. pain, weakness and a loss of function. Outcome 
assessment is conducted by participant self-completion questionnaires and as such, 
interviewer bias and clinical rater bias is avoided. This form of outcome measurement has 
consistently performed well in comparison to clinician based assessments and general health 
status measures. All participants, including those who have withdrawn from their allocated 
intervention but who still wish to be involved in the study, will be followed up, with analysis 
based on the intention to treat principle. 
 
Participants will receive questionnaires at the following time points (Appendix IV): 
• Baseline questionnaire – completed before randomisation 
• 2 and 8 weeks post treatment – questionnaire completed over the phone and includes a 
conservative programme compliance questionnaire if applicable 
• 8, 12 and 24 months post randomisation 
 
The baseline, 12 and 24 month post randomisation questionnaires will also incorporate a cost-
effectiveness analysis. Questions relating to information on primary care consultations, other 
consultations, out-of-pocket costs and work-impact of the intervention received will be 
included. 
 
The study office in Aberdeen will contact participants whose questionnaires have not been 
returned. In the first instance this will be through a reminder letter by post or email, 
depending on the participant’s preference (Appendix III). If the questionnaire is still not 
returned by the specified time-frame, the study office in Aberdeen will telephone the 
participant and address any administrative issues that may have arisen, such as change of 
address, loss of questionnaire. If any clinical issues are identified the study office in Oxford 
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will contact the participant, if appropriate, and address these issues. The time period allocated 
to the follow-up checks will depend on which outcome assessment it relates to. 
 
4.2 MRI scan 
A number of authors have reported high rates of re-rupture of the rotator cuff tear (20-54%) 
after surgery, with some reporting a significant correlation between re-rupture and poor 
outcome15. In addition, MRI scanning has been shown to have high sensitivity and 
specificity (85-95%) in the detection of full thickness tears16. For these reasons, participants 
randomised to surgery will be asked to have an MRI scan at 12 months post operation to 
assess the state of the rotator cuff repair. These will take place locally and will be arranged by 
the study office in Oxford, at a time agreed to by the Trust and the participant. The MRI 
scans will be collected centrally and read by an independent consultant radiologist who is 
unaware of the type of surgery that was performed. Any re-tears will not be reported to the 
participating surgeons, so as not to deviate from their normal practise. However, if patients 
represent to surgeons with symptoms of a re-tear, the surgeon may contact the UKUFF office 
in Oxford to ask for the MRI scan results. Incidental abnormalities will be routinely reported 
to the 
surgeon. 
 
5. ANALYSIS 
Statistical analyses will be based on all people randomised, irrespective of subsequent 
compliance with the randomised intervention. The principal comparisons will be: 
 
i. all those allocated arthroscopic surgery versus all those allocated rest and exercise 
(Strata A & B) 
ii. all those allocated open surgery versus all those allocated rest and exercise (Strata A 
& C) 
iii. all those allocated open versus all those allocated arthroscopy surgery (Strata A, B & 
C) 
 
5.1 Measure of outcome 
The primary outcome measure is: 
• Oxford Shoulder Score at 24 months after randomisation 
 
The primary measure of cost effectiveness is: 
• Incremental cost per quality-adjusted life years 
 
Secondary outcome measures include: 
• Oxford Shoulder Score at 12 months after randomisation 
• Eq-5d at 12, 24 months after randomisation 
• MHI-5 at 12, 24 months after randomisation 
• Shoulder pain and disability index (SPADI) at 12, 24 months after randomisation 
• Participant’s pleasure with shoulder symptoms at 12, 24 months after randomisation 
• Participant’s view of state of shoulder at 12, 24 months after randomisation 
• Surgical complications (intra and post-operative) at 12, 24 months after randomisation 
• Economic outcomes 
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The way in which this data will be analysed is set out in Appendix V (Dummy Tabulations). 
5.2 Planned subgroup analyses 
(i) Size of tear (small versus medium/large); 
(ii) Age <65 or ³65; 
 
Stricter levels of statistical significance (2p<0.01) will be sought, reflecting the exploratory 
nature of these subgroup analyses. 
 
5.3 Statistical analysis 
Reflecting the possible clustering in the data, the outcomes will be compared using multilevel 
models, with adjustment for minimisation variables and participant baseline values. Statistical 
significance will be at the 2.5% level with corresponding confidence intervals will be 
derived. All participants will remain in their allocated group for analysis (intention to treat). 
Comparisons (i) and (ii) will be based upon the respective direct randomised evidence only. 
For comparison (iii), a meta analysis will be used to combine the results from the direct 
comparison (using stratum A) and an indirect comparison (using strata B and C). A 
secondary analysis will investigate the impact of surgical expertise level (learning curve 
effects)17. All study analyses will be according to a statistical analysis plan that will be 
agreed in advance by the Trial Steering Committee. A single main analysis will be performed 
at the end of the trial when all follow up has been completed. An independent Data 
Monitoring Committee (DMC) will meet early in the trial to agree its terms of reference and 
other procedures and will review confidential interim analyses of accumulating data at least 
annually as directed. 
 
5.4 Economic evaluation 
A cost-effectiveness analysis will be performed. A simple patient cost-related questionnaire 
will be sent out at baseline and at 12 and 24 months post randomisation, to obtain information 
on primary care consultations, other consultations, out-ofpocket costs, work-impact of the 
intervention received and return to work. Unit costs will come from national sources and 
participating hospitals. The patient questionnaire will also be used to administer the EQ-5D, 
which will also be obtained at baseline. The main health economic outcome will be within-
trial and extrapolated quality adjusted life-years, estimated using the EQ-5D. 
 
Incremental cost-effectiveness will be calculated as the net cost per quality-adjusted life year 
gained, for arthroscopic surgery versus Rest then Exercise, open surgery versus Rest then 
Exercise, either surgical versus Rest then Exercise and arthroscopic surgery versus open 
surgery. Power calculations (see following section) are based on clinical rather than cost-
effectiveness outcomes, which will be estimated rather than used in hypothesis testing. Cost-
effectiveness ratios and net-benefit statistics will be calculated. We will report within-trial 
cost-effectiveness; if the trial produces sufficient evidence to plausibly model future quality 
of life or costs (e.g. based on projected failure rates) we will also extrapolate long-term cost-
effectiveness beyond the trial period. 
 
An important component of this trial will be assessment of cost. Therefore, an accurate record 
of procedures at each of the proposed centres is essential. To evaluate costs of each type of 
surgery, information from the operating theatres will be collected. Theatre managers will be 
contacted and visited at each site. Resources used, equipment costs and standard procedures 
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for rotator cuff repairs will be looked at. Per case information will also be analysed. A 
checklist of equipment, consumables, implants, time and staff utilized during each case will 
be completed by theatre staff. Information from theatres will be collected by the Oxford 
UKUFF office and used in a cost comparison between the arthroscopic and open surgery. 
 
6. SAMPLE SIZE AND FEASIBILITY 
6.1 Sample size sought 
Based on our experience of using and developing the OSS score in a variety of settings, a 3 
point difference (0.33 of a SD) would be deemed a clinically important change. Using the 
informal survey of surgeons’ preferences, we aim to recruit at least 8 surgeons to stratum A, 
10 to stratum B and 40 to stratum C. From this we have assumed the following numbers of 
participants in each strata: Stratum A – 70 participants in each group; stratum B - 120 
arthroscopic surgery : 120 Rest then Exercise management and stratum C - 120 open surgery 
: 120 Rest then Exercise management (see Table 1) giving 690 participants in total. 
 
Table 1 – Proposed number of randomised participants 
 Arthroscopic 
surgery 
 
Open surgery Rest then Exercise 
 
Stratum A 70 70 70 
 
StratumB 120 None 120 
 
StratumC None 120 120 
 
 
For comparison (i), results from the arthroscopic surgery and Rest then Exercise groups in 
strata A and B can be combined without introducing any systematic bias (resulting in 190 
arthroscopic:190 Rest then Exercise). Such a study has greater than 80% power at 2.5% 
significance level (to account for multiple testing) to detect a difference in mean OSS of 0.33 
of a SD, using a two sample two-sided t-test. With an SD of about 9, this would translate to 
having adequate power to be able to detect a difference in mean OSS score between two 
groups of about 3 units.  
 
For comparison (ii), the same power (>80%) and detectable difference (0.33 of a SD) as 
given above are obtained by combining the open surgery and Rest then Exercise management 
groups in strata A and C (n=190 in each arm).  
 
For comparison (iii), due to the small numbers of surgeons willing to randomise to this 
comparison we propose to use a mixture of direct (randomised) and indirect (non 
randomised) comparisons. The direct comparison is in stratum A where 70 arthroscopic: 70 
open surgeries have 80% power at 2.5% significance to detect a difference of 0.5 of a SD. An 
indirect comparison using only the results from strata B and C would have 80% power (at 
2.5% significance level) to detect a difference of 0.55SD18. Combining the direct and 
indirect comparison estimate (using recognised meta analysis techniques) gives 
approximately 80% power at 2.5% significance to detect a difference of 0.38SD. 
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Attrition is expected to be low (10%) as are the effects of clustering of outcomes within 
surgeon19,20 (intra cluster correlation less than 0.03). Whilst we do not have a direct 
estimate from a shoulder trial, other orthopaedic datasets available to our team (e.g. KAT) 
support this low ICC estimate. Both these factors require the sample size to be inflated; 
however, the primary analysis adjusts for baseline OSS score which conversely allows the 
sample size to be decreased by a factor of (1-correlation squared)21. Our previous studies 
(section 3.2) showed that the correlation in the OSS score pre surgery to 6 months post 
surgery in patients similar to potential trial participants was 0.57. Assuming a conservative 
correlation of 0.5 implies that the sample size could be reduced by 25% and still maintains 
the same power. Therefore, a study with 690 participants will still have sufficient power to 
detect a clinically 
important change in each comparison assuming attrition and clustering accounts for 
approximately 25% of variation in the data. 
 
6.2 Recruitment rate 
Trial centres will be recruited in a staggered way, bringing on 3 centres in each of months 4 
and 5, and then 6 or 7 centres per month during months 6 through 13, making a total of 58 
centres (8 in menu A:O:R; 10 in menu A:R, and 40 in menu O:R). Steady state will be 
achieved by month 11 for the two menus involving arthroscopy, and by month 13 for the O:R 
option. We anticipate having in aggregate 188 centre months for A:O:R (steady state monthly 
rate of 9 to achieve 210 participants), 233 centre months for A:R (steady state monthly rate 
10 to achieve 240 participants, and 856 centre months for O:R (steady state monthly rate 11 
to achieve 240 participants), or 690 randomised participants in total. The Hospital Episode 
Statistics data for 2004/2005 indicates that 1295 rotator cuff repairs took place in NHS 
hospitals in England alone giving a mean of 15 per trust. With fifty eight centres recruited 
there is a potential recruitment rate in the order of 75 patients per month. In steady state we 
will need to be recruiting 30 patients per month, or 40% of the available throughput. 
Expected recruitment milestones will be 16 (month 6); 142 (month 12); 320 (month 18); 507 
(month 24) and 690 (month 30).  
 
Participant recruitment 
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We anticipate that the trial will require the participation of 58 centres. If the recruitment of 
patients is failing to meet targets and cannot be increased at participating centres then we 
would increase the number of centres in the trial. 
7. ORGANISATION 
7.1 In summary 
A detailed plan and timetable of study organisation is given in the Gantt chart (Appendix VI). 
In summary, it is as follows – 1-4 months: set up office, assemble team, obtain ethical 
approval and establish first centre; 5-13 months: establish study in all centres; 4-30 months: 
identify and recruit participants into the study; 12-38 months: 8 month post-randomisation 
follow-up complete; 16-42 months: 12 month post-randomisation follow-up complete, 
including one year post-operative MRI scan; 28-54 months: 24 month post-randomisation 
follow-up complete and database closure; 54-60 months: complete data collection, analysis 
and dissemination. 
 
7.2 Local organisation in centres 
The trial is designed to limit the extra work required by the collaborating clinicians to tasks 
that only they can do. The research teams in Oxford and Aberdeen will facilitate the trail 
remotely and initiate site visits as required. 
 
7.2.1 Lead consultant surgeon 
Each collaborating centre will identify a lead consultant surgeon who will be the point of 
contact for that centre. The responsibility of this person will be to: 
• establish the study locally (e.g. facilitate local research ethics committee approval, 
liaise with the local R&D manager and inform all relevant local staff about the study) 
• take responsibility for the conduct of the research locally 
• notify the study office in Oxford of any unexpected clinical events which might be 
related to study participation 
• provide support and supervision for the local research nurse if applicable 
• represent the centre at UKUFF collaborators meetings 
• initiating recruitment of participants 
• maintaining communication with the study office in Oxford regarding allocated 
surgical treatment, date of operation, discharge instructions and surgery withdrawal 
•  
7.2.2 Research nurse (if applicable) 
Some centres will identify a research nurse to organise the recruitment of the participants. 
The responsibility of this person will be to: 
• keep regular contact with the lead consultant surgeon and notify them of any problem 
or unexpected development 
• maintain regular contact with the study office 
• keep local staff informed of the progress of the study 
• assist the lead surgeon to inform the participants about the study and answer any 
questions they may have 
• obtain written consent from the participant 
• supply participant with the invitation letter, full consent form (if applicable), baseline 
questionnaires and a pre-paid envelope for their return to the study office in Oxford 
• represent the centre at collaborators meetings 
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7.3 Central organisation of the study 
Reflecting the complex nature of the trial, trial functions will be divided between the Oxford 
coordinating team and the Aberdeen coordinating team. 
 
7.3.1 Study co-ordination in Oxford 
The UKUFF study team in Oxford is divided between the Nuffield Department of 
Orthopaedic Surgery (NDOS) and the Department of Public Health and Primary Care 
(DPHPC). Both departments are a part of the University of Oxford with NDOS having very 
strong links with the Nuffield Orthopaedic Centre NHS Trust. 
 
7.3.1.1 NDOS 
The NDOS team will be responsible for all clinical aspects of the trial including; the 
recruitment and education of surgeons, recruitment of participants, the coordination of the 
Rest then Exercise Programme, daily management and troubleshooting of clinical issues from 
staff and participants in the trial and the coordination of the 12 month post operative MRI 
scans. 
 
7.3.1.2 DPHPC 
The UKUFF team in DPHPC are responsible for the design, conduct and analysis of the 
concurrent economic evaluation and outcome questionnaires. 
 
7.3.1.3 Timing of meetings 
All members of the management team in Oxford will aim to meet quarterly to review trial 
progress. NDOS members will aim to meet weekly to discuss site, surgeon and patient 
recruitment. 
 
7.3.2 Study co-ordination in Aberdeen 
The Aberdeen team are based at the Centre for Health and Randomised Trials within the 
Health Services Research Unit at the University of Aberdeen. They will be responsible for all 
data aspects of the trial including: the design and set-up of trial databases, the randomisation 
system, the management of postal participant follow-up, data management and verification 
and the conduct of final trial analysis. 
 
7.3.2.1 Timing of meetings 
The management team in Aberdeen will meet weekly and a conference call with the CI and 
trial coordinator in Oxford will occur fortnightly. 
 
7.3.3 Production of reports 
The production of all interim reports for the trial steering committee, data monitoring 
committee, and progress reports required by the funding body, sponsor and ethical 
committees will be completed in collaboration with all teams and coordinated by the trial 
managers in Oxford and Aberdeen. 
 
7.4 UKUFF Management Group 
The trial management group will oversee all aspects of the conduct and progress of the trial 
and ensure that the protocol is adhered to. They will be responsible for the daily management 
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of the trial and will meet at 6 monthly intervals to review the progress of the trial. The group 
consists of the grant holders and representatives from both the study office in Oxford and 
Aberdeen. 
 
7.5 UKUFF Steering Committee 
The study is overseen by an independent Steering Committee. The chairman is Professor 
Jeremy Fairbank, with Miss Jo Gibson and Mr Dair Farrar-Hockley acting as the other 
independent members. The study grant holders, along with Mr David Stanley, complete the 
Steering Committee. This committee will meet annually or more frequently if circumstances 
dictate. They will take responsibility for any major decisions, such as the need to close 
recruitment or more parts of the study or to change the protocol for any reason. 
 
7.6 Data and Safety monitoring 
7.6.1 UKUFF DataMonitoring Committee 
The Data Monitoring Committee is independent of the study organisers. The chairman is Mr 
Roger Emery, a Reader in Orthopaedic Surgery, along with Dr Jeremy Lewis (Reader in 
Physiotherapy) and Dr Richard Morris (Senior Lecturer in Medical Statistics). During the 
period of recruitment to the study, interim analyses will be supplied, in the strictest 
confidence, to the data monitoring committee, together with any other analyses that the 
committee may request. This may include analyses of data from other comparable trials. In 
light of these interim analyses, the Data Monitoring Committee will advise the Steering 
Committee if, in its opinion, the trial has provided both: 
a) proof beyond reasonable doubt that for all or some types of participants one 
intervention is clearly indicated in terms of clinical and cost effectiveness 
b) evidence that might reasonably be expected to influence materially the care of the 
people with rotator cuff tears by clinicians who know the results of this and 
comparable trials. 
 
The Steering Committee can then decide whether or not to modify intake to the trial. Unless 
this happens, the Steering Group, Management Group, consultant surgeons and study office 
staff (except those you supplied the confidential analyses) will remain ignorant of the interim 
results.  
 
The frequency of the interim analyses will depend on the judgement of the Chairman 
of the committee, in consultation with the Steering Committee. 
 
7.6.2 Safety concerns 
The UKUFF trial involves three interventions that are well established in clinical practise, 
although unproven for clinical and cost effectiveness. Two of these interventions are surgical 
and so inevitably there are safety concerns surrounding them. These include: 
· surgical site infection 
· frozen shoulder 
· complications relating to anaesthetic and or theatre equipment 
· uncontrolled bleeding 
 
As the techniques are standard treatments for rotator cuff tears, and because the surgeons are 
performing their usual and preferred surgical procedures, the trial participants would not be 
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put at any more risk than is normally associated with the treatment. It is anticipated that none 
of these events would be classified as a serious adverse event but we would respond 
appropriately to any notification (Appendix VII). 
 
Collaborators and participants may contact the chairman of the Steering Committee through 
the trial office in Aberdeen or Oxford about any concerns they may have about the trial. If 
concerns arise about procedures, participants or clinical or research staff (including risk to 
staff) these will be relayed to the Chairman of the Data Monitoring Committee. 
 
7.6.3 Data handling and record keeping 
All data collected and stored as a result of the study will comply with the data protection act. 
 
8. FINANCE 
The UKUFF trial is funded by the UK NHS Health Technology Assessment Programme 
(Ref: 05/47/02). The Nuffield Department of Orthopaedic Surgery in Oxford will manage the 
finances and budget.  
 
Participating sites will be asked to invoice the UKUFF study quarterly in order to receive the 
payment of £200 per randomised patient. The trial coordinator will supply each site with their 
recruitment numbers at the end of each quarter so the invoice can be raised for the correct 
amount. 
 
Participating sites will also be asked to invoice the UKUFF study quarterly in order to receive 
the payment for the required MRI scan. The cost of these scans will be negotiated with each 
site before the first scan is undertaken. This cost is entered into the Clinical Trial Agreement 
implemented between the site and the University of Oxford. 
 
9. SATELLITE STUDIES 
The funds provided by the HTA Programme are to conduct the main trial as described in this 
protocol. Nevertheless, it is recognised that the value of the UKUFF trial will be enhanced by 
smaller ancillary studies of specific aspects. Plans for such studies should, however, be 
discussed and agreed in advance with the Management Group. Details of all satellite studies 
are outlined in Appendix VIII. 
 
10. INDEMNITY 
The UKUFF study is sponsored by the University of Oxford. Indemnity and/or compensation 
for negligent harm arising specifically from an accidental injury for which the University is 
legally liable as the Research Sponsor will be covered by the University of Oxford. 
 
The University of Oxford have authority to audit the process of the UKUFF trial. Authorised 
University staff may review aspects of the trial, such as; the consenting process, data 
collection and storage. UKUFF state that a period of 10 working days notice must be given 
before these reviews occur. 
 
The NHS will owe a duty of care to those undergoing clinical treatment, with Trust 
Indemnity available through the NHS Litigation Authority Scheme. 
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11. PUBLICATION 
The success of the trial depends entirely on the wholehearted collaboration of a large number 
of health care workers. For this reason, chief credit for the trial will be given, not to the 
committees or central organisers, but to all those who have wholeheartedly collaborated in 
the trial. The trials’ publication policy is described in Appendix IX. The results of the trial 
will be reported first to trial collaborators. The main report will be drafted by the UKUFF 
Management Group, and the final version will be agreed by the Trial Steering Committee 
before submission for publication, on behalf of the UKUFF collaborators. 
 
To safeguard the integrity of the main trial, reports of satellite studies will not be submitted 
for publication without prior agreement from the UKUFF Management Group. 
 
We plan to maintain interest in the study by publication of UKUFF newsletters at three 
monthly intervals for collaborators and annually for participants. The newsletters will inform 
their audience of how the study and recruitment is progressing and any relevant interim 
results. UKUFF have deemed it important to communicate with the collaborators so that 
common problems may be addressed and protocol adherence may be monitored. 
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